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Abbreviations 
 
Aa(s)      amino acid(s) 
A      adenosine 
AMPA      α-amino-3-hydroxyl-5-methyl-4-isoxazolepropionic acid 
AMPAR      α-amino-3-hydroxyl-5-methyl-4-isoxazolepropionic acid receptor 
AP      alcaline phosphatase 
APS      ammonium persulfate 
ATP       adenosine triphosphate 
bp      base pair 
BES      N,N-Bis(2-hydroxyethyl)-2-Aminoethansulfonic acid 
BSA      bovine serum albumin 
C      cytidine 
ºC      degrees Celsius 
cDNA      complementary DNA 
CIP       calf intestine phosphatase 
CNS      central nervous system 
Cont      control 
CEFPICT    Complete EDTA-free protease inhibitor cocktail tablet 
d      distilled 
Da      Dalton 
DIV      days in vitro 
DMEM      Dulbeccoʼs modified Eagleʼs medium 
DMSO      dimethylsulfoxid 
DNA      desoxyribonucleic acid 
dNTP      deoxyribonucleotide-5ʼ-triphosphate 
dsRED     red fluorescent protein from Discosoma sp. 
DTT      dithiothreitol 
E      day after embryo formation 
E.coli      Escherichia coli 
EDTA      ethylenediamine tetra acetic acid 
e.g.      exempli gratia 
ER      endoplasmic reticulum 
FCS       fetal calf serum 
g      gram 
G      guanosine  
  II 
GABA      γ-aminobutyric acid 
GABAAR    γ-aminobutyric acid receptor type A 
GBM      Gephyrin binding motif 
GFP      green fluorescent protein 
Gly      glycine 
GlyR      glycine receptor 
GlyRβ49  49  amino  acids  (from  position  378  to  426)  of  the  intracellular  loop  located 
between transmembrane domains 3 and 4 of the GlyRβ subunit 
GlyRβ78  78  amino  acids  (from  position  378  to  455)  of  the  intracellular  loop  located 
between transmembrane domains 3 and 4 of the GlyRβ subunit 
GSH      glutathione 
GST       glutathione-S-transferase 
GTP      guanosine triphosphate 
HEK      human embryonic kidney  
HPLC      high performance liquid chromatography 
h      hour 
HRP      horseradish peroxidase 
IPTG      isopropyl-β-thiogalactopyranoside  
k      kilo 
KO      knock out 
l      liter 
LB      Luria Bertani 
LGIC      ligand gated ion channel 
mAb      monoclonal antibody 
m      milli 
µ      micro 
M      molar 
MEM      minimum essential medium 
min      minute 
mRNA      messenger RNA 
MW      molecular weight 
n      nano or number  
n.s.      non significant  
NMDA      N-methyl-D-aspartic acid 
NMDAR    N-methyl-D-aspartic acid receptor 
NMJ      neuromuscular junction 
NTP      nucleoside triphosphate 
OD       optical density  
  III 
p      pico 
PAGE       polyacrylamide gel electrophoresis 
PBS      phosphate buffered saline 
PCR      polymerase chain reaction 
PFA      paraformaldehyde 
pH      potentium Hydrogenii 
PKA      protein kinase A 
PRD      proline-rich domain 
PSD      postsynaptic density 
PVDF      polyvinylidene fluoride 
rAAV      recombinant adeno-associated virus 
RNA       ribonucleic acid 
shRNA     small hairpin RNA  
rpm      revolutions per minute 
RT      room temperature 
s      second 
SBM       SH3 binding motif 
SDS      sodium dodecyl sulfate 
SDS-PAGE    SDS-polyacrylamide gel electrophoresis 
T      thymidine 
TAE      tris-acetate-EDTA buffer 
TBS      tris buffered saline 
TE      Tris-EDTA-buffer 
TEMED     N,N,Nʼ,Nʼ-tetramethylethylendiamine 
TGN      trans Golgi network 
TMD      transmembrane domain 
Tris      tris-hydroxymethyl-aminomethane 
U      unit 
UV       ultraviolet 
V      Volt 
v/v      volume per volume 
VIAAT      vesicular inhibitory amino acid transporter 
Vps      vacuolar protein sorting 
WB      western blot 
WT      wild type 
w/v      weight per volume 
 SUMMARY 
 
  1 
1  SUMMARY 
The glycine receptor (GlyR) is the major inhibitory neurotransmitter receptor in spinal cord and 
brainstem. Heteropentameric GlyRs are clustered and anchored at inhibitory postsynaptic sites 
by the binding of the large intracellular loop between transmembrane domains 3 and 4 of the 
GlyRβ subunit (GlyRβ-loop) to the cytoplasmic scaffolding protein gephyrin. GlyRs are also co-
transported with gephyrin along microtubules in the anterograde and retrograde direction due to 
the binding of gephyrin to microtubule-associated motor proteins. Additionally, GlyRs undergo 
lateral diffusion in the plasma membrane from extrasynaptic to synaptic sites and vice versa. 
Since its discovery, gephyrin has remained for many years the only binding partner interacting 
directly with the GlyRβ subunit.  
In  an  attempt  to  elucidate  further  mechanisms  involved  in  GlyR  function  and  regulation  at 
inhibitory postsynaptic sites, a proteomic screen for putative binding partners to the GlyRβ loop 
was  performed.  Three  proteins  were  identified  as  putative  interactors.  In  this  thesis,  the 
interaction between these putative binding proteins and the GlyRβ subunit was analyzed and 
characterized.  Binding  studies  with  glutathione-S-transferase  fusion  proteins  revealed  that  all 
putative  binding  proteins,  Syndapin  (Sdp),  Vacuolar  Protein  Sorting  35  (Vps35)  and 
Neurobeachin (Nbea), interact specifically with the GlyRβ loop.  
The  Sdp  family  of  proteins  are  F-BAR  and  SH3  domain  containing  proteins. 
Inmmunocytochemical experiments showed that SdpI as well as the isoforms SdpII-S and SdpII-
L  colocalize  with  the  full-length  GlyRβ  subunit  in  a  mammalian  cell  expression  system.  In 
cultured spinal cord neurons, a partial colocalization of endogenous SdpI with several excitatory 
and inhibitory synaptic markers was demonstrated. Mapping experiments using deletion mutants 
narrowed  the  SdpI  binding  site  down  to  22  amino  acids.  Peptide  competition  experiments 
confirmed the specificity of the interaction between SdpI and this sequence of the GlyRβ subunit. 
Point mutation analysis revealed a SH3-proline rich domain dependent interaction between SdpI 
and the GlyRβ subunit, respectively. In addition, binding studies in mammalian cells showed that 
both splice variants of SdpII as well as SdpI interact with the GlyR scaffolding protein gephyrin. 
Although  the  SdpI  and  gephyrin  binding  sites  do  not  overlap,  protein  competition  studies 
revealed that interaction of the E-domain of gephyrin with the GlyRβ loop interferes with SdpI 
binding. Since SdpI is a dynamin binding protein involved in vesicle endocytosis and recycling 
pathways,  a  possible  function  of  SdpI  in  the  regulation  of  GlyR  synaptic  distribution  was SUMMARY 
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investigated.  Co-immunoprecipitation  experiments  confirmed  a  SdpI-GlyR  association  in  the 
vesicle-enriched fraction of rat spinal cord tissue. Immunocytochemical studies of SdpI knock out 
mice  showed  that  the  clustering  and  distribution  of  GlyRs  in  the  brain  stem  is  unchanged. 
However, acute down-regulation of SdpI in rat spinal cord neurons by viral shRNA expression 
led to a reduction in the number and size of GlyR clusters, an effect that could be rescued upon 
shRNA-resistant SdpI overexpression. Further immunocytochemical analysis of the localization 
of gephyrin, the γ2 subunit of the type A γ-aminobutyric acid receptor (GABAARγ2 subunit) and 
the  vesicular  inhibitory  amino  acid  transporter  (VIAAT)  under  SdpI  knock-down  conditions 
showed that both the number and average size of the γ2-subunit containing GABAA receptor 
clusters were significantly reduced in spinal cord neurons. In contrast to GlyR and GABAARγ2 
immunoreactivity, the number and average size of gephyrin and VIAAT clusters were barely 
reduced  upon  SdpI  downregulation.  These  results  suggest  that  SdpI  has  a  role  in  GlyR 
trafficking that can be compensated by other syndapin isoforms or other trafficking pathways. 
Furthermore,  SdpI  might  be  required  for  the  clusters  of  GlyRs  and  γ2-subunit  containing 
GABAARs in spinal cord and brainstem.  
Vps35  is  the  core  protein  of  the  retromer  complex,  which  mediates  the  endosome  to  Golgi 
apparatus retrieval of different types of receptors in mammals and yeast. Here, protein-protein 
interaction assays revealed for the first time that Vps35 interacts directly with the GlyRβ loop as 
well as with gephyrin. The generation of specific Vps35 antibodies allowed to determine the 
distribution of this protein in the central nervous system. Immunocytochemical analyses revealed 
the presence of Vps35 in the somata and neurites of spinal cord neurons, suggesting a possible 
interaction of Vps35 with the GlyR under physiological conditions.  
Nbea is a BEACH domain containing, neuron-specific protein. Binding studies revealed a direct 
interaction between two regions of Nbea and the GlyRβ loop. Immunocytochemical experiments 
confirmed  a  somatic  and  synaptic  distribution  of  Nbea  in  primary  cultures.  In  spinal  cord 
neurons, a partial colocalization of Nbea with excitatory and inhibitory synaptic markers suggests 
a possible interaction of Nbea with the GlyR at inhibitory synaptic sites. 
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2  INTRODUCTION 
Neurons  are  cells  specialized  in  reception,  integration  and  delivery  of  information.  They 
communicate  with  other  neurons  by  two  types  of  functional  cellular  contacts:  electrical  and 
chemical  synapses.  At  electrical  synapses,  information  transfer  between  two  neurons  takes 
place though gap junctions composed of many connexons. Connexons are oligomeric integral 
membrane  protein  assemblies  that  cross  the  membranes  of  both  cells  and  connect  their 
cytoplasms. The gap junctions provide a conducting pathway by which the depolarizing current 
of  one  neuron  directly  flows  into  the  next  and,  if  this  surpasses  the  threshold,  leads  to  its 
depolarization.  Chemical  synapses  are  specialized  contact  sites  formed  between  neurons  or 
between  neurons  and  muscle  or  gland  cells.  They  are  characterized  by  membrane 
specializations,  which  contain  highly  specific  sets  of  proteins  that  allow  neurotransmission. 
Neurotransmission is the unidirectional transfer of information from a presynaptic neuron to a 
postsynaptic cell mediated by a neurotransmitter. Neurotransmitter transporters fill vesicles with 
neurotransmitters  at  the  presynaptic  terminal  of  neurons  and  in  glial  cells.  Many  different 
molecules  function  as  neurotransmitter,  e.g.  monoamines,  peptides  and  amino  acids.  In  the 
vertebrate CNS, the main neurotransmitters are glutamate, γ-aminobutyric acid (GABA), glycine 
(Gly),  dopamine,  serotonine,  histamine  and  epinephrine.  Neurotransmitter  release  into  the 
synaptic  cleft  through  fusion  of  the  neurotransmitter  containing  vesicles  with  the  plasma 
membrane  of  the  presynaptic  neuron  leads  to  the  activation  of  neurotransmitter  receptors 
localized  in  the  plasma  membrane  of  the  postsynaptic  cell.  There  are  two  classes  of 
neurotransmitter  receptors:  metabotropic  and  ionotropic  ones.  Metabotropic  neurotransmitter 
receptors  are  transmembrane  proteins  coupled  to  guanine  nucleotide-binding  proteins  (G-
proteins) and therefore named G-protein coupled receptors (GPCRs). Agonist binding to GPCRs 
activates G-proteins, which dissociate into Gα and Gβγ subunits. These subunits modulate ion 
channels or neurotransmitter receptors directly or through second messenger pathways, thereby 
inducing  a  depolarization  or  hyperpolarization  of  the  plasma  membrane.  Ionotropic 
neurotransmitter receptors are transmembrane proteins that form ion-permeable channels, and 
therefore are named ligand-gated ion channels (LGICs). Activation of a LGICs leads to an influx 
of ions into the postsynaptic neuron. The activation of excitatory LGICs leads to an influx of Na
+ 
and Ca
2+ into the neuron that depolarizes the cell and may result in an action potential. On the 
contrary,  activation  of  inhibitory  LGICs  leads  to  an  increase  in  chloride  conductance  that 
hyperpolarizes the cell, thus inhibiting neuronal firing.  INTRODUCTION 
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2.1  Inhibitory neurotransmitters in the central nervous system 
Glycine and GABA are the two major inhibitory neurotransmitters in the central nervous system. 
At mature inhibitory synapses, glycine activates glycine receptors (GlyRs) whereas at excitatory 
synapses,  glycine  is  a  co-agonist  of  glutamate  required  for  the  activation  of  N-methyl-D-
aspartate (NMDA) receptors (Kleckner and Dingledine, 1988). GABA binds to two distinct types 
of  receptors,  ligand-gated  ionotropic  type  A  GABA  (GABAA)  and  type  C  GABA  (GABAC) 
receptors and G-protein-coupled metabotropic type B GABA (GABAB) receptors (Hevers and 
Lüddens, 1998), thus mediating both fast and slow inhibition of excitability at central synapses.  
A different situation is present in neurons during neonatal stages. Due to a different chloride 
gradient, synaptically relased glycine and GABA depolarize the neuronal membrane pre- and 
perinatally. Upon further development, the switch to the mature phenotype is mediated by the 
expression of a K
+-Cl
- cotransporter (KCC) 2. This transporter is responsible for the reduction of 
the  internal  Cl
-  concentration,  thereby  shifting  the  Cl
-  equilibrium  potential  to  more  negative 
values  and  converting  the  activation  of  the  glycine  and  GABA  receptors  from  excitatory  to 
inhibitory (Tapia, 1998; Stil et al., 2009).  
2.2  Ligand-gated ion channels 
Ligand-gated ion channels (LGIC) mediate synaptic communication in the nervous system. In 
mammals, there are three families of LGICs: the Cys-loop, the glutamate and the P2X receptor 
channel families. In each case the binding of transmitter to the receptor leads to the opening of a 
pore, through which ions flow down their electrochemical gradient. Neurotransmitter receptors 
that  belong  to  the  Cys-loop  LGIC  superfamily  include  nicotinic  acetylcholine,  serotonine, 
GABAA/C and glycine receptors (GlyR). All receptors of this superfamily are composed of five 
homologous subunits (Fig. 2.1). These subunits share characteristic structural features: a large 
extracellular amino-terminal domain that harbours the agonist binding site and a Cys-loop, four 
transmembrane  domains  (listed  as  TM1-TM4),  with  the  transmembrane  domain  TM2 
contributing to the central water-filled pore, a large intracellular loop between TM3 and TM4 and 
a short extracellular C-terminal tail (Fig. 2.1.A).  INTRODUCTION 
 
  5 
 
Fig. 2.1. Structure of ligand gated ion channels. A. Membrane threading pattern common to all cysteine-loop 
receptor-subunits is charachterized by four hydrophobic transmembrane domains (TMDs), a large N-terminus, a short 
C-terminus and a large intracellular loop between TMD 3 and 4. B. Proposed structure of a LGIC. Five subunits 
assemble to form and pentameric ion channel. Transmembrane domain 2 from different LGIC subunits forms the 
channel pore (color code is the same as in A) (modified from Moss and Smart, 2001). 
 
2.3  Glycine receptors (GlyRs) 
The GlyR is a membrane-embedded protein that contains an intern Cl
- selective pore. Glycine 
binding to the N-terminal region activates and leads to the opening of the Cl
- channel, whereas 
the competitive antagonist strychnine blocks receptor activation (Young and Snyder, 1973; Betz 
and Becker, 1988).  
2.3.1  Molecular structure and diversity of GlyRs 
Five different genes (GLRA1-4 and GLRB) encode for the five subunits of the GlyR, α(1-4) and 
β. Two subunits were discovered in 1982 when the first purification of the GlyR by H. Betz and 
colleagues unveiled three distinct aminostrychnine-binding proteins of molecular masses 48, 58 
and 93 kDa. The 48 and 58 kDa proteins corresponded to the α1 and β subunits respectively 
(Pfeiffer et al., 1982). Subsequently, novel α subunits, namely α2, α3 and α4 (Grenningloh et al., 
1990; Kuhse et al., 1990; Matzenbach et al., 1994) and splice variants thereof were identified by 
homology  screening.  The  splice  variant  GlyRα1
ins  generated  by  alternative  splicing  of  the 
GlyRα1 pre-mRNA was identified in rat spinal cord, but not in other brain regions (Malosio et al. 
1991). For rat GlyRα2, two splice variants GlyRα2A and GlyRα2B, which differ by two amino INTRODUCTION 
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acid substitutions, were described (Kuhse et al., 1991). Also two splice variants of the human 
GlyRα3 subunit have been found: α3L and α3K, the latter lacking 15 amino acids in the large 
intracellular loop (Nikolic et al. 1998). Up to date, only one splice variant of GlyRα4 has been 
discovered, a zebrafish GlyRα4
ins harbouring a 15 amino acid insert in the ligand-binding domain 
(Devignot  et  al.  2003).  For  GlyRβ,  two  intronic  polymorphisms  in  the  GLRB  gene  had  been 
described previously (Milani et al. 2003). Recently, a new splice variant of the mouse GlyRβ 
subunit lacking TM1 and TM2 has been found by CM. Becker and his colleagues (Oertel et al., 
2007).  
The GlyRα1 and GlyRβ subunits share 47% homology, whereas the GlyRα subunits display > 
90% homology to each other (Grenningloh et al., 1987; Grenningloh et al., 1990). In LGICs, the 
large  intracellular  loop  between  TM3  and  TM4  transmembrane  domains  is  the  most  poorly 
conserved domain with respect to both length and aa sequence. In case of the GlyR, the splice 
variants of the α1 and the α3 subunit differ by inserts, of 8 and 15 aas, respectively, in this 
region, and the GlyRβ subunit possesses an intracellular loop of 120 aas, which is remarkably 
larger than the intracellular loop of the GlyRα1 subunit which spans only 86 acids. Thus, the 
variability in aa sequences of the TM3-4 loops in the GlyRα and GlyRβ subunits as well as their 
intracellular  localization  present  this  domain  as  a  key  mediator  of  specific  GlyR  subunit 
interactions with cytoplasmic elements.  
2.3.2  GlyR assembly 
The assembly of LGICs is a multi-step process that requires proper folding, post-translational 
modifications  and  inter-subunit  interactions  to  result  in  a  correct  quaternary  structure,  and  is 
thought to take place in the endoplasmic reticulum (ER) (Green and Millar 1995). The transport 
of new synthesized receptors to the plasma membrane depends on correct assembly of the 
subunits  with  a  defined  stoichiometry.  The  subunit  composition  of  GlyRs  was  originally 
determined by cross-linking approaches, in which the largest cross-linked product found had a 
size corresponding to five times the mean size of an individual subunit. Thus, it was concluded 
that  GlyRs  are  composed  of  five  subunits  (Langosch  et  al.,  1988).  GlyRs  exist  as 
homopentamers  and  heteropentamers.  Heterologous  expression  in  HEK293  cells  and  in 
Xenopus oocytes revealed that all GlyRα subunits are able to oligomerize and to form functional 
homopentameric receptors (Schmieden et al., 1989; Griffon et al., 1999). By co-expression of α1 
and  α2,  it  was  shown  that  the  different  GlyRα  subunits  can  also  form  heteropentameric INTRODUCTION 
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receptors  (Kuhse  et  al.,  1993).  However,  the  GlyRβ  subunit  expressed  alone  produces  no 
glycine-gated currents and requires co-expression with other GlyRα subunits to form functional 
heteromeric  GlyRs  (Bormann  et  al.,  1993;  Grenningloh  et  al.,  1990).  Homopentameric  and 
heteropentameric GlyRs composed of α subunits only can be easily detected and distinguished 
from each other by their different agonist dose-response profiles. Insensitivity to picrotoxin is a 
pharmacological hallmark of αβ heteromeric receptors. Whereas homomeric glycine receptors 
are  inhibited  by  10  µM picrotoxin,  the  glycine-gated  currents  in  cells  co-expressing  α  and  β 
subunits require much higher concentrations of the alkaloid for silencing (Pribilla et al., 1992). 
Whereas stoichiometry in heteromeric receptors formed out of different α subunits is variable 
(Kuhse et al., 1993), α1β heteromeric receptors assemble at a fixed subunit stoichiometry of 
2α3β (Grudzinska et al., 2005).  
For  GlyR  subunit  assembly,  the  N-terminal  extracellular  domain  plays  a  very  important  role. 
Homo-oligomerization of GlyRα1 subunits needs an 8 aa sequence in the N-terminal domain 
and N-glycosilation occurring before subunit assembly (Griffon N et al., 1999). Assembly boxes 
in the extracellular N-terminal domain of α and β subunits are crucial for the homo-oligomeric 
channel formation or stoichiometric assembly of GlyR in vivo (Kuhse et al. 1993). In addition, the 
formation of an intramembrane four-helical bundle by TM1-4 is crucial for stoichiometric subunit 
assembly (Haeger et al., 2010). 
2.3.3  Localization of glycine receptors in the central nervous system 
The  first  studies  of  GlyR  subunit  localization  in  the  central  nervous  system  used  in  situ 
hybridization to reveal the presence of GlyRα1 transcripts mainly in spinal cord and brain stem 
nuclei  and,  although  at  lower  levels,  also  in  the  superior  and  inferior  colliculi,  thalamus  and 
hypothalamus;  no  signals  were  found  in  cortical  regions.  Transcripts  of  GlyRα3  showed  the 
same  but  less  prominent  distribution  as  GlyRα1,  with  maximal  expression  levels  for  both 
subunits occurring around postnatal day 15 (Malosio et al., 1991). Transcripts of the GlyRα2 
subunit are highly expressed prenatally throughout most of the CNS and decrease postnatally 
until  postnatal  day  20  (Akagi  et  al.,  1991),  whereas  expression  of  GlyRα4  is  very  low  but 
detectable in some regions, e.g. the spinal cord (Harvey et al., 2000). The expression of the 
GLRB gene starts in the embryo, increases after birth and persists into adulthood throughout 
most brain regions (Fujita et al., 1991). INTRODUCTION 
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The formation of functional GlyRs reflects the receptorsʼ subunit composition. Antibodies against 
different GlyR subunits were generated to investigate protein expression and distribution of GlyR 
subunits (Pffeifer et al., 1984; Schröder et al., 1991). The present data on GlyR subunit protein 
and  mRNA  expression  patterns  supports  a  developmental  switch  from  non-synaptic  α2-
homopentameric  GlyRs  at  embryonic  stages  to  synaptically  localized  heteropentameric  α1β 
GlyRs in the adult CNS (Becker et al., 1988).  
The  major  inmunocytochemical  results  obtained  for  the  human  and  rat  CNS  agree  with 
autoradiographic studies, in which GlyRs were prominently seen in the ventral and dorsal horns 
of  the  spinal  cord  and  in  brainstem  (Triller  1985;  Baer  2003).  However,  different 
immunocytochemical and electrophysiologucal studies have evidenced the presence of GlyR in 
various  subpopulations  of  the  human  forebrain,  e.g.  substancia  nigra,  hippocampus  and 
striatum, as well as in the rat cerebellum and retina (Wässle et al., 1998; Waldvogel et al., 2007; 
Dumoulin et al., 2001; Chattipakorn et a., 2002). Some of the GlyR immunoreactivity has been 
found  to  colozalize  with  GABAARs  at  synapses  where  GABA  and  glycine  are  co-released; 
accordingly,  mixed  GABA/glycinergic  synapses  are  present  in  spinal  cord,  brain  stem  and 
cerebellum (van den Pol and Gorcs, 1988; Jonas et al., 1998; Kotak et al., 1999; Dumoulin et al., 
2001).  Furthermore,  electrophysiological  studies  have  provided  evidences  for  a  presynaptic 
localization of GlyRs in spinal cord, retinal bipolar cells and the dentate gyrus (Jeong et al., 
2003;  Lee  et  al.,  2009;  Mφrkve  and  Hartveit,  2009;  Kubota  et  al.,  2010).  In  the  latter,  GlyR 
expression declines during development.  
2.3.4  Clustering of glycine receptors at postsynaptic sites 
Postsynaptic membranes in the nervous system are specialized structures highly enriched in 
neurotransmitter  receptors.  The  enrichment  or  “clustering”  of  neurotransmitter  receptors  at 
postsynaptic sites is crucial for efficient signal transduction and integration in neurons. Receptor 
clustering at postsynaptic sites requires interactions with scaffolding proteins that oligomerize 
beneath the postsynaptic membrane. At excitatory synapses, NMDA-receptors (NMDAR) cluster 
via  their  interaction  with  the  synaptic  scaffolding  protein  PSD95/synapse  associated  protein 
(SAP) 90 and its family members SAP102 and PSD93 (Niethammer et al., 1996; O´Brien et al., 
1998). At glycinergic synapses, the 93 kDa protein co-purifying with the α and β subunits of the 
GlyR and named gephyrin (meaning “bridge” in Greek) serves as receptor scaffold (Betz et al., 
1991).  Gephyrin  is  a  tubulin-binding  protein,  which  has  a  function  at  inhibitory  synapses 
homologous  to  that  of  the  actin-binding  and  nAchR  clustering  protein,  rapsyn,  at  the INTRODUCTION 
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neuromuscular junction (Bloch et al., 1987). Gephryin as well as rapsyn are thought to serve as 
linker elements between the receptors and the cytoskeleton (Phillips et al., 1991; Kirsch et al., 
1992; Prior et al., 1992; Ramarao et al., 2001). The loss of GlyR clusters in spinal cord neurons 
treated with antisense oligonucleotide and in gephyrin KO mice (Kirsch et al., 1993; Feng et al., 
1998) shows that gephyrin is essential for GlyR cluster formation at synaptic sites. Gephyrin 
binding  by  the  GlyR  is mediated  by  a  hydrophobic  sequence  of  18  aas located  in  the  large 
cytoplasmic loop of the β subunit (Meyer et al., 1995). 
2.3.5  GlyR neuronal trafficking and diffusion  
The  mechanisms  underlying  GlyR  intracellular  transport  and  the  dynamics  of  GlyR  lateral 
diffusion  have  been  investigated  during  the  past  ten  years.  A  prerequisite  for  GlyR  synaptic 
clustering is the functionality of the GlyRs, as demonstrated by strychnine block, which induces 
the  internalization  of  GlyRs  from  synaptic  sites  (Kirsch  and  Betz,  1998).  On  the  same  line, 
increased activity and/or depolarization in neurons had the same effect on GlyR clustering as 
strychnine blockade indicating that synaptic GlyR trafficking is activity-dependent (Maas et al, 
2009). Time-lapse imaging showed that gephyrin and GlyR are co-transported on vesicles and 
the co-purification of gephyrin and GlyR from synaptic vesicles indicated that gephyrin serves as 
an  adaptor  in  GlyR  transport  in  addition  to  its  function  as  a  synaptic  scaffolding  protein. 
Importantly,  GlyR  and  gephyrin  influence  reciprocally  the  synaptic  clustering/oligomerization, 
respectively, in a feedback regulation process, since the down-regulation of gephyrin inhibits 
GlyR clustering, and the blockade of GlyR activates negatively affects the synaptic localization of 
gephyrin (Kirsch et al., 1998; Maas et al., 2009).  
Gephyrin-mediated GlyR vesicular transport requires motor proteins (see Fig. 2.2) The dynein 
light  chains  1  and  2  (Dlc1/2),  are  subunits  of  the  dynein  multi-protein  complex  mediating 
transport  towards  the  minus  ends  of  MT.  Binding  of  gephyrin  to  Dlc1  is  not  required  for 
gephyrin/GlyR  clustering,  but  necessary  for  gephyrin  transport  in  the  retrograde  direction 
(Fuhrmann et al., 2002, Maas et al., 2006). In contrast, the anterograde transport of gephyrin-
GlyR complexes is mediated by isoform 5 of the kinesin protein family (KIF5) (Maas et al., 2009).  
Neuronal  activity  has  direct  effects  on  the  cytoskeleteton  and  its  associated  proteins.  GlyR-
blockade has been newly found to induce changes in posttranslational modifications of tubulin 
and microtubule associated proteins (MAP). It increases tubulin polyglutamylation and MAP2 
phosphorylation, whereas the mobility of KIF5 and mRFP-gephyrin is decreased (Maas et al., INTRODUCTION 
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2009). In agreement with these results, the phosphorylation-dependent binding of MAP2 to MT 
is known to negatively influence KIF5 transport (López et al., 1993; von Massow et al., 1989). In 
conclusion,  the  anterograde  and  retrograde  transport  of  GlyRs  appears  to  be  gephyrin-
dependent by requiring, on one hand, gephyrin to function as adaptor protein for GlyR binding to 
motor proteins and, on the other hand, the regulation of post-translational modifications of MTs 
and MAP2 by synaptic activity.  
The  first  evidence  for  GlyR  lateral  diffusion  was  obtained  by  single  particle  tracking  with 
antibody-coated latex-beads and by immunocytochemical analysis of GlyRα1 subunit insertion 
into the plasma membrane over time (Meier et al., 2001; Rosenberg et al., 2001). These studies 
demonstrated  that  newly  synthesized  GlyRs  are  inserted  into  the  plasma  membrane  at 
extrasynaptic locations, and that individual GlyRs diffuse freely within the plasma membrane. 
Quantum dot tracking approaches allowed single GlyR trajectories to be monitored at synaptic, 
perisynaptic  and  extrasynaptic  sites  in  living  neurons.  Analysis  of  the  resulting  single  GlyR 
trajectories  revealed  that  GlyRs  dynamically  exchange  between  synaptic  and  extrasynaptic 
membrane compartments whilst passing through an intermediate perisynaptic state (Dahan et 
al., 2003). 
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Fig. 2.2. GlyR-gephyrin intracellular co-transport along microtubules. After synthesis and assembly, GlyRs leave 
the Golgi apparatus and are actively transported along cytoskeletal elements to the plasma membrane. KIF5 is a 
motor protein that moves anterogradely towards the plus ends of microtubules and connects to GlyRs via gephyrin. 
After insertion into the plasma membrane, GlyRs are clustered at synaptic sites by gephyrin. Endo- and exocytosis 
occurs at extrasynaptic sites. Once GlyR are endocytosed, Dlc1, a motor protein travelling towards the minus end of 
microtubles, mediates the retrograde transport of GlyR-gephyrin complexes (modified from Dumoulin et al., 2010). INTRODUCTION 
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2.4  Objectives of the present study 
As  described  in  2.3.5,  the  intracellular  tranport  of  GlyRs  is  gephyrin-  and  motor  protein-
dependent for both anterograde and retrograde transport along microtubules (Maas et al., 2006; 
Maas et al., 2009). Furthermore, a model for GlyR lateral diffusion and synaptic/extrasynaptic 
exchange  involving  multiple  states  of  GlyR/gephyrin  association  has  been  postulated 
(Ehrensperger et al., 2007). Although the GlyRβ subunit is a key determinant of GlyR synaptic 
localization, gephyrin has been the only GlyRβ binding-protein known (Betz et al., 1991). In order 
to shed further light on GlyR transport and distribution mechanisms, in this thesis, the interaction 
of novel GlyR binding proteins was investigated. Putative binding proteins were isolated in a 
proteomic screen from rat brain homogenate using the intracellular loop of the GlyRβ subunit as 
bait and identified by mass-spectrometry (Paarmann et al., 2006). The main aspects of these 
new GlyRβ binding proteins, synaptic dynamin binding protein (Sdp), vacuolar protein sorting 
ps35  (Vps35)  and  neurobeachin  (Nbea),  are  introduced  below  (see  2.4.1,  2.4.2,  2.4.3).  The 
interactions of these proteins with the GlyRβ subunit and gephyrin were examined and deletion 
approaches  were  used  to  map  the  SdpI  binding  site.  Peptide  competition  approaches  were 
performed to investigate the specificity of the SdpI-GlyR interaction. Point mutations introduced 
in  the  SH3  binding  domain  of  the  GlyRβ  subunit  were  tested  in  order  to  characterize  the 
interaction. The production of specific antibodies and immunocytochemical experiments allowed 
to determine the neuronal localization of these proteins.  
All proteins identified here as GlyRβ binding partners have been implicated in different trafficking 
steps b etween  membrane  compartments.  On  this  basis,  the  functional  role  SdpI  in  GlyR 
trafficking  and  synaptic  distribution  was  investigated.  To  this  end,  co-immunoprecipitation 
experiments  were  performed  to  demonstrate  an  interaction  of  endogenous  GlyRs  and  SdpI. 
Additionally,  SdpI  deficient  mice  (SdpI-/-)  and  SdpI  knockdown  approaches  were  used  to 
examine the physiological consequences of SdpI deficiency on GlyR distribution in spinal cord 
neurons. INTRODUCTION 
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2.4.1  Syndapin  
Syndapin I (SdpI) (synaptic dynamin-associated protein I) was initially identified in a screen for 
proteins interacting in rat brain cytosol with the proline-rich domain of dynamin (Qualmann et al., 
1999). Two other isoforms of SdpI were subsequently identified in human and murine cDNA 
libraries: syndapin II (SdpII) (Qualmann and Kelly, 2000) and syndapin III (SdpIII) (Sumoy et al., 
2001), both with high sequence conservation. For SdpII, there are two splice variants known: the 
long form syndapin II-l (SdpII-l) and the short form syndapin II-s (Sdp II-s) (Qualmann and Kelly, 
2000). The SdpI gene has been found in mammals, nematodes and insects but not in plants and 
single-cell eukaryotes. Moreover, up to five Sdp genes have been identified in fugu and zebra 
fish (Kessels and Qualmann, 2004). 
2.4.1.1  Molecular structure and diversity of the syndapin protein family 
All  Sdps  share  a  common  organization  with  an F -BAR  (Fes/CIP4  homology-
Bin/Amphiphysin/Rvsp) domain and an SH3 (src homology 3) domain. The aa sequences of 
SdpI  and  both  splice  variants  of  SdpII  comprise  additional  NPF  motifs  (named  after  their 
asparagine-proline-phenylalanine  repeats),  whereas  SdpIII  contains,  a  proline-rich  domain 
instead of NPF domains (Fig. 2.3.A). 
F-BAR domains constitute a subfamily of the BAR domains, protein modules that stabilize and/or 
induce  membrane  curvature.  The  F-BAR  domains  are  composed  of  a  FCH  (Fes  and  CIP4 
homology) domain followed by a coiled-coiled region, which by direct interaction forms dimers 
and tetramers in vitro (Halbach et al., 2007). SdpI requires the α-helical part of the N-terminal-
FCH  region  to  form  oligomers  in  vitro  and  in  vivo  (Kessels  and  Qualmann,  2006).  The 
crystalization of F-BAR dimers revealed a sickle-shaped structure of the domain, with a shallow 
curvature when seen from the side and a tilde shape when viewed from below (Henne et al., 
2007, Fig. 2.3.B). Like classical BAR domains, this BAR-related domain is able to bind to flat or 
curved lipid bilayers due to an enrichment of positively charged residues at the concave surface, 
which  forms  the  major  membrane  interaction  interface.  This,  together  with  its  ability  to 
oligomerize  with  other  F-BAR  domains  and  to  form  intermolecular  interactions,  induces 
membrane-tubule formation and shapes helical coats for their stabilization (Shimada et al., 2007; 
Frost  et  al.,  2008).  In  contrast  to  the  class  of  F-BAR  domains  that  prefer  weakly  curved 
membrane  tubules  (Itoh  et  al.,  2005;  Shimada  et  al.,  2007),  the  F-BAR  domain  of  SdpI INTRODUCTION 
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constitutes  a  scaffold  that  is  optimized  for  the  stabilization  of  a  high  degree  of  membrane 
curvature (Wang et al., 2009).  
The C-terminal SH3 domain is highly conserved among all Sdps and widely known as a proline 
recognition motif (Feng et al., 1994, Li et al., 2005). This domain is responsible for the interaction 
of  SdpI  with  several  proline-rich  domain  (PRD)  containing-proteins  of  the  endocytic  pathway 
such  as  dynamin  (Sever  et  al.,  2000),  the  phosphatidylinositol  5-phosphatase  synaptojanin 
(Cremona et al., 1999), synapsin I (Hilfiker et al., 1999) and the neural Wiskott-Aldrich syndrome 
protein (N-WASP) (Qualmann et al., 1998). The NPF motifs are also implicated in protein-protein 
interactions and mediate binding of SdpI and SdpII to EHD proteins implicated in endosomal 
recycling (Braun et al., 2005). 
2.4.1.2  Cellular and sub-cellular distribution of the Sdp protein family 
In mammals, the expression patterns of the three Sdp isoforms are rather different. Whereas 
SdpI  is  expressed  exclusively  in  the  CNS,  both  splice  variants  of  SdpII  are  expressed 
ubiquitously  in  all  tissues,  and  SdpIII  is  present  in  skeletal  muscle  and  heart  and  weakly 
expressed in brain. Developmental expression of SdpI gene and protein levels is detectable at 
embryonic day (E) 17 and increases continuously up to the adult stage. Studies in pluripotent 
cells with the ability to differentiate only to neuron-like cells revealed that SdpI gene expression 
starts as soon as cells stop proliferating and begin to differentiate into neurons (Plomann et al., 
1998). Interestingly, the splice variants of SdpII display different distributions, with SdpII-l being 
prominent in neuronal and heart tissues and SdpII-s being ubiquitously expressed (Qualmann 
and Kelly, 2000).  
At the sub-cellular level, SdpI distributes along processes surrounding the cell bodies of neurons 
and  is  found  at  excitatory  presynaptic  terminals  and  postsynapses  as  well  as  at  the 
tubulolamellar postsynaptic membrane system of D. melanogaster NMJ (Qualmann et al., 1998; 
Kumar et al., 2009).  
2.4.1.3  Functional relevance of Sdp protein family in the CNS 
Since the initial identification of SdpI in 1999, the investigation of Sdp functions in the CNS has 
become the object of several scientific reports. In the zebrafish (Danio rerio), loss of function 
experiments revealed a key function of SdpIII in cell migration and columnar organization of the 
notochord.  This  study  presented  for  the  first  time  evidence  for  a  functional  role  of  SdpIII  in 
developmental  differentiation  (Edeling  et  al.,  2009).  In  cultured  hippocampal  neurons,  SdpI INTRODUCTION 
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regulates  neuromorphogenesis  by  binding N -WASP,  releasing  N-WASP  autoinhibition  and 
inducing actin nucleation at the cell cortex (Dharmalingam et al., 2009). Additionally, subcellular 
fractionation experiments recently demonstrated that the F-BAR domain of SdpI and SdpII is 
necessary for Sdp-binding to phosphatidylserine containing membranes and required for SdpI 
targetting to the plasma membrane in neurons (Dharmalingam et al., 2009).  
The name Sdp, for synaptic dynamin binding protein, points toward the currently best-studied 
function of Sdp in vivo. A dephosphorylation-dependent interaction of the large GTPase dynamin 
with SdpI is essential for synaptic vesicle endocytosis in neurons under intense stimulation, but 
is not required for clathrin-mediated endocytosis in non-stimulated cells. When neuronal activity 
is  elevated,  neuronal  depolarization  induces  a  calcineurin-mediated  dephosphorylation  of 
dynamin  that  triggers  SdpI-dynamin  protein  complex  formation  and  activity-dependent  bulk 
endocytosis (Ferguson et al., 2007; Anggono et al, 2006; Anggono et al., 2007; Clayton et al., 
2009). On the same line, SdpII joins dynamin II in vesicle formation from the trans-Golgi network 
(Kessels et al., 2006). Due to the ability of SdpI to oligomerize through the F-BAR domains and 
to  interact  with  protein  elements  affecting  actin  polymerization  (N-WASP)  and  endocytosis 
(dynamin), Sdp has been proposed to link vesicle formation and cortical cytoskeleton dynamics 
(Kessels and Qualmann 2002; Kessels and Qualmann 2006). Furthermore, the interaction of 
EHD proteins, regulators of the endocytic recycling compartment transport, with SdpI and SdpII 
via their NPF repeats has been shown to be required for transferrin receptor recycling events 
(Braun  et  al.,  2005).  Similarly,  activity-dependent  vesicle  recycling  at  presynaptic  terminals 
under  intense  stimulating  conditions  requires  a  dynamin-SdpI-N-WASP  intact  complex 
(Andersson  et  al.,  2008).  This  demonstrates  that  SdpI  has  a  role  as  key  regulator  of 
compensatory endocytosis, coordinating vesicle formation and actin functions.  
In  contrast  to  the  established  function  of  Sdp  in  vesicle  endocytosis  and  recycling  at  the 
presynapse, the functional role of Sdps at postsynaptic sites remains still poorly understood. 
Studies performed at the NMJ of D. melanogaster have excluded a role of SdpI in presynaptic 
vesicle endocytosis but shown that Sdp is predominantly associated to postsynaptic terminals, 
where it mediates the expansion of the subsynaptic reticulum (Kumar et al., 2008; Kumar et al., 
2009). Furthermore, in hippocampal neurons an NPF domain-dependent interaction of SdpI, but 
not SdpII, with NR3A-containing NMDA receptors is crucial for the removal of NR3A subunit 
containing NMDA receptors from synaptic sites (Pérez-Otaño et al., 2007).  INTRODUCTION 
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Another  protein  which  binds  SdpI  and  SdpII  is  the  mammalian  son-of-sevenless  (mSOS),  a 
guanine  exchange  factor  for  the  small  GTPases  Ras  and  Rac  (Wasiak  et  al.,  2001).  The 
recruitment of SdpI/II to mSOS and actin at growth cones together with the ability of SdpI to 
induce filopodia formation through N-WASP mediated activation of Arp2/3 is consistent with Sdp 
regulating  actin  dynamics  during  filopodia  and  lamellipodia  formation  (Qualmann  and  Kelly, 
2000). 
Fig.  2.3.  Domain  organization  of  the  Sdp  protein  family  and  model  of  vesicle  budding,  invagination  and 
fission processes. A. Domain organization of Sdp isoforms and both splice variants. F-BAR: Fes/CIP4 homology-
Bin/Amphiphysin/Rvsp domain, NPF: asparagine-proline-phenylalanine repeats, SH3: src homology 3 domain, PxxP: 
proline-rich sequence. B. 1. First adaptor proteins and clathrin coats assemble. 2. Then the F-BAR domain sense the 
curvature  of  the  clathin  coated  bud  and  oligomerizes,  thereby  inducing  membrane  tubulation.  F-BAR  domain-
containing proteins like Sdp recruit dynamin and N-WASP through the SH3 domain. 3. N-WASP induces Arp2/3-
mediated actin polymerization, and BAR-domain containing proteins like amphiphysin bind to the narrowed vesicle-
neck and contributes as well to dynamin recruitment. 4. GTPase activity of dynamin and actin polymerization lead 
finally to vesicle fission from the plasma membrane (modified by Dennis Koch from Shimada et al. 2007). INTRODUCTION 
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2.4.2  Vacuolar protein sorting 35 (Vps35) 
Eukaryotic  cells  contain  distinct  membraneous  organelles,  whose  identity  is  defined  by  their 
protein  composition.  The  maintenance  of  sub-compartment  identity  is  achieved  through  the 
specific  sorting  and  delivery  of  proteins  to  each  organelle.  In  the  lysosomal  protein  delivery 
pathway, post-translational modifications like the attachment of mannose-6-phosphate groups to 
N-linked  oligosaccharide  side  chains  of  lysosomal  hydrolases  takes  place  in  the  Golgi 
apparatus. In the trans-Golgi network, this native tag is recognized by mannose-6-phosphate 
receptors  (MPRs)  in  mammals,  or  N-terminal  signal  peptides  of  the  carboxipeptidase  Y  are 
recognized by vacuolar hydrolases sorting receptors, such as Vps10p in yeast (Hoflack et al., 
1987; Johnson et al., 1990), which then leads to the sorting of the hydrolase-receptor complexes 
to endosomes. There, the hydrolases dissociate from the receptor due to the acidic environment 
of the endosomes, and both proteins follow then divergent pathways. Hydrolases are delivered 
to lysosomes, and MPR as well as Vps10p proteins are recycled back to the Golgi apparatus 
where they mediate further rounds of sorting (Braulke and Bonifacino 2009).  
Vacuolar  protein  sorting  (vps)  genes  were  first  identified  in  Saccharomyces  cerevisiae  by  a 
genetic screen for mutants defective in protein trafficking to the lysosome-like vacuole (Paravicini 
et al., 1992). The first hint for a retrieval function of Vps35, Vps30 and Vps29 in yeast was 
provided  by  mutants  of  these  three  proteins,  which  led  to  a  mislocalization  of  the 
carboxipeptidase Y receptor Vps10p to the yeast vacuole (Seaman et al., 1997). Moreover, this 
study  also  provided  the  first  evidence  for  a  central  role  of  Vps35  as  a  receptor  recognition 
element  (Seaman  et  al.,  1997;  Nothwehr  et  al  2000).  A  heteropentameric  protein  complex 
composed of Vps35, Vps29, Vps26, Vps17 and Vps5 was identified in yeast as a membrane-
associated  coating  complex,  which  is  responsible  for  receptor  retrieval  from  endosomal  and 
plasma membranes to the Golgi apparatus, and hence was named retromer complex (Seaman 
et al 1998). 
2.4.2.1  Subunit composition of the retromer complex 
The retromer complex is organized in two subcomplexes preserved from yeast to mammals: a 
membrane-targeting  heterodimer  and  a  cargo  recognition  heterotrimer  (Horazdovsky  et  al., 
1997; Seaman et al 1998; Fig. 2.4). The membrane heterodimer is composed of proteins of the 
sorting nexin family: Vps5 and Vps17 in yeast or their mammalian counterparts SNX1/SNX2 and INTRODUCTION 
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SNX5/SNX6  (Griffin  et  al.,  2005;  Rojas  et  al.,  2007;  Wassmer  et  al.,  2007).  SNX  proteins 
comprise  a  BAR  domain  and  a  phox  homology  (PX)  domain.  BAR  domains  are  banana-like 
domains with a curved structure different from F-BAR domains. They form dimers and act as 
membrane  curvature  sensors,  thereby  ensuring  the  localization  of  SNX  at  highly  curved 
membrane  tubules  (Carlton  et  al  2004;  Gallop  et  al.,  2005).  PX  domains  bind  to  specific 
phosphoinositides, e.g. phosphatidylinositol 3-phosphate and phosphatidylinositol biphosphate, 
and thus constitute another membrane binding interface in SNX dimers (Worby et al., 2002; 
Carlton et al., 2005; Fig. 2.4). The cargo recognition subcomplex is composed of the core protein 
Vps35 and two regulatory proteins, Vps29 and Vps26. Vps35 directly mediates cargo binding 
through its interaction with the cytosolic tails of transmembrane proteins. Several of the binding 
sequences  in  different t ransmembrane  proteins  have  been  identified  and  share  common 
features,  like  their  hydrophobicity  and  the  presence  of  aromatic  aas  (Seaman  et  al.,  2007; 
Nielsen  et  al.,  2007).  Both  Vps29  and  Vps26  require  Vps35  for  their  incorporation  into  the 
retromer complex, due to binding at the C- and the N-termini of Vps35, respectively (Shi et al., 
2006; Hierro et al., 2007). 
2.4.2.2  Functional relevance of the retromer complex 
The retromer complex, as a novel sorting device for retrograde endosome/plasma membrane to 
TGN  transport,  has  become  the  focus  of  a  recent  flurry  of  studies.  The  latter  revealed  its 
participation in a broad range of physiological processes. Its function in intracellular transport is 
necessary for the retrieval of receptors, e.g. Vps10p, sortilin, SorLA (Mari et al., 2007), the plant 
seed  storage  protein  receptor  AtVSR1/AtELP  (Shimada  et  al.,  2006;  Fuji  et  al.,  2007)  and 
membrane transporters, such as the iron transporter DMT1-II (Tabuchi et al., 2010). Additional 
evidence  for  a  role  of  the  retromer  complex  in  protein  recycling  is  its  interaction  with  EHD 
proteins (Gokool et al., 2007). The retromer complex is also responsible for transcytosis of the 
polymeric  immunoglobulin  receptor  (pIgR)  and  its  cargo  IgA  in  epithelial  cells,  i.e.  their 
translocation  from  the  basolateral  to  the  apical  cell  surface  (Verges  et  al.,  2004).  Moreover, 
bacterial  toxins  like  the  Shiga  toxin  B  subunit  also  use  a  retromer-mediated  internalization 
mechanism  to  get  to  the  ER  and  the  cytosol  (Utskarpen  et  al.,  2007).  Finally,  the  retromer 
complex  mediates  endosome  to  TGN  transport  of  the  amyloid  precursor  protein  (APP),  β-
secretase and/or γ-secretase, and therefore is thought to have a role in Alzheimerʼs disease 
(Muhammad et al., 2008). INTRODUCTION 
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Since several protein machineries mediating retrograde trafficking between endosomes and the 
TGN have been identified, their interactions and regulation has only recently received attention. 
Initial studies proposed a sequential two-step model for retrograde sorting, in which retromer 
formation would be clathrin dependent (Popoff et al., 2007). Recent reports, however, suggest a 
model, in which two membrane proteins interacting with SNX1 and Hsc 70, a clathrin uncoating 
ATPase, affect clathrin dynamics in an antagonistic manner and thereby determines whether 
either a retromer or a clathrin mediated retrograde sorting process is used (Popoff et al., 2009).  
 
Fig. 2.4. Protein composition of the retromer complex. Schematic depiction of protein interactions in the retromer 
complex  of  yeast.  Vps35p  interacts  with  Vps26p  through  its  N-terminus  and  with  Vps29p  through  its  C-terminus 
forming the cargo recognition subcomplex that binds to the receptor (Vps10p in yeast or CI-MPR in mammals). Thus, 
Vps5p and Vps17p in yeast are members of the SNX family of proteins that constitute the membrane association 
subcomplex. SNX proteins form dimers through their C-terminal BAR domains and comprise as well PX domains 
binding to PI3P and PI35BP in membranes. Abbreviations: Vps: vacuolar protein sorting, BAR: Bin-amphiphysin-Rvs 
domain,  PX:  phox  homology  domain,  CI-MPR:  cation-independent  mannose-6-phosphate  receptor,  PI3P: 
phosphatidylinositol 3-phosphate, PI35BP: phosphatidylinositol 3,5-biphosphate (modified from Seaman 2005).  INTRODUCTION 
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2.4.3  Neurobeachin  
Ten years ago, in an attempt to screen for new synaptic plasma membrane proteins, a novel 
protein was identified as the large neuron-specific protein Neurobeachin (Nbea) (Wang et al., 
2000).  This  protein  belongs  to  the  BEACH ( named  after  beige  mouse  and  Chediak-Higashi 
syndrome) protein family and to the A-kinase anchor protein (AKAP) family present in unicellular 
and  multicellular  eukaryotes  (Lozanne,  2003). Since  its  identification,  many  studies  aimed  to 
disclose the function of this novel protein in the central nervous system. 
2.4.3.1  Molecular structure of Nbea  
Nbea is a multimeric protein with a molecular weight of 327 kDa. The BEACH protein family 
members share, apart from the characteristic C-terminal BEACH domain, a Pleckstrin homology 
(PH) domain and tryptophan-aspartic acid (WD)40 repeats, localized N- and C-terminally of the 
BEACH domains, respectively, as well as a N-terminal concanavalin-A (ConA)-like lectin domain 
(Nagle et al., 1996; Jogl et al., 2002; Burgess et al., 2009; Fig. 2.5). Crystal structure analyses 
have shown a close proximity of the PH and BEACH domains and led to the postulate that both 
domains function as a single unit in protein-protein interactions (Jogl et al. 2002). On the same 
line,  WD40  repeats  are  domains  involved  in  protein-protein  interactions  (Neer  et  al.,  1994). 
Moreover, the identification of a ConA-like lectin domain in the Nbea sequence implies that this 
protein could also recognize carbohydrate side chains of their target proteins (Burgess et al., 
2009). A particular feature of Nbea is its high-affinity binding site in the B domain for the type II 
regulatory protein kinase A (PKA RII) (Wang et al., 2000; Fig. 2.5). Due to the association of 
Nbea  with  tubulo-vesicular  membranes,  it  may  function  as  AKAP  and  target  PKA  to  proper 
locations in the cell.  
2.4.3.2  Functional relevance of Nbea in the CNS 
BEACH-domain containing proteins are thought to act in cellular trafficking, since mutations in 
the prototypic BEACH domain protein, LYST, lead to protein sorting defects and giant inclusion 
bodies  (Nagle  et  al.,  1996;  Faigle  et  al  1998).  Different  studies  indicate  a  predominantly 
postsynaptic  localization  of  the  Nbea  protein.  Additionally  a  coat-like  GTP-dependent  and 
brefeldin-A sensitive membrane binding activity of Nbea to trans-Golgi-near endomembranes of 
neurons has been observed (Wang et al., 2000). The analysis made on Nbea-deficient mice 
revealed a complete impairment of spontaneous and evoked excitatory and inhibitory synaptic INTRODUCTION 
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neurotransmission.  In  these  studies,  a  reduction  in  synaptic  protein-content  was  found, 
suggesting that Nbea plays a central role in synapse formation and function (Medrihan et al., 
2009).  However,  studies  of  the  NMJ  of  Nbea  -/-  mice  demonstrated  an  impairment  of  only 
evoked but not spontaneous neurotransmission as well as normal NMJ morphology. Thus, Nbea 
may have distinct roles at central and neuromuscular synapses (Su et al., 2004).  
The precise function of Nbea in the CNS is of medical interest, since genetic studies linked de 
novo translocations of the locus encompassing the Nbea-encoding gene to idiopathic autism 
(Castermans et al., 2003). Furthermore, the Nbea gene is localized to candidate regions for 
autism on chromosome 13 and spans the fragile site FRA13A (Barret et al., 1999; Savelyeva et 
al., 2006). These findings, together with the demonstrated expression of Nbea in the CNS during 
development and Nbea-dependent inhibitory-excitatory synaptic imbalance, point to the Nbea 
gene as an important disease gene in autism.  
 
 
Fig.  2.5.  Domain  organization  of  BEACH  domain-containing  proteins.  Domain  organization  of  three  BEACH-
related proteins starting at the C-temrinus. PH domains are depicted as green boxes followed by BEACH domains and 
WD40 repeats depicted as yellow boxes and ovals, respectively. Grey boxes indicate conserved sequences, and 
numbers above show the percentage in aa sequence identity among these BEACH-related proteins. Horizontal lines 
indicate regions not conserved. Binding sites for the type II regulatory protein kinase A (PKA RII) are marked by red 
boxes. Oblique lines indicate that the N-terminal sequences of LRBA and DAKAP550 are incomplete. Abbreviations: 
LRBA: lipopolysaccharide-responsive vesicle trafficking, beach and anchor containing protein; DAKAP550: ortholog of 
Nbea in D.melanogaster (modified from Wang et al., 2000).  
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3  MATERIALS AND METHODS 
 
3.1  MATERIALS 
3.1.1  Chemicals and plastic materials 
All chemicals, unless otherwise stated, were ordered from the following companies: Applichem 
(Darmstadt, Germany), Bio-Rad (Munich, Germany), Biotrend (Cologne, Germany), Calbiochem 
Merck Biosciences (Schwalbach, Germany), DifcoLaboratories (Detroit, USA), Eppendorf (New 
York,  USA),  Fluka  (Buchs,  Switzerland),  GE  Healthcare  Biosciences  (Freiburg,  Germany), 
Gibco-BRL  (Karlsruhe,  Germany),  Invitrogen  (Carlsbad,  USA),  Merck  (Darmstadt,  Germany), 
New England Biolabs (Ipswich, USA) Roche Diagnostics (Basel, Switzerland), Roth (Karlsruhe, 
Gemany),  Serva  (Heidelberg,  Germany)  and  Sigma-Aldrich  (Munich,  Germany).  All  solutions 
were prepared with Milli-Q water (Millipore, Wartford, USA). 
Plastic materials were from the following companies: Falcon (Le Pont De Claix, France), Perbio 
Sciences  (Bonn,  Germany),  Roth  (Karlsruhe,  Germany),  Greiner  (Darmstadt,  Germany)  and 
Eppendorf (Hamburg, Germany).  
 
3.1.2  Enzymes 
All  restriction  enzymes,  Quick  T4  DNA  ligase  and  Deep  Vent  DNA  polymerase  used  were 
obtained from New England Biolabs (Frankfurt, Germany). T4 DNA Ligase and Proteinase K 
were  purchased  from  Roche  (Mannheim,  Germany),  Benzonase  from  Novagen  (Darmstadt, 
Germany), PANScript DNA polymerase from PAN Biotech (Aidenbach, Germany) and Clonases 
from Invitrogen (Karlsruhe, Germany).   MATERIALS AND METHODS 
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3.1.3  Kits 
Name  Description  Company 
BLOCK-iT Pol II miR RNAi 
Expression Vector Kit 
Gateway-adapted  expression 
vector  for  the  expression  of 
microRNA  in  mammalian  cells 
under control of Pol II promoters 
Invitrogen 
(Carlsbad, USA) 
DC Protein Assay Kit  Determination of protein amount  BIO-RAD (Munich) 
HiSpeed Plasmid Maxi-Kit  Rapid purification of transfection 
grade plasmid DNA 
QIAGEN (Hilden) 
QIAGEN Plasmid-Midi-Kit  Purification of DNA  QIAGEN (Hilden) 
QIAGEN Plasmid-Mini-Kit  Purification of DNA  QIAGEN (Hilden) 
QIAquick  Gel-Extraction-
Kit 
Isolation of DNA fragments from 
agarose gels 
QIAGEN (Hilden) 
REDExtract-N-AmpTissue 
PCR-Kit 
Rapid  extraction  and 
amplification  of  genomic  DNA 
from mouse tails 
SIGMA (USA) 
Silver Stain Plus Kit  Silver  staining  of  SDS-
polyacrylamide gels 
BIO-RAD (Munich) 
 
3.1.4  DNA standard 
As a reference marker for DNA, the SmartLadder-Marker from Eurogentec (Cologne, Germany) 
was used following the manufacturerʼs instructions. This marker contains DNA fragments of the 
following sizes: 10, 8, 6, 5, 4, 3, 2.5, 2, 1.5, 1, 0.8, 0.6, 0.4 and 0.2 kbp.   
 
3.1.5  Protein standard 
As reference for protein gels, the SeeBlue2-Marker from Invitrogen (Carlsbad, USA) was used. 
This marker mix contains the following proteins: myosin (250 kDa), phosphorylase (148 kDa), 
BSA (98 kDa), glutamate dehydrogenase (64 kDa), alcohol dehydrogenase (50 kDa), carbonic 
anhydrase (36 kDa), myoglobin (22 kDa) lysozyme (16 kDa), aprotinine (6 kDa) and insuline (β-
chain) (4 kDa).  
 
3.1.6  Membranes and films 
Nitrocellulose membranes from Schleicher and Schuell GmbH (Dassel, Germany) and PVDF MATERIALS AND METHODS 
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transfer membrane from GE Healthcare (Little Calfont, UK) with a pore size of 0.45 µm were 
used for Western blot analysis. Files for autoradiography were purchased from BIOMAX MR 
(Kodak, Cedex, France) or HyperfilmTM MP (GE Healthcare Limited, Little Calfont, UK). 
3.1.7  Oligonucleotides 
Oligonucleotides were ordered from Metabion (Mastinsried, Germany), received as lyophilized 
pellets  and  dissolved  in  pure  water  (Braun  Melsungen  AG,  Melsungen,  Germany)  to  a  final 
concentration of 100 pmol/µl. They were used for PCR reactions, genotyping, sequencing and 
mutagenesis. In the following list of oligonucleotides, restriction sites and point mutations are 
indicated by an underline and lower-case, respectively.  
 
Table 1. Primers used for mutagenesis or addition of restriction sites.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2. Primers used for genotyping 
 
 
 
 
 
 
Primer  Purpose  Orientation  Sequence 
IP50  Forward  5ʼ– GAAACAGTAGCcTATG 
AATTTATGTCCCAG – 3ʼ 
IP51 
Generation of point 
mutation to remove the 
NdeI restriction site from 
the Vps35 coding 
sequence 
Reverse  5ʼ– CTGGGACATAAATTCATAgG 
CTACTGTTTC – 3ʼ 
IP48  Forward 
5ʼ– CGCCGCTCGAGCATATG 
CCTACAACACAGCAGTC – 3ʼ 
IP49 
Addition of a XhoI-NdeI 
site at the 5ʼ and a 
BamHI at the 3ʼ end of 
the Vps35 coding 
sequence 
Reverse 
5ʼ– CGGGATCCTTAAAGG 
ATGAGACCTTCATAG – 3ʼ 
IP67  Forward  5ʼ– GGAATTCCATATG 
TTGGTGTTGGTACTAGGAGA – 3ʼ 
IP68 
Addition of a NdeI site at 
the 5ʼ and a BamHI site 
at the 3ʼ end of the 
Vps29 coding sequence  Reverse 
5ʼ– GCGGATCCGCTTTA 
CGACTTTTTATACTCA – 3ʼ 
IP89  Forward 
5ʼ– GAAGATCTATGGCCT 
CCTCCGAGGACGTCA – 3ʼ 
IP90 
Addition of BglII sites at 
the 5ʼ and 3ʼ ends of the 
mRFP coding sequence 
and sequencing of the 
GlyRβ-mRFP construct 
Reverse 
5ʼ– GAAGATCTGGCGCCGG 
TGGAGTGGCGGCCC – 3ʼ 
Mouse line  Primer  Orientation  Sequence 
IP77  Forward   5ʼ– AGAGATGTTGAGATGTGTAC – 3ʼ 
IP78  Reverse  5ʼ– AAGGGAGTCTGGATGCAAGG – 3ʼ 
IP79  Forward   5ʼ– ATCTGAGGAGACCCATTCAG – 3ʼ 
SdpI 
IP80  Reverse   5ʼ– CGGTAGAATTGACGAAGTTCC – 3ʼ MATERIALS AND METHODS 
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Table 3. Primers used for sequencing 
Vector  Primer  Orientation  Sequence 
IP81  Forward   5ʼ– AATTAACCCTCACTAAAGGG – 3ʼ 
IP92  Reverse  5ʼ– CTTTCAGAGGTTATTTCAGGC – 3ʼ 
pRK5 
pCMVfor  Forward   5ʼ– CGCAAATGGGCGGTAGGCGTG – 3ʼ 
pDP  pDP  Forward   5ʼ– AGAGTGCTTTCCCGTGTCAG – 3ʼ 
T7  Forward   5ʼ– TAATACGACTCACTATAGGG– 3ʼ  pCMV 
T3  Forward   5ʼ– AATTAACCCTCACTAAAGGG– 3ʼ 
pQEfor  Forward   5ʼ– GTATCACGAGGCCCTTTCGTCT– 3ʼ  pQE5 
pQErev  Reverse   5ʼ– CATTACTGGATCTATCAACAGGAG – 3ʼ 
pGEXfor  Forward   5ʼ– ATAGCATGGCCTTTGCAGG – 3ʼ  pGEX 
pGEXrev  Reverse   5ʼ– GAGCTGCATGTGTCAGAGG – 3ʼ 
pEGFP-C1for  Forward  5ʼ– GATCACTCTCGGCATGGAC – 3ʼ 
pEGFP-N1for  Forward  5ʼ– GTCGTAACAACTCCGCCC – 3ʼ 
pEGFP 
pEGFP-N1rev  Reverse  5ʼ– GTCCAGCTCGACCAGGATG – 3ʼ 
IP51  Reverse  5ʼ – 
CTGGGACATAAATTCATAGGCTACTGTT 
TC – 3ʼ 
IP52  Reverse  5ʼ– CACTGTAGCCACCTGTTGTG – 3ʼ 
IP53  Forward  5ʼ– AACGAGAGAGAGACAAGAACTGA – 3ʼ 
Vps35 
_pBlue- 
script 
IP55  Forward  5ʼ– CTCAGGACCAGGTAGATTCC – 3ʼ 
6Pfor  Forward  5ʼ– AGGAGTCGTGTCGTGCCTGAG– 3ʼ  pAAV 
6Prev  Reverse  5ʼ– AGCAGCGTATCCACATAGCG – 3ʼ 
 
3.1.8  Organisms 
3.1.8.1  Bacteria 
Name  Genotype  Source 
E.  coli  XL1- 
Blue 
recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 
lac [F´ proAB lacI
qZ∆M15 Tn10 (Tet
r)] 
Stratagene (La 
Jolla, USA) 
E.  coli  BL21 
codon plus 
E.  coli  B  F–ompT  hsdS(rB
–mB
–)dcm
+  Tet
r  gal 
λ(DE3)endA  Hte  [argU  proL  Cam
r]  [argU  ileY 
leuW Strep/Spec
r]  
Stratagene (La 
Jolla, USA) 
E.  coli  Turbo 
cells 
F´ proA
+B
+ lacI
q ∆ lacZ M15/ fhuA2 ∆(lac-proAB) 
glnV  gal  R(zgb-210::Tn10)Tet
S  endA1  thi-1 
New  England 
Biolabs MATERIALS AND METHODS 
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∆(hs
dS-mc
rB)5 
E.  coli  Sure2 
cells 
e14
-(McrA
-)  ∆(mcrCB-hsdSMR-mrr)171endA1 
supE44  thi-1  gyrA96  relA1  lac  recB  recJ  sbcC 
umuC::Tn5  (Kan
r)uvrC  [F´  proAB  lacI
qZ∆M15 
Tn10 (Tet
r) Amy Cam
r] 
Stratagene (La 
Jolla, USA) 
E.  coli  Top10 
cells 
F
-  mcrA  ∆(mrr-hsdRMS-mcrBC)  φ80lacZ∆M15 
∆lacX74  nupG  recA1  araD139  ∆(ara-leu)7697 
galE15 galK16 rpsL(Str
R) end A1 λ  
Invitrogen 
(Carlsbad, 
USA) 
 
3.1.8.2   Animals 
The  house  mouse  Mus  musculus  is  the  principal  model  organism  used  to  investigate  gene 
function in mammals. The SdpI deficient mice used in this work had been generated using the 
Cre/loxP  system  in  Dr.  Britta  Qualmann´s  group  at  the  University  of  Jena  (Germany).  Cre 
induced recombination led to the excision of exon 1 of the SdpI gene encoding the start codon, 
thus eliminating SdpI expression in all brain regions (Koch D., PhD thesis). SdpI-deficient mouse 
line  was  maintained  in  the  animal  house  of  the  Max-Planck-Institute  for  Brain  Research 
(Frankfurt, Germany) by backcrossing of SdpI heterogyzous mice with C57BL/6J mice.  
For the preparation of rat primary neurons, pregnant Wistar rats were purchased from Charles 
River Laboratories Inc. (Kisslegg, Germany).  
3.1.9  Cell lines  
Name  Donor organism  Source 
HEK 293T (Human embryonic kidney 
cells expressing the SV40 large T-
antigen) 
Human  ATCC (Manassas, 
USA) #CRL_1573 
COS-7 (African Green Monkey SV40-
transformed kidney fibroblast) 
Monkey  Stratagene (La Jolla, 
USA) 
 
3.1.10 Antibodies 
3.1.10.1 Primary antibodies for Western blot and immunostaining 
Dilution  Name  Species 
WB  ICC/IHC 
Source/Reference 
B1  Mouse  1:1000  1:1000  PROGEN (Heidelberg, Germany) 
myc  Rabbit  1:1000  1:1000  Santa  Cruz  Biotechnology 
(Heidelberg, Germany) 
GlyR 
(mAb4a) 
Mouse    1:250  Synaptic  Systems  (Göttingen, 
Germany)(Pfeiffer et al., 1984) 
Gephyrin  Mouse    1:400  Synaptic  Systems  (Göttingen, MATERIALS AND METHODS 
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(mAb7)  Germany)(Pfeiffer et al., 1984) 
SdpI  Rabbit  1:1000  1:500  Synaptic  Systems  (Göttingen, 
Germany) 
anti-
calnexin 
Mouse    1:1000  BD  Biosciences  (Heidelberg, 
Germany) 
Anti-His6  Mouse  1:2000    Novagen (Darmstadt, Germany) 
Anti-GST  Goat  1:5000    GE Healthcare (Freiburg, Germany) 
Anti-Nbea  Rabbit    1:250  Generated  by  Dr.  M.  Kilimann  group 
(Wang et. al, 2000) 
Anti-PSD-95  Mouse    1:200  Affinity bioreagents (CO, USA) 
Anti-SdpI  Rabbit  1:1000  1:1000  Generation  in  Magdeburg  by  Dr.  B. 
Qualmann  group  (Qualmann  et.  al. 
1999) 
Gephyrin  Mouse  1:1000    BD  Biosciences  (Heidelberg, 
Germany) 
Anti-VIAAT  Rabbit    1:4000  Synaptic  Systems  (Göttingen, 
Germany) 
Anti-VIAAT  Mouse    1:1000  Synaptic  Systems  (Göttingen, 
Germany) 
Anti-Vps35  Rabbit  1:1000  1:1000  Generated in this work 
GFP  Rabbit  1:1000    Clontech (Heidelberg, Germany) 
TGN38  Mouse  1:250    BD  Biosciences  (Heidelberg, 
Germany) 
Anti-GAD67  Mouse    1:2500  Chemicon international (CA,USA)  
Anti-
GABAARγ2 
Guinea 
pig 
  1:2000  Generated  by  Dr.  J.M.  Fritschy 
(Fritschy and Mohler, 1995) 
   
3.1.10.2 Fluorescent secondary antibodies for immunostaining 
Name  Dilution  Source/Reference 
Alexa 488-anti-mouse  1:1000  Molecular Probes (Eugene, USA) 
Alexa 546-anti-mouse  1:1000  Molecular Probes (Eugene, USA) 
Alexa 488-anti-rabbit  1:1000  Molecular Probes (Eugene, USA) 
Alexa 546-anti-rabbit  1:1000  Molecular Probes (Eugene, USA) 
Alexa 635-anti-rabbit  1:500  Molecular Probes (Eugene, USA) 
Alexa 635-anti-mouse  1:500  Molecular Probes (Eugene, USA) 
Alexa 546-anti-guinea-
pig 
1:1000  Molecular Probes (Eugene, USA) 
 
3.1.10.3 Peroxidase-linked secondary antibodies for Western blot  
Name  Dilution  Source/Reference 
HRP-anti-mouse  1:5000  Promega (Madison, USA) 
HRP-anti-rabbit  1:5000  Promega (Madison, USA) 
HRP-anti-goat  1:5000  Promega (Madison, USA) 
HRP-anti-mouse  1:10000  Sigma (Saint Louis,Missouri, USA) 
HRP-anti-rabbit  1:30000  Cell signalling Technology (Frankfurt, 
Germnay) MATERIALS AND METHODS 
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HRP-anti-goat  1:10000  Dianova (Hamburg, Germany) 
 
3.1.11 Solutions and media  
3.1.11.1 Antibiotics 
Antibiotic  Stock solution  Final 
concentration 
Ampicilline  100 mg/ml  100 µg/ml 
Kanamycine  50 mg/ml  50 µg/ml 
Spectinomycine  10 mg/ml  50 µg/ml 
Tetracycline  10 mg/ml  10 µg/ml 
 
3.1.11.2 Solutions and media for cell biology 
Name  Composition 
BBS, 2X  50 mM N,N-bis(2-hydroxyethyl)-2-
aminoethanesulfonic acid (BES), 280 mM NaCl, 1.5 
mM Na2HPO4, pH 6.95 
Culture  medium  for  COS-7 
cells 
10% (v/v) FCS, 50 U/ml penicillin, 50 µg/ml 
streptomycin, 2 mM L-glutamine in DMEM (Invitrogen, 
Kalsruhe) 
Culture  medium  for  HEK 
293T cells 
10% (v/v) FCS, 50 U/ml penicillin, 50 µg/ml 
streptomycin, 2 mM L-glutamine in MEM (Invitrogen, 
Kalsruhe) 
Hybridoma freezing medium  10% (v/v) dimethylsulfoxide (DMSO) in culture 
medium 
Digestion solution for primary 
culture 
10 µg/ml DNase, 0.5 mg/ml papain, 10 mM glucose in 
PBS, pH 7.5 
Neurobasal  medium  for 
primary culture  
2% (v/v) B27 supplements (Invitrogen, Kalsruhe), 25 
µg/ml sodium pyruvate, 50 U/ml penicillin, 50 µg/ml 
streptomycin, 2 mM L-glutamine in Neurobasal 
medium (Invitrogen, Kalsruhe) 
Preparation  medium  for 
primary cultures 
10% (v/v) FCS, 23 mM sodium pyruvate, 50 U/ml 
penicillin, 50 µg/ml, streptomycin, 2 mM L-glutamine in 
DMEM 
 
3.1.11.3 Solutions for immunostaining  
Name  Composition 
Blocking solution  10% (v/v) goat serum in PBS, pH 7.5 
Fixative solution  10% (w/v) PFA in PBS, pH 7.5 
Permeabilization  solution  for 
immunocytochemistry 
0.5% (v/v) IgePal, 4% (v/v) goat serum in PBS, pH 7.5 
 
Permeabilization  solution  for 
immunohistochemistry 
0.5% (v/v) Triton X-100, 4% (v/v) goat serum in PBS, 
pH 7.5 MATERIALS AND METHODS 
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Quenching solution  25 mM glycine in PBS, pH 7.5 
Na-Citrate  buffer  for 
immunohistochemistry 
10 mM sodium citrate, 0.05% (v/v) Tween 20, pH 8.0 
 
3.1.11.4 Solutions and media for molecular biology  
Name  Composition 
LB medium  1%  (w/v)  pepton  140,  0.5%  (w/v)  yeast  extract,  1% 
(w/v) NaCl, pH 7.4 
LB-Agar  LB medium with 1.8% (w/v) agar 
Lysis buffer for mouse tails  50 mM Tris, 100 mM EDTA, 100 mM NaCl, 1% (w/v) 
SDS, pH 8.0 
TE buffer  10 mM Tris pH 8.0, 1mM EDTA 
DNA-Gel loading buffer 10X  30%  (v/v)  glycerol,  0.25%  (w/v)  xylene  cyanol  FF, 
0.25% (w/v) bromphenol blue in TE buffer, pH 8.0 
TAE  electrophoresis  buffer 
1X 
2 mM Na2EDTA⋅ 2H2O, 40 mM Tris-acetate, pH 8.5 
 
Medium  A  for  production  of 
chemocompetent cells 
10 mM MgSO4, 0.2% (w/v) glucose in LB medium, pH 
7.0  
 
Medium  B  for  generation  of 
chemocompetent cells 
36%  (v/v)  glycerol,  12%  (w/v)  PEG  (MW  7500),  12 
mM MgSO4, in LB medium, pH 7.0 
NZY* Broth medium  1%  (w/v)  NZ  amine,  0.5%  (w/v)  yeast  extract,  0.5% 
(w/v) NaCl, 12.5 mM MgCl2, 12.5 mM MgSO4, 20 mM 
glucose, pH 7.5 
 
3.1.11.5 Solutions for protein biochemistry 
Name  Composition 
Blocking  solution  (Western 
blot  with  monoclonal 
antibodies) 
1% (w/v) milk powder in TBS (see below) 
Blocking  solution  (Western 
blot  with  polyclonal 
antibodies) 
5% (w/v) milk powder in TBS (see below) 
Coomassie-staining solution  0.1% (w/v) Coomassie G (Serva), 50% (v/v) methanol, 
10% (v/v) acetic acid  
Coomassie-destaining 
solution 
7% (v/v) methanol, 7% (v/v) acetic acid 
Dnak removal buffer  2 mM ATP, 10 mM MgSO4, 50 mM Tris-Cl pH 7.4 
Elution  buffer  for  Ni-NTA 
beads 
300 mM NaCl, 250 mM imidazol, 50 mM Tris pH 8.0 
Fixative  enhancer  solution 
(Silver staining) 
50% (v/v) methanol, 10% (v/v) acetic acid, 10% (v/v) 
fixative enhancer concentrate (Bio-Rad) and 30% H2O 
Im-Ac buffer   20  mM  Hepes,  100  mM  KCl,  5  mM  EGTA,  5  mM 
MgCl2, 0.5% (v/v) Trition X-100, 1 CEFPICT in 50 ml 
H2O, pH 7.2 
Lysis buffer for bacteria (GST  1  Complete  EDTA  free  protease  inhibitor  cocktail MATERIALS AND METHODS 
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fusion proteins)  (CEFPICT) tablet in 50 ml PBS, pH 7.5 
Lysis  buffer  for  Bacteria 
(His6-Fusion proteins) 
500  mM  NaCl,  50  mM  Tris-Cl,  5  mM  β-
mercaptoethanol, 20 mM imidazol, 1 CEFPICT in 50 
ml H2O, pH 7.4 
HEK  293T  cell  homogenate 
buffer 
100 mM NaCl, 25 mM Tris-Cl, 1 CEFPICT in 50 ml 
H2O, pH 7.4 
Homogenate  buffer  (rAAV 
purification) 
150 mM NaCl, 50 mM Tris-Cl pH 8.0 
PBS 1X  137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4⋅7H2O, 
1.4 mM  KH2PO4, pH 7.5 
PBS-MK  1 mM MgCl2, 2.5 mM KCl, in 1X PBS pH 7.5 
PBS-T  1% (v/v) Tween 20 in PBS pH 7.5 
Ponceau-staining solution  3% (w/v) TCA, 2% (w/v) Ponceau S 
Protein  sample  buffer  (GST 
pulldown) 
192 µM glycine, 0.1% (w/v) SDS, 25 mM Tris-Cl pH 
7.5 
SDS loading buffer 6X  36%  (w/v)  glycerol,  0.012  %  (w/v)  bromphenolblue, 
6% (v/v) β-mercaptoethanol, 10% (w/v) SDS, 350 mM 
Tris-Cl pH 6.8 
SDS Stacking buffer (3, 4 or 
5%) 
3,4 or 5% (v/v) acrylamide, 0.1 % (w/v) SDS, 130 mM 
Tris-Cl pH 6.8 
 
SDS Resolving buffer (8, 10 
or 12%) 
8,10  or  12%  (v/v)  acrylamide,  0.1%  (w/v)  SDS,  390 
mM Tris pH 8.8 
10X  SDS-PAGE  running 
buffer 
2 M glycine, 1% (w/v) SDS, 0.25 M Tris pH 8.3 
 
TBS  150 mM NaCl, 10 mM Tris-Cl pH 7.5 
TBS-T  0.1 % (v/v) Tween 20 in TBS pH 7.5 
TBS-TT  50  mM  NaCl,  0.2%  (v/v)  Triton  X-100,  0.05%  (v/v) 
Tween 20, 20 mM Tris-Cl pH 7.5 
Transfer  buffer  for  Western 
Blot 
10% (v/v) methanol in 1X SDS-PAGE running buffer 
Washing  buffer  for  GST 
pulldown 
0.5% (v/v) Triton X-100 in PBS pH 7.5 
Washing  buffer  for  His6-
proteins 
500  mM  NaCl,  5  mM  β-mercaptoethanol,  20  mM 
imidazol, 50 mM Tris-Cl pH 7.4 
Washing  buffer  for  Affi-Gel 
matrix 
500 mM NaCl, 10 mM Tris-Cl pH 7.5 
 
3.1.12 Vectors 
Name  Source/Reference 
pBK-CMV  Stratagene (La Jolla, CA, USA) 
pBluescriptSK+  Stratagene (Heidelberg, Germany) 
pEGFP-C3  Clontech (Heidelberg, Germany) 
pGEX-4T-1  GE Healthcare Biosciences (Freiburg, Germany) 
pGEX-5x-1,2,3  GE Healthcare Biosciences (Freiburg, Germany) 
pGEX-RB  Optimized pGEX vector (Brundiers et al. 1999) 
pET-15b  Novagen (Darmstadt, Germany) MATERIALS AND METHODS 
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pQE-30  Stratagene (La Jolla, CA, USA) 
pAAV-6P-SEWB  Sebastian Kügler (Göttingen, Germany)  
pAAV_6P_noTB_attR_WB  Sebastian Kügler (Göttingen, Germany)  
pDP1 and pDP2  Jürgen Kleinschmidt (Heidelberg, Germany) 
 
3.1.13 Plasmid constructs 
Name  Insert   Receiving 
vector 
Restriction 
sites 
Source/Reference 
Myc-SdpI-pRK5  -  -  -   Kessels et al., 2006 
SdpII-l-pCMV-Tag3B  -  -  -  Kessels et al., 2006 
SdpII-s-pCMV-Tag3B  -  -  -  Kessels et al., 2006 
Myc-SdpI-6P-SEWB  Myc-SdpI  6P-SEWB  NheI-HindIII  In this work 
Myc-SdpI-siR-6P-
SEWB 
Myc-SdpI-
siR 
6P-SEWB  NheI-HindIII  In this work 
SdpISH3-P434L-
pBluescriptSK+ 
SdpISH3-
P434L 
pBluescript
SK+ 
BamHI-
EcoRI 
by Dr. Paarmann 
SdpISH3-pGEX-4T-1  SdpISH3  pGEX-4T-1  Sty-EcoRI  by Dr. Paarmann 
SdpISH3-
pBluescriptSK+ 
SdpISH3  pBluescript
SK+ 
BamHI-
EcoRI 
In this work 
SdpIΔSH3-pRSETA  SdpIΔSH3  pRSETA  BamHI-
EcoRI 
by Dr. Paarmann 
SdpIP434L-pRSETA  SdpP434L  pRSETA  BamHI-
EcoRI 
by Dr. Paarmann 
SdpII-l-pRSETA  SyndapinII-l  pRSETA  BamHI-
EcoRI 
by Dr. Paarmann 
SdpII-s-pRSETA  SyndapinII-
s 
pRSETA  BamHI-
EcoRI 
by Dr. Paarmann 
GlyRβ378-426-pGEX-5x-
1 
-  -  -  Meyer G. et al. 1995 
GlyRβ-GFP-pRK5        Maas et al. 2006 
GlyRβ-mRFP-pRK5  mRFP  GlyRβ-
pRK5 
BglII  In this work 
GlyRβΔUTR-mRFP-
pRK5 
mRFP  GlyRβ-
pRK5 
BglII  In this work 
GlyRβKKAA-mRFP1-
pRK5 
GlyRβKKAA  pRK5  EcoRI-HindIII  by Dr. Schmitt 
GlyRβPPAA-mRFP1-
pRK5 
GlyRβPPAA  pRK5  EcoRI-HindIII  by Dr. Schmitt 
DSRed2-C1  -  -  -  Clontech (Germany) 
GE45-pRSET  -  -  -  Sola et al. 2004 
Gephyrin-peGFP-C2  -  -  -  Fuhmann et al. 2002 
Gephyrin-pmRFP1  -  -  -  Maas et al. 2006 
Gephyrin-pGEX-5x-1  -  -  -  Fuhmann et al. 2002 
pEGFP-N1/CbII  -  -  -  by Dr. Papadopolous 
CollybistinII2-240-
pRSETA 
CollybistinII
2-240 
pRSETA  NheI-HindIII  by Dr. Paarmann 
Myc-Dlc1-pcDNA3  -  -  -  Fuhmann et al. 2002 
NbeaA-peGFP-N1  -  -  -  Dr. Kilimann MATERIALS AND METHODS 
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(Uppsala) 
NbeaBCD-peGFP-C1  -  -  -  Dr. Kilimann 
(Uppsala) 
NbeaEFG-peGFP-C1  -  -  -  Dr. Kilimann 
(Uppsala) 
Vps29-pGEX-RB  Vps29  pGEX-RB  NdeI - 
BamHI 
In this work 
Vps29-pCMV-SPORT6  -  -  -  RZPD 
Vps35-
pBluescriptSK+ 
Vps35  pBluescript
SK+ 
XhoI - BamHI  In this work 
Vps35-pCMV-SPORT6  -  -  -  RZPD 
Vps35-peGFP-C3  Vps35  peGFP-C3  NdeI - 
BamHI 
In this work 
Vps35-pET-15b  Vps35  pET-15b  NdeI - 
BamHI 
In this work 
Vps35-pGEX-RB  Vps35  pGEX-RB  XhoI - BamHI  In this work 
RZPD: Deutsches Ressourcenzentrum für Genomforschung GmbH. 
 
3.2  MOLECULAR BIOLOGY METHODS 
3.2.1  Alcohol precipitation of nucleic acids 
Two volumes of ice-cold 100% ethanol were added to the DNA solution mix that was left on ice 
for 15 min. The sample mix was then centrifuged for 15 min at 13.000 rpm in a table centrifuge 
at room temperature (RT). The DNA pellet was washed with 70% (v/v) ethanol at RT, centrifuged 
again for 5 min, air-dried in a vacuum centrifuge for 5 to 10 min and resuspended in water. 
3.2.2  Isolation and purification of plasmid DNA from E. coli XL1-Blue 
DNA plasmid extractions were performed using QIAGEN (Hilden, Germany) plasmid purification 
kits according to the manufacturerʼs protocol. The procedure is based on alkaline lysis of the 
bacterial cell wall (Barber et al., 1971) and consists of removal of the cell debris while keeping 
the supernatant containing the nucleic acids, followed by the degradation of RNA by RNase and 
binding of plasmid DNA to a silica-gel matrix. Washing with medium-salt solution removes RNA, 
proteins and low-molecular-weight impurities, and then DNA is eluted in a high-salt buffer.  
3.2.2.1  Small scale plasmid purification 
5 ml LB medium containing the appropriate antibiotic was inoculated with transformed E. coli 
XL1-Blue and incubated overnight at 37ºC and 250 rpm. Cells were then pelleted at 5000 x g for 
15  min,  and  plasmid  purification  was  performed  by  using  the  QIAGEN  Plasmid  Mini-kit 
(QIAGEN, Hilden, Germany) following the manufacturerʼs instructions. DNA was resuspended in 
50 µl dH2O and stored at -20ºC. MATERIALS AND METHODS 
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3.2.2.2  Large scale plasmid purification 
Bacteria were grown and harvested as cited above (3.2.2.1) but with 100 or 250 ml medium. 
Plasmid purification was performed by using the QIAGEN Plasmid Midi-kit or HiSpeed Plasmid 
Maxi-kit (QIAGEN, Hilden, Germany) following the manufacturerʼs instructions. In the case of 
plasmid Midi-preparation, 1/5 volume of 10 M ammonium acetate (pH 5.0-5.2) was added to the 
DNA solution to equalize ion concentrations and an alcohol-precipitation was performed (see 
3.2.1). DNA was resuspended in water to a final concentration of 1 µg/µl and stored at -20ºC. 
3.2.3  Determination of DNA concentration by spectrophotometry 
The concentration of a DNA solution was analyzed using a spectrophotometer Nanodrop ND-
100  (Thermo  Fisher  Scientific,  Waltham,  USA)  following  the  manufacturerʼs  instructions.  The 
concentration of DNA plasmids was determined at 260 nm and adjusted to 1µg/µl (1 OD260 nm = 
50 µg/µl for double stranded DNA). In addition, the 260 nm/280 nm ratio was measured to check 
protein contamination in the sample. This ratio should fall within a range of 1.7 to 1.8. If the ratio 
is larger than 1.8, it indicates RNA contamination. 
3.2.4  DNA sequencing 
The sequencing, separation and detection of DNA products were performed by MWG Biotech 
Inc.  (Ebersberg,  Germany).  Reactions  were  performed  with  a  non-radioactive  dideoxy  chain 
termination / cycle sequencing method (Sanger et al., 1977). 
3.2.5  Polymerase chain reaction (PCR) 
PCR, in vitro DNA amplification, invented by Kary B. Mulliscan is a technique to exponentially 
amplify in vitro a small quantity of a specific nucleotide sequence. This amplification is performed 
in the presence of template sequence, two oligonucleotide primers that hybridize to opposite 
strands and flank the region of interest in the target DNA, a thermostable DNA polymerase and a 
mixture containing the four desoxyribonucleotide triphosphates (dNTP). The reaction is cycled 
involving template denaturation, primer annealing, and the extension of the annealed primers by 
DNA polymerase. The annealing temperature is set depending on the melting temperature (Tm) 
of the primers, 5°C below the lowest melting temperature of the primers to be used. The melting 
temperature (Tm) is calculated on the basis of base composition following the simple rule: Tm = 
4 x (#C + #G) + 2 x (#A + #T). The length of the amplified fragment and the elongation kinetics of 
chosen polymerase (1 kb per min for the DNA polymerases used in this thesis) determine the MATERIALS AND METHODS 
 
  34 
elongation duration.  
 
Preparative PCR reaction: 
 
Component  Amount 
Template DNA  500 ng 
Sense primer  (100 pmol/µl)  0.5 µl 
Antisense primer (100 pmol/µl)  0.5 µl 
dNTP mix (2.5 mM each)  2.5 µl 
DNA polymerase  0.5 µl 
ThermoPol Reaction Buffer (10 X)   5 µl 
H2O  Add up to 50 µl 
 
Criteria for choice of DNA polymerase:  
-  Deep Vent: 3ʼ to 5ʼ proofreading exonuclease activity, high fidelity, used for preparative 
PCR.  
-  Taq: high yield, no proofreading activity, used for analytical PCR. 
Program for preparative PCR: 
Phase  Temperature  Time  Cycles 
Initial denaturating  95ºC  5 min  1 
Denaturing  95ºC  30 sec 
Annealing  50ºC  30 sec 
Elongation  72ºC  1min/kb DNA 
 
20 
Final elongation  72ºC  3 min  1 
 
PCR  products  were  purified  by  agarose  gel  electrophoresis  (see  3.2.6.3)  and  eluted  (see 
3.2.6.4), further elongated with other PCR products and then cloned into the desired vector. For 
elongation with other PCR products, the PCR reaction was performed as detailed above, but the 
reaction contained both purified amplicons, the sense primer of the amplicon to be elongated 
upstream and the antisense primer of the amplicon to be elongated downstream.  
 
3.2.6  Cloning procedures 
Primer design and all major cloning steps were first simulated using MacVector 8.0 software 
(Accelrys Inc. Sand Diego, USA). Restriction sites necessary for cloning of the DNA fragments 
into respective plasmids, as well as epitope sequences were introduced in the cDNAs by PCR MATERIALS AND METHODS 
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using  the  corresponding  primers.  All  basic  cloning  procedures  were  essentially  performed 
according  to  the  protocols  described  in  Molecular  Cloning  Laboratory  Manual,  3rd  edition 
(Sambrook, J. et al., 1989).  
3.2.6.1  Site-directed mutagenesis 
In order to introduce desired point mutations in a DNA sequence, site-directed mutagenesis was 
employed using the PCR technique. For this purpose, 3´ and 5´primers containing a different 
base in the center of the primer sequence were designed with at least 10-15 bases at both the 
5ʼ- and 3ʼ- ends of the primer with 100% sequence complementarity. Primer length was about 30 
bp, with a G+C content of about 50%, and was adjusted depending on the G+C content, melting 
temperature  (as  in  3.2.5)  or  web-based  prediction  (Promega).  Mutagenic  oligonucleotides 
incorporate  at  least  one  base  change,  but  can  be  designed  also  to  generate  multiple 
substitutions, insertions or deletions. When using such primers in a PCR reaction, the amplicon 
will contain the desired point mutation.  
 
3.2.6.2  DNA restriction by endonucleases 
For  the  sequence-specific  digestion  of  doubled  stranded  DNA,  restriction  enzymes  and  the 
corresponding buffer from the companies Roche (Mannheim, Germany) or NEB (Ipswich, USA) 
were  employed.  Buffers  and  temperatures  for  the  reaction  were  chosen  according  to 
manufacturerʼs instructions. Per 1 µg of DNA, 2-5 U of restriction enzyme were used. Since high 
concentrations of glycerol inhibit enzyme activity, all glycerol-containing enzyme suspensions 
were  diluted  at  least  10  times.  DNA  digestion  with  two  different  restriction  enzymes  was 
performed  simultaneously  whenever  possible.  Otherwise,  when  serial  DNA  restriction  was 
required,  the  DNA  was  precipitated  after  the  first  digestion  with  Sureclean  (Bioline  GmbH, 
Luckenwalde, Germany) following the manufacturer´s instructions. Incubations were carried out 
according  to  conditions  suitable  for  the  corresponding  enzyme:  37°C  during  4-6  h  for  PCR 
cloning, 2 h for non-PCR cloning or 30 min for electrophoretic analysis.  
Standard reaction mix:  
Component  Amount (for analysis)  Amount (for cloning) 
Plasmid DNA  0.5 µg   5 µg 
Buffer 10 X  1 µl  2 µl 
BSA 10 X  1 µl  2 µl 
Enzyme 1 (10 U/µl)  0.5 µl  1 µl 
Enzyme 2 (10 U/µl)  0.5 µl  1 µl 
H2O  Add up to 10 µl   Add up to 20 µl MATERIALS AND METHODS 
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3.2.6.3  Separation of oligonucleotides by agarose gel electrophoresis 
A horizontal agarose gel electrophoresis system was used for the separation of double- stranded 
DNA in both analytical and preparative studies (plasmids solutions, PCR products). Depending 
on the expected sizes of the DNA fragments, gels with different concentrations of agarose (0.5-
2% (w/v); Biozym, Hess. Oldendorf) in TAE buffer were prepared. DNA samples were mixed 
with 1/10 of loading buffer 10X, loaded onto the gel in parallel with 10 µl of DNA SmartLadder 
marker (Eurogentec, Cologne, Germany) and run in TAE buffer for 30 min at 120 V. For the 
detection and visualization of DNA by UV illumination (254 nm), gels were stained with 1µg/ml 
ethidium bromide solution. Images were taken using the Gel Documentation 2000 System (Bio-
Rad, Hercules, USA). 
3.2.6.4  Isolation of DNA fragments from agarose gels 
To isolate DNA fragments from a sample after restriction digestion or PCR amplification, the 
samples  were  subjected  to  gel  electrophoresis  (see  3.2.6.3).  Under  302  nm  illumination, 
fragments of desired size were cut out of the gel using a sterile scalpel and placed in 1.5 ml 
micro-centrifuge  tubes.  DNA  was  purified  with  the  QIAquick  Gel  Extraction  Kit  (QIAGEN, 
Germany) based on the principle of spin-column technology which exploits the selective binding 
properties of a silica-gel membrane. The purified samples were vacuum-dried and resuspended 
in 10 µl H20.   
3.2.6.5  Dephosphorylation of DNA ends 
In  order  to  avoid  re-ligation  of a   linearized  vector,  the  free  ends  of  the  vector  were 
dephosphorylated  after  restriction  digestion.  3  U  of  calf  intestinal  alkaline  phosphatase  were 
added to the restriction reaction per 1 µg of DNA and incubated at 37ºC for 60 min. The reaction 
was stopped by incubation at 56ºC for 10 min, and the product was analysed and purified by gel 
electrophoresis (see 3.2.6.3).  
3.2.6.6  Ligation of DNA fragments 
To  generate  new  constructs  by  sticky  end  ligation  of  a  DNA-insert  into  a  dephosphorylated 
vector,  gel-purified  fragments  were  quantified  on  agarose  gels  by  comparing  their  staining 
intensity with weight marker bands of the standard SmartLadder. Fragments were used for the 
ligation reaction according to the following standard protocol:  
Component  Amount 
Vector  fragment  50 ng  MATERIALS AND METHODS 
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Insert fragment  x 
T4 DNA ligase (1U/µl)  0.5 µl 
Quick Ligation Buffer (2 X)  5 µl 
10 mM ATP   0.5 µl 
H2O  Add up to 10 µl 
x : calculated amount for vector: insert molar ratio, generally 1:3 
 
As a negative control, the same reaction was run in the absence of insert. Ligation reactions 
were performed at 25ºC for 30 min. 
3.2.6.7  Direct purification of PCR products 
After amplification by PCR, DNA fragments were isolated from the reaction mixture via reversible 
binding to a silica matrix using the QIAquick PCR Purification Kit (QIAGEN, Hilden, Germany) 
and following the manufacturerʼs instructions. 
3.2.6.8  Transformation of chemo-competent cells  
A frozen 50-100 µl aliquot of chemo-competent E. coli was thawed on ice for 5 min. To the 
bacterial solution, 5-10 µl of the ligation reaction or 10-100 ng of plasmid DNA was added. The 
mixture was stirred and incubated on ice for 30 min. The cells were then subjected to a heat-
shock pulse at 42ºC for 20 seconds for E. coli BL21 cells and 30 seconds for other  E. coli 
strains, then chilled on ice for 1-2 min and diluted in SOC medium for the transformation of E. 
coli Turbo cells (NEB, Ipswich, USA), and into LB for other E. coli strains. E. coli Turbo cells 
were directly plated on agar plates. Other E. coli strains were incubated at 37ºC under rotation 
for  60  min  to  allow  bacterial  growth.  The  bacterial  suspension  was  then  pelleted  in  a  table 
centrifuge at 400 x g for 10 min. The bacterial pellet was resuspended in 200 µl LB medium to 
spread the bacteria on agar plates containing the appropriate antibiotic concentration. Plates 
were incubated overnight at 37ºC. 
3.2.6.9  Transformation of electro-competent cells 
A frozen aliquot of electro-competent E. coli XL1-Blue bacteria was thawed on ice for 5 min and 
kept on ice. The DNA ligation product (3 - 5 ng DNA) or 100 ng of plasmid-DNA were then added 
to 50 µl of the electro-competent E. coli cells. The mixture was transferred to a cuvette prechilled 
on ice, and subjected to electroporation with a Gene Pulser II (Bio-Rad, Munich, Germany) at a 
voltage of 2.5 kV, a pulse controller- low resistance of 200 Ω, and a capacitance of 25 µF. 
Immediately  after  the  pulse,  1  ml  of  LB  medium  was  added  to  the  cells,  and  the  bacterial 
suspension was transferred to a sterile tube. The transformed E. coli were incubated for 40 min 
under  shaking  at  37ºC,  and  spread  on  agar  plates  containing  the  appropriate  antibiotic MATERIALS AND METHODS 
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concentration for clone selection. Plates were incubated overnight at 37ºC.  
3.2.7  Preparation of glycerol stocks 
For long-term storage of transformed XL1-Blue or Turbo E. coli, 800 µl of grown bacterial culture 
were added to 200 µl of autoclaved glycerol under sterile conditions. After vortexing, the cells 
were mixed and stored at -80°C. 
3.2.8  Preparation of chemo-competent bacterial cells 
Chemo-competent bacteria were prepared according to the method of Nishimura et al. (1990). E. 
coli XL1-Blue cells were spread on agar-plates containing 10 µg/ml tetracycline and incubated 
overnight at 37ºC. A single colony was inoculated in a pre-culture of 10 ml LB medium, which 
was incubated overnight at 37ºC. A culture of 50 ml of medium A (see 3.1.11.4) was inoculated 
with 0.5 ml of the overnight grown pre-culture and incubated at 37ºC until the mid logarithmic 
phase  (OD600  nm  =  0.3-0.5).  The  presence  of  10  mM  Mg
2+  in  the  medium  stimulates 
transformation efficiency, and the increased growth rate due to the extra carbon source glucose 
enhances transformation efficiency. The cells were then kept on ice for 10 min, pelleted at 1500 
x g for 10 min at 4° C, resuspended gently in 0.5 ml of ice-cooled medium A, and then 2.5 ml of 
ice-cooled  storage  solution,  medium  B,  sterilized  by  filtration  (see  3.1.10.4),  was  added  and 
mixed well without vortexing. The resulting competent cells were divided in aliquots of 0.1 ml 
each in Eppendorf tubes, rapidly frozen in liquid nitrogen and stored at –80°C until use for up to 
6 months. 
3.2.9  Genotyping of SdpI -/- mice 
The  SdpI  -/-  mouse  line  was  generated  during  the  thesis  project  of  Dr.  D.  Koch  in  Jena  
(Germany) and at our disposal on a collaborative basis.  
3.2.9.1  Extraction of genomic DNA from mouse tail tissue 
Approximately  5  mm  of  tail  tissue  from  newborn  mice  were  digested  overnight  in  a  solution 
containing 500 µl of lysis buffer (see 3.1.11.4) and 3.2 µl of Proteinase K at 55ºC under 1400 
rpm shaking. Then the tubes were vortexed briefly and centrifuged at 13000 rpm for 5 min in a 
table centrifuge. 450 µl of the supernatant were transferred to a new tube, and 500 µl of 2-
propanol  added.  Tubes  were  shaken  and  centrifuged  again  for  10  min  at  13000  rpm  to 
precipitate genomic DNA. The resulting pellets were washed with 250 µl of 70% (v/v) ethanol, MATERIALS AND METHODS 
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dried in vacuum centrifuge for 5 min and resuspended in 100 µl of TE buffer (see 3.1.11.4). 
3.2.9.2  Rapid extraction of genomic DNA from embryonic tissue 
During the preparation of KO and WT spinal cord cultures, fast genotyping of embryonic tissue 
was required. For this, the REDExtract-N-AmpTissue PCR-Kit (Sigma, USA) was used following 
the  manufacturerʼs  instructions.  For  the  analysis  of  mouse  tails,  two  different  PCR  reactions 
were performed: one WT-lox PCR (IP77 forward primer and IP78 reverse primer) to detect the 
WT allele and one KO-lox PCR (IP79 forward primer and IP80 reverse primer) to identify the KO 
allele.  
The following components were included in each PCR-reaction mixture (25 µl total volume): 
Component  Amount 
NH4
+ reaction buffer + 1.5 mM MgCl2  3.25 µl  
dNTP mix (10 mM each)  0.5 µl 
PANScript (5 U/µl)  0.125 µl 
Primer mix (5 µM each)  5.0 µl 
Tail DNA  0.5 µl 
H2O  15.625 µl 
 
Both the WT and KO PCR reactions were performed with the following amplification program: 
Phase  Temperature  Time  Cycles 
Initial denaturating  95ºC  5 min  1 
Denaturing  95ºC  30 sec 
Annealing and 
elongation 
60ºC  30 sec 
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Final elongation  72ºC  3 min  1 
 
To the PCR samples, 1/10 volume of 10 X DNA-loading buffer was added. 20 µl of each DNA 
sample were loaded onto an agarose gel and analyzed by gel electrophoresis (see 3.2.6.3). 
Expected  sizes  of  amplified  DNA  fragments  were  355  bp  for  WT  and  227  bp  for  KO, 
respectively.  
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3.3  PROTEIN BIOCHEMISTRY METHODS 
3.3.1  Colorimetric determination of protein concentration 
For determining protein contents, the DC Protein Assay Kit from Bio-Rad (Munich, Germany) 
was used. Assays were performed following the manufacturerʼs instructions in 96-well plates. 
For each protein sample, three replicates of sample solution and protein standard (BSA) solution 
were analyzed. Absorption at 750 nm was measured using a Fluostar Galaxy spectrophotometer 
(BMG Labtech, Offenburg, Germany). 
 
3.3.2  Discontinuous Polyacrylamide Gel Electrophoresis (PAGE) 
In  a  discontinuous  PAGE  system  (Laemmli,  1970),  protein  complexes  migrating  through  a 
stacking gel of low density (3-5% polyacrylamide) are concentrated in a very thin zone on the 
surface  of  a  resolving  gel.  By  migrating  through  the  resolving  gel  of  higher  density  (8-12% 
polyacrylamide), proteins are then separated according to their molecular mass. Before proteins 
are loaded into this discontinuous pH-gel system, they are dissociated by heating the samples in 
the  presence  of  the  strong  anionic  detergent  such  as  sodium  dodecyl  sulfate  (SDS)  in 
combination  of  a  reducing  agent  β-mercaptoethanol  or  dithiothreitol  (DTT).  The  denatured 
polypeptides bind SDS and become negatively charged. Because the amount of SDS bound is 
almost always proportional to the molecular weight and largely independent of the aa sequence, 
the migration of polypeptides through the SDS-gel is solely determined by their size.  
Here, the polymerized gel was mounted in a vertical mini-electrophoresis chamber (MiniProtean 
3, Bio-Rad; Munich, Germany), and reservoirs were filled with 1X SDS-PAGE running buffer. 
Before loading, 1/6 volume of SDS loading buffer was added to the protein samples, which were 
then heated at either 48ºC for the analysis of membrane proteins, or at 95ºC for the analysis of 
soluble proteins, for 10 min. The electrophoresis was carried out at 25 mA per gel, until the 
bromphenol blue dye in the sample buffer had reached the bottom of the gel. Protein bands were 
either  visualized  by  Coomassie  staining  (see  3.3.3),  or  silver  staining  (see  3.3.4),  or  were 
transferred to a membrane by Western blotting for immunodetection (see 3.3.5). 
 
3.3.3  Coomassie staining of protein gels 
Proteins  separated  by  SDS-PAGE  were  simultaneously  fixed  and  stained  with  Coomassie MATERIALS AND METHODS 
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staining solution (Wilson, 1983). Coomassie Brilliant Blue R/G 250 is a triphenylmethane dye 
that binds nonspecifically to proteins and forms strong but not covalent complexes with positively 
charged aa. This method has a detection limit of 50-100 ng of protein per band.  
In order to visualize proteins on gels, gels were stained by incubating with Coomassie staining 
solution for 10 min on a shaker at 50 rpm. The staining solution was replaced by destaining 
solution and kept overnight on the shaker at 50 rpm to wash away unspecifically bound dye. The 
gels were then inspected under bright light, and pictures were taken either with a digital camera 
or the gel documentation 2000 system (Bio-Rad; Munich, Germany).  
 
3.3.4  Silver staining of protein gels 
When staining a SDS polyacrylamide gel with a solution of silver nitrate, ions of silver bind to the 
side chains of aa and are afterwards reduced, thus giving a brown-black colour to the protein 
bands. This method has a detection limit lower than the Coomassie staining, of about 0.1-1 ng of 
protein per band. Silver staining of SDS polyacrylamide gels was performed using the Silver 
Stain Plus-Kit from Bio-Rad (Munich, Germany) following the manufacturerʼs instructions. 
3.3.5  Western blot analysis 
Western blotting is extremely useful for the identification and quantification of a specific protein in 
complex  mixtures  of  proteins  that  are  not  radiolabeled.  In  this  technique,  electrophoretically 
separated protein samples (see 3.3.2) are transferred from a gel to a solid membrane support 
and probed with antibodies that react specifically with a particular antigenic epitope. Proteins can 
be detected down to femtomole quantities, well below the detection limit for most other staining 
methods. 
3.3.5.1  Membrane transfer 
Following SDS-PAGE the separated proteins were transferred to a membrane by electrotransfer 
using  a  Mini  Trans-Blot  electrophoretic  chamber  (Bio-Rad;  Munich,  Germany).  PVDF 
membranes were pre-rinsed in pure methanol for 2 min and equilibrated in transfer buffer for 10 
min.  Nitrocellulose  membranes  were  pre-rinsed  in  transfer  buffer  for  2  min.  Subsequently, 
membranes  were  stapled  at  the  cathode  side  of  the  transfer-cassette  in  the  following  order: 
Whatman paper, protein gel, nitrocellulose membrane/ PVDF filter and again Whatman paper. 
The transfer was carried out in transfer buffer (see 3.1.11.5) at 10 V overnight, or at 100 V for 1h 
30 min, on ice. After transfer, membranes were taken out and processed for immune detection MATERIALS AND METHODS 
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with specific antibodies.  
3.3.5.2  Immune detection with specific antibodies 
The specific identification of protein bands was done by indirect immune detection. To avoid 
unspecific binding of the primary antibody, the membrane was incubated with blocking solution 
(see 3.1.11.5) for at least 45 min at RT under shaking. The membrane was then incubated, 
depending of the primary antibody to be used, overnight at 4ºC, or for 1 h 30 min at 25ºC, with 
blocking  solution  containing  a  proper  dilution  of  the  primary  antibody.  Subsequently,  the 
membrane  was  washed  twice  with  TBS-TT/TBS-T  for  10  min  to  remove  unbound  primary 
antibody,  and  once  with  TBS  for  10  min  to  remove  detergent.  Then  the  membrane  was 
incubated with blocking solution containing a dilution of secondary antibody conjugated to HRP 
for 1 h at (RT). After washing at least four times for 10 min with TBS-TT, visualization of the 
protein  bands  was  performed  by  chemiluminecence.  The  membrane  was  incubated  with 
enhanced chemiluminescence (ECL) solution (Super Signal West Pico, Perbio Science GmbH; 
Bonn Germany) following the manufacturerʼs instructions for 5 min at RT. HRP is an enzyme that 
catalyzes  the  oxidation  of  the  luminol-based  substrate, l eading  to  an  excitation  of  the 
chemiluminescent  substrate  that  generates  light  at  the  site  of  reaction  which  is  visualized 
through exposure to an X-ray film. The membrane was exposed to X-ray films (3.1.6) for variable 
times.  An  AGFA X -OMAT  2000  processor  (Kodak,  Atlanta,  USA)  was  used  to  develop  the 
exposed films.  
3.3.5.3  Scanning of bands  
Developed films were scanned using Epson Perfection 4780 Photo (Epson, Long beach, USA). 
Images were obtained and optimized using Epson and Adobe Photoshop software. The images 
were  analyzed  subsequently  for  determining  binding,  expression,  antibody  specificity,  etc. 
Parameters like band size or band intensity for the protein of interest were determined using the 
ImageJ image analysis software (NIH, USA). Each experiment was performed three times. Data 
are presented as means ± standard error (S.E.M.) Statistical significance was evaluated with a 
two tailed Studentʼs t-test. 
 
3.3.6  Expression of recombinant proteins in E. coli BL21 
For  the  expression  of  recombinant  proteins  in  bacteria,  the  desired  plasmid  construct  was 
transformed by heat-shock into E. coli BL21 DE3 (see 3.2.6.8.). The bacteria were spread on an MATERIALS AND METHODS 
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agar plate with the respective antibiotic and incubated overnight at 37ºC. With a single colony, a 
pre-culture of 20 ml LB medium containing the proper antibiotic was inoculated and incubated 
overnight at 37ºC under shaking. The next day, 5 ml of the pre-culture medium were used to 
inoculate 200 ml LB medium containing antibiotic, which then was left shaking at 250 rpm and 
37ºC. When the culture reached the exponential growth phase (OD600nm between 0.7-0.9), an 
aliquot equivalent to 1 OD was separately stored at  
-20ºC for SDS-PAGE analysis. The culture was then cooled down to 25ºC. This gives newly 
formed  proteins  more  time  to  fold  correctly  and  thus  increases  the  protein  yield.  Protein 
expression was induced by the addition of IPTG (Isopropyl-β-D-thiogalactopyranoside) to a final 
concentration of 0.2 mM. IPTG compound is used as a molecular mimic of allolactose, a lactose 
metabolite that triggers transcription of the lac operon in the plasmid. The culture was left at 
25ºC with shaking at 250 rpm overnight. The OD600 of the induced culture was measured the 
next day, and a culture equivalent to 1 OD600 was separately stored for analysis as previously 
described. Then, the bacterial culture was centrifuged at 5000 x g for 20 min, and the pellet was 
either frozen at -20ºC for further analysis or resuspended in PBS for direct use. For examining 
protein expression, aliquots of the culture prior to and after induction were separated by SDS-
PAGE and stained with Commassie (see 3.3.3) or further analyzed by Western blotting (see 
3.3.5). 
3.3.7  Affinity purification of GST- and His6- fusion proteins 
In order to reduce protease activity, all steps were carried out on ice, with cold buffer and using 
cold centrifuges. Recombinant GST- or His6- fusion proteins were expressed from pGEX-5x-1, 
pGEX-RB, pGEX-4T-1, pQE-30, pQE-32, pRSET-A or pET-15b in E. coli BL21 DE3 (see 3.3.6). 
All procedures were performed in the cold room whenever possible. 
3.3.7.1  Lysis of bacteria by sonication 
Bacterial  pellets  (see  3.3.6)  were  resuspended  in  1  ml  of  lysis  buffer.  Lysis  of  the  bacterial 
membrane was achieved by applying several sonication pulses of 1 min with a Branson Sonifier 
(Kyonggi-do, Korea) at an output level of 4 and with a 50% duty cycle on ice. To the sonified 
suspension, 20 % (v/v) Triton X-100 was added to a final concentration of 1% (v/v), and tubes 
were placed on an overhead shaker at 4ºC for 30 min for solubilization of membrane proteins. 
For the removal of cell debris, the resulting lysate was centrifuged at 10000 x g for 30 min. The 
supernatant was aliquoted in 100 µl aliquots, shock frozen in liquid nitrogen and stored at -70ºC. MATERIALS AND METHODS 
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3.3.7.2  Purification of His6- fusion proteins 
The purification of recombinant proteins tagged with six consecutive histidine residues at the N-
terminus  was  performed  using  a  nickel-nitrilotriacetic  acid  (Ni
2+-NTA)  metal-affinity 
chromatography  agarose  matrix  from  Qiagen  (Hilden,  Germany).  The  Ni
2+-NTA/His-tag 
purification  system  is  based  on  the  high-affinity  binding  of  6  neighboring  histidines  to 
immobilized metal ions such as Ni
2+. The metal ion is bound to a sepharose matrix by NTA, 
which is a chelator with four sites available for interaction with metal ions and thus minimizes 
leaking of the metal from the solid support. Proteins containing the His6 tag are bound to the 
matrix  through  their  interaction  with  the  Ni
2+  cations,  whereas  unbound  proteins  are  washed 
through. The bound His-tagged protein can then be recovered by elution with imidazole. 
Per 10 ml bacterial lysate, 600 µl of Ni
2+-NTA agarose matrix were used. The matrix was washed 
first with PBS and then incubated on an overhead shaker with the bacterial lysate for 2 h at 4ºC. 
Afterwards, unbound proteins were washed out by washing twice with PBS, and contaminant 
proteins like the DnaK chaperones were removed from binding proteins by washing with 10 bead 
volumes of DnaK removal buffer, once under overhead rotation for 10 min at 37ºC and once 
shortly at 4ºC. Furthermore, the protein suspension was washed once with PBS and twice with 
washing buffer for His6-tagged proteins. Elution of the bound His6-fusion proteins from the matrix 
was performed in five elution steps. For each step, 70 µl of the elution buffer for Ni-NTA beads 
were used per 100 µl Ni-NTA agarose beads. The eluates were mixed, and reducing and toxic 
components like β-mercaptoethanol and imidazol were removed from the protein suspension by 
dialysis against the respective elution buffer lacking β-mercaptoethanol and imidazol. Dialysis 
was with 200-500 times the volume of the sample at 4ºC overnight, with dialysis buffer changes 
after 2 and 4 hours. The protein in the dialysed solution was then concentrated to 0.4-0.5 µg/ml 
by centrifugation using an Amicon filter, with an appropriate molecular weight cut off following 
the manufacturerʼs instructions (Millipore, Wartford, USA). Protein samples were shock-frozen in 
liquid nitrogen and stored at -80ºC until further use. 
3.3.7.3  Purification  of  GST-fusion  proteins  by  glutathione-sepharose  affinity 
chromatography 
In the GST-pulldown technique (Kaelin et al., 1991) recombinant proteins fused to glutathione-S-
transferase (GST) are purified due to the high affinity binding of GST to glutathione immobilized 
on sepharose GSH-matrix (GE Healthcare, Freiburg). An amount of 28-35 µl GSH-matrix was 
washed twice with 1 ml of PBS. Then the glutathione-sepharose matrix was incubated with the 
bacterial lysate (see 3.3.7.1) for 2 h at 4ºC under overhead shaking. The protein-loaded matrix MATERIALS AND METHODS 
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was washed once with 1 ml of 0.1% (v/v) Triton X-100 in PBS, once with 1 ml DnaK removal 
buffer and once with 1 ml 0.1% (v/v) Triton X-100 in PBS.  
3.3.8  GST pull-down assay for the analysis of protein-protein interactions 
To analyze the interaction between two proteins, one of the binding partners was tagged with 
GST  and  immobilized  on  a  GSH-matrix  (see  3.3.7.3).  The  immobilized  protein  bound  to  the 
matrix was then incubated with a protein suspension, lysate from E. coli or detergent extract 
from mammalian cells, for 2 h at 4ºC on an overhead shaker to allow putative binding partners to 
bind to the GST protein. The incubation was performed in the presence of 1% (v/v) Triton X-100 
to prevent unspecific binding. Then the matrix was washed four times with 1 ml of wash buffer; 
washing included centrifugation at 2000 x g for 2 min at 4ºC and removal of the supernatant. 
After the last washing step, the supernatant was completely removed, and bound proteins were 
eluted from the matrix by two incubations with 20 µl of sample buffer followed by shaking at 48ºC 
and 1400 rpm in a thermo-mixer and centrifugation at 2000 x g at RT. The eluates were then 
mixed with 7 µl of SDS loading buffer and further analyzed by SDS-PAGE (see 3.3.2) or Western 
blotting (see 3.3.5). 
3.3.9  Co-immunoprecipitation  
Solubilization of membrane proteins in the P3 fraction isolated from spinal cord homogenates 
was performed by the addition of 0.5% (v/v) Triton X-100 and incubation for 30 min at 4ºC under 
shaking.  50  µl  of  protein  G-agarose  (Roche  Diagnostics,  Mannheim,  Germany)  was  washed 
twice with Im-Ac buffer. 600 µl of P3 lysate were pre-cleared by incubation with 50 µl of protein 
G-agarose for 1 h at 4ºC. After the agarose beads had been spun down at 5000 x g for 1 min, 
150 µl of the pre-cleared supernatant was incubated with the corresponding antibody diluted 
1:10 overnight at 4ºC under shaking. Subsequently, 1 volume of protein G-agarose slurry was 
washed  once  with  Im-Ac  buffer,  centrifuged  at  5000  x  g  for  1  min.  The  bead  pellet  was 
resuspended in one volume of Im-Ac buffer to obtain a 50% slurry. 50 µl of this bead slurry was 
added to the spinal cord detergent extract incubated with antibodies and re-incubated for 4 h at 
4ºC. Afterwards, the agarose matrix was washed with 1 ml of Im-Ac buffer for four times. Bound 
proteins were eluted by the addition of 50 µl of SDS sample buffer (3.1.11.5) and analysed by 
SDS-PAGE (3.3.2) and Western blotting (3.3.5). MATERIALS AND METHODS 
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3.3.10 Production of polyclonal antibodies 
The production of polyclonal antibodies against Vps35 was carried out through a collaboration 
with  the  group  of  Jaroslav  Blahos  at  the  Academy  of  Sciences  of  the  Czech  Republic.  Two 
rabbits  were  immunized  5  times  with  purified  His6-tagged  Vps35  (see  3.3.7.2)  following  the 
schedule given below:  
 
Day  Procedure 
0  1
st Injection 
7  2
nd Injection 
14  3
rd Injection 
21  Sera test 
28  4
th Injection 
35  Sera test 
42  5
th Injection 
49  Final bleed 
 
The  specificity  of  the  resulting  immunesera  was  analysed  by  Western  blotting  and 
immunocytochemistry.  In  western  blot,  immunoreactivity  against  the  following  antigens  was 
tested:  purified  recombinant  His6-Vps35,  detergent  extract  of  COS-7  cells  expressing  eGFP-
Vps35 and of untransfected COS-7 cells, and detergent extract of rat spinal cord.  
3.3.11 Purification of polyclonal antibodies by antigen affinity chromatography 
The previously purified His6-tagged Vps35 (see 3.3.7.2) was immobilized onto a pre-activated 
Affi-Gel 15 matrix (Bio-Rad, Munich, Germany). Before coupling the antigen to the gel, the matrix 
was washed with three bed volumes of dH2O at 4ºC. Then, 4ml of 0.5 mg/ml His6-tagged Vps35 
protein was added to 2 ml of matrix, which was gently agitated to get a uniform suspension. The 
mixture was incubated for 5 h at 4ºC on an overhead shaker. The remaining active ester groups 
were blocked by adding 0.1 ml of 1 M glycine, pH 8.0, per 1 ml of gel for 1 h. The gel was 
transferred to a glass column and intensely washed first with water, then with 10 bed volumes of 
10 mM Tris-Cl, pH 7.5, and subsequently with 10 bed volumes of 100 mM glycine-HCl, pH 2.5, 
followed by 10 volumes of 10 mM Tris, pH 8.8, until the pH of the column effluent reached a 
value of 7.5. The polyclonal serum was diluted 1:10 in 10 mM Tris-Cl, pH 7.5, and passed three 
times through the column to ensure complete binding of the antibody. Afterwards the gel was 
washed  with  20  bed  volumes  of  10  mM  Tris-Cl,  pH  7.5,  and  then  with  20  bed  volumes  of MATERIALS AND METHODS 
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washing buffer. Antibodies bound to the immobilized antigen by acid-sensitive interactions were 
eluted by passing 10 bed volumes of 100 mM glycine-HCl, pH 2.5, through the column. The 
eluates were immediately neutralized by collecting them in tubes containing 1 bed volume of 1 M 
Tris-Cl,  pH  8.0.  The  pH  value  should  adjust  to  pH  8.0  and  was  rapidly  checked.  If  needed, 
additional 1 M Tris-Cl buffer, pH 8.0, was added to the eluates. Then, columns were washed 
with 10 mM Tris-Cl, pH 8.8, until the pH reached a value of 8.8. Antibodies bound to the column 
by base-sensitive interactions were eluted by passing 10 bed volumes of freshly prepared 100 
mM triethylamine, pH 11.5, through the column. Eluates were neutralized by collection in a tube 
containing 1 bed volume of 1 M Tris-Cl, pH 8.0. Subsequently, columns were washed with 10 
mM Tris-Cl, pH 8.8, until the pH of the column had reached a value of 8.8. For further use, the 
columns were stored in 0.01 % merthiolate.  
 
3.4  METHODS FOR VIRAL INFECTION 
3.4.1  Calcium phosphate transfection for the production of recombinant adeno-
associated virus (rAAV) 
In  the  calcium  phosphate  transfection  method  (Graham  and  Van  der  Eb,  1973),  a  sodium 
phosphate solution (BES) is mixed with a calcium phosphate solution containing a DNA sample. 
The resulting calcium phosphate-DNA complexes adhere to the cell membrane and enter the 
cytoplasm by endocytosis.  
The calcium phosphate transfection of HEK 293T cells was carried out in 10 cm cell culture 
dishes. Cells were split into 20 culture dishes one day before transfection. At the time point of 
the  transfection  cultures  were  approx.  50%  confluent.  For  each  dish,  10  µg  of  DNA  mix 
containing 10µg pDP1, 10µg pDP2 and 5 µg of the rAAV encoding the gene of interest were 
mixed with 375 µl dH2O and 125 µl 1 M calcium chloride. Rapidly 500 µl of 2 X BES buffer was 
added to the solution, vortexed for 5 seconds and incubated at RT for 5 min. The mixture was 
added to 7 ml of pre-heated MEM medium, which was then used to replace the culture medium 
of  one  dish.  Cells  were  then  incubated  overnight  at  37ºC  and  3%  CO2.  After  24  hours,  the 
medium was replaced by fresh medium. The transfected cells were then transferred to a 5% CO2 
incubator and left for another 24 hours in culture. Subsequently, the cells were washed and 
resuspended with PBS and transferred to a 15 ml falcon tube. After 10 min centrifugation at 
1000 x g, supernatant was removed, and the cell pellet was stored at -20ºC until further analysis. MATERIALS AND METHODS 
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3.4.2  Preparation of HEK 293T detergent extract for rAAV purification 
Forty-eight hours after transfection, cells were harvested from the culture dishes after removing 
the medium by using a cell scraper. Cells from 20 dishes were resuspended in 8 ml homogenate 
buffer,  DNAse  treatment  was  carried  out  by  adding  1.6  µl  of  Benzonase  (300  U/µl)  and 
incubation for 30 min at 37°C. Afterwards the cells were subjected to a “shock freeze” cycle in an 
ethanol dry-ice bath three times for approximately 10 min and afterwards in a 37°C waterbath. 
During these incubations, the suspension was slightly shaken every 5-10 min. Subsequently the 
suspension was spun for 30 min at 4000 x g. The supernatant containing the virus particles was 
removed from the pellet, and further purification of virus was performed as explained below (see 
3.4.3). 
3.4.3  rAAV purification through an iodixanol gradient 
To obtain different Iodixanol (Opti Prep
TM Fresenius Kabi, Norge, Axis-Shield, Oslo, Norway) 
gradients, solutions were intermixed as is indicated in the following table: 
Gradient  54% Iodixanol 
(working solution) 
2 M NaCl  PBS-MK  Final volume 
15 %  12 ml  21.6 ml  9.6 ml  43.2 ml 
25 %  20 ml  -  23.2 ml  43.2 ml 
40 %  32 ml  -  11.2 ml  43.2 ml 
 
Diluted supernatant containing the virus particles (see 3.4.2) was carefully loaded onto 25 x 89 
mm centrifuge  tubes  (Beckmann  Instruments,  CA,  USA)  filled  with  a  discontinuous  iodixanol 
gradient. The gradients were composed of 6 ml of 15 %, 4 ml of 25 %, 3 ml of 40 % and 3 ml of 
54  %  iodixanol.  The  discontinous  gradient  was  prepared  with  an  underlayering  technique  in 
which solutions with higher density are underlayed beneath lighter ones avoiding the generation 
of air-bubbles. The gradients were spun for 2 h at 50000 rpm (50.1 Ti-rotor) and 18° C. The viral 
particles are mainly found above the 54% fraction and were collected carefully with a syringe. 
The viral particle solution was then further concentrated using a filter (Amicon, Millipore, Cork, 
Ireland) of 100 KDa molecular weight cut-off and washed 2-3 times with 10 ml 1X PBS-MK. After 
concentrating  the  solution  down  to  roughly  200  µl,  the  preparation  was  aliquoted  into  20  µl 
samples, shock-frozen in liquid nitrogen and kept at -70° C for long-term storage.  
3.4.4  rAAV infection in primary cultures 
In order to assess the number of completely assembled rAAV that can effectively carry out an MATERIALS AND METHODS 
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infection, i.e. infectious units per ml (i.u/ml), serial dilutions of purified virus were added to the 
medium of hippocampal neurons cultured (see 3.5.4) for seven days in vitro (DIV7). Neurons 
were fixed at DIV10 and the neuronal expression of the reporter gene, GFP, was analyzed. For 
the down-regulation of SdpI in spinal cord neurons, 10 µl of PBS containing equivalent i.u. of 
each miR-rAAV were added to spinal cord neuron cultures (see 3.5.5) at DIV6-7. For rescue 
experiments additional 10 µl containing equivalent i.u. of rAAV encoding the miR-resistant SdpI 
protein were added simultaneously to miR-rAAV infection for SdpI knockdown. Neurons were 
further analyzed by immunocytochemistry (see 3.5.9) or Western blotting (see 3.3.5)  
3.5  CELL BIOLOGY METHODS 
3.5.1  Coating of coverslips and well plates with poly-L-ornithine 
To facilitate the attachment of cells on glass and plastic surfaces, sterile and ethanol-washed 
cover-slips placed in 24-well-plates and 6-well-plates were incubated for at least 2 h with poly-L-
ornithine (15 µg/ml in PBS, pH 7.5) (Sigma, USA) at 37ºC and 5% CO2. Before use, the coating 
solution was removed, and the wells were washed three times with PBS. 
3.5.2  Culture and maintenance of HEK 293T and COS-7 cells 
All steps were performed in a sterile hood with sterile solutions and media (MEM or DMEM). 
Solutions and media were pre-warmed for 30 min prior to use in a water-bath at 37ºC. Twice per 
week, cells at a confluence of approx. 70-90% were split. For splitting, cells were washed with 4 
ml PBS. The adherent cells were harvested by incubation with 1 ml of preheated 0.25 % trypsin-
EDTA (Gibco, Invitrogen, Kalsruhe, Germany) for 1 min. Then, cells were resuspended in 5 ml of 
PBS and 1ml aliquot of the resuspended cells was plated in new 10 cm dishes containing 10 ml 
of the respective culture medium. Cells were cultured at 37ºC and 5% CO2. After 30 rounds of 
splitting, a new batch of each cell line was thawed. 
3.5.3  Freezing and thawing of cell lines 
Cells growing in a 10 cm dish with a confluence of approx. 80-90% were washed once with PBS, 
pH 7.5, incubated for 1 min with 1 ml of 0.25 (v/v) % Trypsin-EDTA (Gibco, Invitrogen, Kalsruhe, 
Germany). Cells were centrifuged at 100 x g for 5 at RT, resuspended in hybridoma freezing 
medium  (see  3.1.11.2)  to  a  final  concentration  of  10
6-10
7  cells/ml.  The  cell  dilution  was 
transferred  in  1  ml  aliquots  to  Cryo-Tubes
TM ( Thermo  Fischer  Scientific,  Langenselbold, MATERIALS AND METHODS 
 
  50 
Germany). The tubes were left overnight at -80ºC in a cryocontainer filled with isopropanol. In 
the cryocontainer, cells were cooled down to -70ºC with a velocity of about 1ºC/min. The frozen 
cells were then stored in liquid nitrogen. 
To revitalize frozen cells, the Cryo-tubes
TM were rapidly warmed up in a 37ºC water bath. Then 
the  thawed  cell  suspension  was  transferred  to  several  10  cm  dishes  containing  pre-warmed 
culture medium, and cells were further incubated at 37ºC as described under 3.5.2.  
3.5.4  Preparation of rat hippocampal neuron cultures  
For the isolation of hippocampal neurons from mouse or rat embryos as described by Fuhrmann 
et al. (2002), a pregnant female at embryonal day 18 (E18) was anesthetized by inhalation of 
isofluorane (Deltaselect, Pfullingen, Germany) and killed by cervical dislocation. The embryos 
were then removed from the uterus, killed by decapitation, and their heads were collected in 10 
cm dishes containing PBS + 10 mM glucose on ice. Brains were taken out of the skull and 
placed for further preparation in a new 10 cm dish containing PBS/glucose. Hemispheres were 
separated,  and  the  covering  meninges  were  removed  such  that  the  inner  surface  of  the 
hemisphere  faced  upward.  Hippocampi  were  surgically  isolated  and  immersed  in  tubes 
containing PBS/glucose on ice. After setting down, the hippocampi were transferred to a tube 
containing 200-500 µl of digestion solution for primary culture, and incubated at 37ºC for 20 min. 
The digested tissue was then washed with 10 ml of preparation medium for primary culture and 
dissociated  by  10-15  times  pipetting  up  and  down  with  a  1  ml  pipette  (Gilson)  in  1  ml  of 
preparation medium. Following cell number determination using a Neubauer counting chamber, 
neurons  were  diluted  and  seeded  on  poly-L-ornithine  coated  24  well  plates  (see  3.5.1)  at  a 
density of 40.000-60.000 neurons per well. After 3-4 hours at 37ºC and 5% CO2, the medium 
was replaced by neurobasal medium. At DIV3, the proliferation of non-neuronal, e.g. glial, cells 
was inhibited by the addition of cytosine-D-arabinofuranoside to a final concentration of 3 µM.  
3.5.5  Preparation of spinal cord neuron cultures 
For the isolation of spinal cord neurons from mouse or rat embryos as described by Kirsch and 
Betz (1995), a pregnant female at embryonal day E14 was anesthetized, killed and embryos 
were  removed  as  described  under  3.5.4.  After  placing  the  embryos  face-down  in  a  dry  cell 
culture dish, the skin of the back was cut along the mid line in anterior-posterior direction. Spinal 
cords were dissected and collected in a 3 cm culture dish containing PBS supplemented with 33 
mM glucose. The meninges covering the spinal cord tissue were carefully removed, and the MATERIALS AND METHODS 
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spinal cord fragments were then cut into small pieces and dissociated by gentle trituration for 
three times with a glass pipette. After allowing cell clumps to settle for 2-3 min, the supernatant 
was  carefully  collected  into  a  new  tube,  and  the  dissociation  process  was  repeated  for  the 
remaining cells and tissue clumps. A total 6 ml supernatant containing the dissociated neurons 
was centrifuged at 100 x g for 10 min. After discarding the supernatant, 1 ml of neurobasal 
medium was added to the pellet and the suspension was mixed gently. Following cell number 
determination using a Neubauer counting chamber, neurons were diluted and seeded onto poly-
L-ornithine  coated  24  well  plates  (see  3.5.1)  at  a  density  of  1.2  x  10
5  neurons/well.  Neuron 
cultures were maintained in the incubator for 14 to 30 days.  
3.5.6  Lipofection of HEK 293T and COS-7 cells  
Cells were seeded on poly-L-ornithine coated coverslips with culture medium in the absence of 
antibiotic. The lipofection reagent, Lipofectamine 2000 (Invitrogen, Kalsruhe, Germany), builds 
cationic lipid vesicles, which form complexes with negatively charged DNA. These complexes 
enter the cytoplasm by endocytosis. Lipofection was carried out following the manufacturerʼs 
instructions.  
3.5.7  Preparation of detergent extract from HEK 293T cells 
Cells were resuspended in 10 ml PBS, transferred to a 15 ml falcon tube and harvested by 
centrifugation at 100 x g for 10 min. The supernatant was discarded and the cell pellet was 
stored at -20ºC. Cell pellet was mixed with 300 µl of HEK 293T cell homogenate buffer per 10 
cm dish and slowly thawed. Then cells were resuspended in the HEK 293T cell homogenate 
buffer  by  pipetting  up  and  down  and  homogenized  on  ice  using  a  hand-held  rotor-stator 
homogenizer (Xenox Motorhandstück 2.35, Carl Roth, Kalsruhe, Germany) for 1 min. For the 
solubilization of proteins, 20 % Triton X-100 and 1 M DTT were added to final concentrations of 
1 % and 5 mM, respectively, and the homogenate was left shaking under overhead rotation for 
30 min at 4ºC. Finally, cell debris was removed by centrifugation for 10000 x g for 10 min. The 
resulting detergent extract was directly used for analysis or stored at -20ºC.  
3.5.8  Fractionation of spinal cord neuron homogenate 
The spinal cords of adult rats were dissected and homogenized in Im-Ac buffer without Triton X-
100. The homogenate was clarified by centrifugation at 1000 x g for 10 min. The postnuclear 
supernatant (S1) was centrifuged at 10000 x g for 10 min to pellet large membrane organelles MATERIALS AND METHODS 
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(P2). The remaining supernatant was then centrifuged at 100000 x g to collect small membrane 
organelles (P3). This P3 fraction was resuspended in Im-Ac buffer for  co-immnoprecipitation 
experiments (3.3.9).  
3.5.9  Immunocytochemistry 
Cells cultured in 24-well plates on coverslips coated with poly-L-ornithine were washed once with 
cold PBS and then incubated with 0.5 ml of cold fixative solution for 2 min for GlyR staining, or 5-
10 min for staining with other antibodies, at RT. To quench unspecific fluorescence due to the 
fixation procedure, cells were incubated for 15 min with 25 mM glycine in PBS following two 
washes  with  PBS.  To  permeabilize  cell  membranes,  cells  were  incubated  with  0.5  ml  of 
permeabilization buffer for 30 min at RT. Unspecific antibody binding was blocked by incubating 
the cells in 0.5 ml of blocking solution for 1 h at RT. Subsequently the fixed cells were incubated 
with the primary antibody diluted in blocking solution at dilutions as summarized under 3.1.10.1. 
100 µl of the dilutied antibody were placed onto a piece of Parafilm (Pechiney, Chicago, USA) in 
a moist chamber to prevent drying. Coverslips were then located with cells facing down over the 
antibody solution and incubated for 1 h at RT. Following three washing steps with PBS for 5 min 
each, cells were incubated with a fluorescently labelled secondary antibody diluted in blocking 
solution (for dilution, see 3.1.10.2) for 45 min at RT. Followed by three washes with PBS, for 
staining of cell nuclei, cells were incubated in DAPI solution diluted 1:1000 in blocking solution 
for 2 min at RT in a dark chamber and again washed twice with PBS. Coverslips were mounted 
onto microscope glass slides (76 x 26 x 1 mm) (Paul Marienfeld, Lauda-Königshofen, Germany) 
by  placing  them  upside  down  on  a  drop  of  Aqua  Polymount  (Polysciences  Inc.  Warrington, 
USA). They were allowed to dry and stored at 4°C.  
3.5.10 Immunohistochemistry 
3.5.10.1 Cryostat brain sectioning 
For immunohistochemical analysis, 1 year-old mice were anesthetized by inhalation of isofluoran 
(Deltaselect, Pfullingen, Germany) and killed by cervical dislocation. Heads were cut off with 
scissors,  brains  were  carefully  removed  from  the  skull  and  rapidly  frozen  at  -70ºC  through 
contact with a piece of dry ice. The frozen brains were then embedded in Tissue-Tak (Sakura 
Finetek, Zoeterwoude, The Netherlands), placed on a cryostat holder and left at -18ºC to allow 
the embedding gel to polymerize. Transversal or sagital slices of 15-30 µm width were cut in a 
Cryostat (Leica, Jung Frigocut, 2800E). During slicing, the temperature of the chamber reached -MATERIALS AND METHODS 
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19ºC,  whereas  the  temperature  of  the  tissue  remained  at  -16ºC.  Between  4-6  slices  were 
transferred to each coated microscope glass slides (75 x 25 x1 mm, SuperFrost
R Plus, Menzel 
Glaeser, Braunschweig, Germany) and either processed rapidly or stored for further analysis at -
80ºC. 
3.5.10.2 Immunostaining of brain sections 
Tissue slices were dried at RT and fixed for 10 min in cold 4 % (w/v) PFA in PBS. Afterwards, 
slices were washed three times for 5 min with PBS to completely remove the fixative. To avoid 
aldehyde- or formalin-derived protein cross-linking and to unmask antigens/epitopes in formalin-
fixed tissue sections, a sodium citrate solution was applied. A first wash for 5 min with Na
+-
citrate buffer at RT was followed by 30 min incubation with Na
+-citrate buffer at 95ºC and a last 
cooling  down  to  RT.  After  two  washes  with  PBS,  membrane  permeabilization  was  achieved 
through  incubation  with  permeabilization  solution  for  30  min  at  RT.  Unspecific  binding  was 
blocked by incubation with blocking solution for 3 h at RT. Primary antibodies diluted at proper 
dilution (see 3.1.10.1) in blocking solution were incubated with the slices overnight at 4ºC in a 
moist chamber. On the next day, unbound antibody was removed by three washes with PBS for 
5 min. Incubation with secondary antibodies (see 3.1.10.2) diluted in blocking solution was in a 
moist chamber for 45 min at RT. Following three washes with PBS, the slides were mounted with 
Aqua Polymount (Polysciences Inc. Warrington, USA). 
3.5.11 Confocal microscopy, image acquisition and analysis  
Immunostained  neurons  and  tissue  sections  were  analyzed  using  a  confocal  Leica  TCS-SP 
Laser  Scanning-Microscope  (Leica  Microsystems,  Bensheim,  Germany).  Specimens  were 
analyzed  in  x,  y  and  z-axis  in  multiple  z-layers.  Pictures  were  obtained  at  1024x1024  pixel 
resolution.  Serial  confocal  images  were  captured  at  a  total  magnification  of  630x.  For 
immunhistochemistry  data  collection,  six  stacks  of  0.1  µm  each  were  compressed  using  a 
maximum projection algorithm in the Leica TCS software. For analysis of cluster number and 
size by immunocytochemistry experiments, maximal projections of 8-12 z-stacks of 0.1 µm each 
were  obtained  with  a  Leica-TCS-NT  software.  For  the  quantification  of  punctate 
immunofluorescence in spinal cord neurons, 50 µm neurite segment emanating from the somas 
of randomly selected cells was marked. The binarization, thresholding and quantification was 
implemented using the ImageJ 1.42q software (National Institutes of Health). Synaptic clusters 
were selected by counting those puncta exceeding 0.4 µm
2.  
For  colocalization  analysis,  single  z-stack  images  were  obtained  using  an  AxioImager MATERIALS AND METHODS 
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microscope equipped with an apotome (Zeiss, Goettingen, Germany). For the quantification of 
colocalizing puncta, the objects in the green channels exceeding a minimal size were counted 
along  neurites.  An  object  was  considered  to  colocalize  if  more  than  0.1  µm
2  of  its  area 
colocalized with signal in the red channel. Images were further developed and organized by 
Adobe Photoshop and Adobe Illustrator software (Adobe, San Jose, USA). Quantifications were 
performed using ImageJ 1.42q software (National Institutes of Health,USA). A minimum of three 
distinct  experiments  of  identically  processed  cultures  were  analyzed  and  10  images  were 
collected  from  randomly  selected  dendrites  of  10  different  neurons.  Data  are  presented  as 
means  ±  standard  error  (S.E.M.)  Statistical  significance  was  evaluated  with  a  two  tailed 
Studentʼs t-test. RESULTS 
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4  RESULTS 
 
4.1  Analysis of the interaction between the Sdp protein family and 
the GlyRβ subunit 
In a attempt to identify novel interaction partners of the glycine receptor β subunit (GlyRβ), a 
GST fusion protein encompassing 78 amino acids (position 378 and 455) of the intracellular loop 
located between transmembrane domains 3 and 4 of the glycine receptor β subunit (GlyRβ78) 
was utilized for the isolation of proteins from rat brain detergent extract. One of the proteins 
bound with an apparent molecular weight of about 52 kDa was identified by matrix-assisted laser 
desorption/ionisation–time of flight mass (Maldi-ToF) spectrometry (Paarmann et al., 2006) as 
SdpI.  In  this  thesis,  the  interaction  between  SdpI  and  the  GlyRβ s ubunit  was  investigated. 
Glutathione-S-transferase  (GST)  pull-down  experiments  using  recombinantly  expressed  Sdp 
isoforms and GlyRβ78 were performed in order to examine the binding activity of SdpI and SdpII 
to  the  large  intracellular  loop  of  the  GlyRβ  subunit  and  gephyrin  in  vitro.  Deletion,  peptide 
competition and point mutation approaches were used to characterize the interaction between 
SdpI and GlyRβ78. Co-localization experiments in COS-7 cells and spinal cord neurons were 
used to investigate a possible interaction of SdpI and SdpII with the full-length GlyRβ subunit 
and gephyrin in vivo. Additionally, the possible implication SdpI in GlyR-trafficking mechanisms 
was investigated. Co-immunoprecipitation experiments using detergent extracts of a spinal cord 
homogenate fraction enriched in small membraneous organelles were performed to disclose a 
possible  interaction  of  SdpI  with  the  GlyR  in  transport  vesicles.  Taking  advantage  of  a  KO 
mouse-line  and  rAAV  techniques,  SdpI  depletion  studies  were  performed  to  analyse  the 
distribution of inhibitory synaptic proteins in brain stem and spinal cord neurons lacking SdpI.  
4.1.1  Characterization  of  the  interaction  between  Sdp  protein  family  members 
and the GlyRβ subunit 
In  order  to  investigate  whether  SdpI  interacts  with  the  GlyRβ  subunit,  GST  pull-down 
experiments  were  performed.  This  in  vitro  protein-protein  interaction  analysis  required  the 
expression  of  one  of  the  binding-partners  as  a  GST  fusion  protein  in  E.  coli  followed  by  its 
immobilization  on  a  glutathione  (GSH)-matrix.  The  immobilized  GST-fusion  protein  was  then RESULTS 
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incubated  with  a  protein  solution  containing  putative  binding  partners,  which  had  been  also 
generated in E. coli (C41 for SdpI, BL21DE3 for others) with a short N-terminal His6-tag to allow 
immnune detection. Proteins binding to the immobilized GST-fusion protein should sediment with 
the beads. The analysis of bound co-sedimented proteins was carried out by SDS-PAGE and 
Western  blotting  using  an  antibody  that  specifically  recognized  the  respective  protein.  To 
validate the specificity of the interaction, GST and GST fusion constructs of unrelated proteins 
were utilized as negative controls. As a positive control, either 50% of the input was loaded onto 
a  SDS-gel,  or  GST  fusion  constructs  of  known  binding  partners  were  used  in  the  pull-down 
experiment.  
4.1.1.1  In  vitro interaction  between  recombinant  proteins:  GST  fusion  proteins  of  the 
GlyRβ loop and His6-tagged Sdps 
The interaction between the 78 amino acids of the large intracellular loop of the GlyRβ subunit 
(GlyRβ78)  and  SdpI  was  confirmed  by  GST  pull-down  experiments.  GST  fusion  proteins  of 
GlyRβ78 and GlyRβ49 as well as GST alone were incubated with a bacterial lysate containing 
His6-tagged SdpI (His-SdpI). After SDS-PAGE, the Coomassie stained gel showed a prominent 
band around 55 kDa in GST-GlyRβ78 pull-downs, but not with GST-GlyRβ49 or GST alone (Fig. 
4.1.A). Bands around 80 kDa in the second lane corresponded to the E.coli DnaK protein, a 
common contamination when dealing with GST fusion proteins. Western blot analysis with an 
anti-His6 antibody confirmed that the band at 55 kDa, indicated in red in Fig. 4.1.A, represented 
the recombinant His6-SdpI protein (see Fig. 4.1.B).  
To further examine whether GlyRβ is binding to Sdps, GST pull-down assays were performed 
using the His6-tagged constructs of SdpI and both splice variants of SdpII. As shown for SdpI, 
SdpII-L and SdpII-S co-precipitated with GST-GlyRβ78 but not with GST-GlyRβ49 or GST alone 
(see Fig. 4.1.C). These results confirm that SdpI and both splice variants of SdpII bind to the 
GlyRβ subunit in vitro. Furthermore, the intensities of the Sdp protein bands eluted from GST-
GlyRβ78 are indicative of strong interactions between SdpI, or SdpII-L and SdpII-S and the GlyRβ 
subunit in vitro.  RESULTS 
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Fig. 4.1. In vitro interaction of Sdp isoforms with the intracellular loop of the GlyRβ subunit. A. GST pull-down 
of recombinantly expressed His6-tagged SdpI from lysates of bacteria expressing: left lane, GST-GlyRβ49; middle lane, 
GST-GlyRβ78; right lane, GST. A prominent band present in the middle lane but not in the two control lanes with a 
molecular weight around 60 kDa is circled in red. Lower molecular weight bands are GST fusion proteins. Double 
bands  for  GST-GlyRβ49  and  GST-GlyRβ78  result  from  partial  cleavage  between  GST  and  fusion  partner.  B. 
Corresponding anti-His6 immunodetection of protein samples shown in A. The prominent band in the second lane 
represents His6-tagged SdpI running above 50 kDa. Some weak unspecific binding to GST was observed in the right 
lane. C. Anti-His6 immunodetection of the GST pull-down of His6-tagged SdpII-S (first three lanes) and His6-tagged 
SdpII-L (last three lanes) with GST-GlyRβ constructs. Both splice variants of SdpII interact with the GST-GlyRβ78 
construct but not with the negative controls GST-GlyRβ49 and GST. Experiments done by Dr. Ingo Paarmann. 
 
4.1.1.2  Mapping of the SdpI binding site on GlyRβ78. 
The  GlyRβ  intracellular  loop  fragment  used  to  isolate  SdpI  from  rat  brain  lysate  contains  a 
gephyrin binding motif (GBM) and a SH3 binding motif (SBM). The binding site of SdpI on GlyRβ 
was first mapped using a deletion approach. Several GST fusion constructs of GlyRβ78 were 
generated and probed for binding to a His6-tagged SdpI protein by GST pull-down. Removal of 
the  first  49  amino  acids  including  the  GBM  did  not  affect  SdpI  binding  (see  Fig.  4.2).  The 
construct lacking the last 15 amino acids of the GlyRβ78 including part of the SBM exhibited a 
slightly reduced binding, whereas GlyRβ49 lacking the complete SBM was not able to bind His-
SdpI at all (Fig. 4.1 and Fig. 4.2). The sequence mediating SdpI binding to the GlyRβ loop thus 
could  be  narrowed  down  to  22  aa  (GlyRβ427-448  construct),  which  included  the  SBM.  These RESULTS 
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mapping  experiments  suggested  that  the  SH3  binding  motif  is  essential  for  the  interaction 
between SdpI and the GlyR intracellular loop.  
 
Fig.  4.2.  Mapping  of  the  SdpI  binding  site  in  GlyRβ78.  SdpI  binding  to  several  GST-tagged  fragments  of  the 
GlyRβ78  was  analysed.  Taking  the  binding  of  SdpI  to  GST-GlyRβ78  and  GST-GlyRβ49  as  maximal  and  minimal 
references  for  SdpI-binding,  respectively,  the  intensities  of  the  SdpI  bands  bound  to  the  different  fragments  as 
revealed by Western blot were compared qualitatively. ++: Strong binding of SdpI. +: Weak binding of SdpI. -: no 
binding of SdpI. GBM: gephyrin binding motif depicted in grey. SBM: SH3 binding motif depicted in blue. Experiments 
done by Dr. Ingo Paarmann. 
 
In conclusion we found that 22 amino acids from positions 427 to 448 containing the entire SBM 
were  sufficient  for  strong  interaction.  This  result  was  confirmed  using  a  peptide  competition 
approach. Immobilized GST-GlyRβ78 was incubated with His6-SdpI and different concentrations 
of either a TAT peptide containing the 22 binding residues identified in our mapping experiments 
(TAT-GlyRβ22)  or  a  TAT  scrambled  peptide  containing  the  same  aa  in  random  order  (TAT-
scrambled) (see Fig. 4.3.A.). As a positive control, GlyRβ78 was incubated with His6-SdpI in the 
absence of peptide. Upon detecting the bound His6-SdpI by Western blotting, it became obvious 
that incubation with the TAT-GlyRβ22 peptide, but not the TAT-scrambled peptide reduced SdpI 
binding  to  GST-GlyRβ78  (Fig.  4.3.B).  When  quantifying  the  SdpI  band  densities  found  by 
Western  blotting  using  the  ImageJ  software,  a  marked  reduction  in  SdpI  band  intensity  was 
observed upon the addition of 100, 10 and 1 µM of TAT-GlyRβ22. Intensity values were 10.9 ± 
7.3%, 14.1 ± 11.9% and 70.6 ± 10.3% of control, respectively (n=3, p < 0.001, p < 0.01 and p < RESULTS 
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0.05, respectively) (Fig. 4.3.C). However, when 100, 10 and 1 µM of TAT-scrambled peptide 
were added, no significant reduction of SdpI band intensity was found (intensity values: 44.6 ± 
24.9%, 55.1 ± 23.8% and 76.1 ± 15.8% of control, respectively; n=3, p > 0.05) (Fig. 4.3.C). 
These results confirm that the region encompassing the amino acids 427 to 448 of the large 
intracellular loop of the GlyRβ subunit is responsible for SdpI binding. Furthermore, they show 
that the interaction between GlyRβ and SdpI is indeed specific.  
 
Fig. 4.3. Sequence-specific interaction between SdpI and amino acids 427-448 of the intracellular loop of the 
GlyRβ subunit. A. Depiction of peptide sequences. TAT sequence for internalization is highlighted in red, whereas 
proline residues are depicted in blue. B. Peptide competition experiment. Pull-down with GST-GlyRβ78 and His6-SdpI 
was  performed  in  the  presence  of  GlyRβ22  peptide  or  scrambled  peptide.  Coomassie  stained  gel  confirmed  the 
presence of GST-GlyRβ78 protein eluted from the beads. Western blot shows reduced SdpI binding when GlyRβ22 
peptide was added to the sample (lanes 2 and 3). SdpI binding did not differ as compared to control (lane 1) when 
scrambled peptide was added to the sample (lanes 5, 6 and 7). C. Quantification of relative SdpI-band intensities from 
peptide  competition  experiment  shown  in  B.  Values  represent  means  ±  SEM  (n=3).  Significant  differences  as 
compared to control (no peptide): *, p < 0.05; **, p < 0.01; ***, p < 0.001. 
 RESULTS 
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4.1.1.3  Identification of GlyRβ point mutants interfering with SdpI binding 
The mapping and peptide competition experiments described above (4.1.1.2) revealed that the 
GlyRβ427-448  sequence  was  sufficient  for  SdpI  binding.  This  region  contains  a  complex  SH3 
binding motif (SBM). Additional mapping experiments showed that an intact SH3 domain of SdpI 
is  essential  for  strong  interaction  (data  not  shown).  Therefore,  we  assumed  that  the  GlyRβ 
subunit binds to SdpI through a SH3-SBM interaction. From previous studies, it was known that 
SH3 domains bind to proline-rich regions and generally favour peptides which bear a PxxP core 
motif (where x represents any amino acid) (Li, 2005), and that the residues flanking this core 
motif define the selectivity of a given SH3 domain (Sparks et al., 1996).  
Inspection of the amino acid sequence of the GlyRβ78 construct used for the pull-down of SdpI 
disclosed the presence of the common R/KxxPxxP SH3 ligand-binding motif (residues K435, 
P438 and P441). In this motif, the R/K side chains would not only provide additional binding 
energy through electrostatic interactions but also orient the ligand with respect to the binding 
groove of the SH3 domain (Li, 2005). Therefore, in order to further delineate the SdpI binding 
site  and  to  establish  the  importance  of  the  SH3  binding  motif  for  GlyRβ-SdpI  binding,  we 
designed  double  point  mutations  to  disrupt  this  motif  (Fig.  4.4.A).  On  the  basis  of  the  GST-
GlyRβ78 fusion protein, two mutants were created in which the proline residues P438 and P441 
(GST-GlyRβ78-PPAA)  as  well  as  the  lysine  residues  K434  and  K435  (GST-GlyRβ78-KKAA)  were 
mutated to alanines. SDS-PAGE analysis showed that both mutant constructs produced fusion 
proteins  of  the  same  apparent  molecular  weight  as  the  wild-type  protein  (Fig.  4.4.C).  When 
these GST-GlyRβ78 mutants were expressed in E. coli and examined for SdpI interaction by GST 
pull-down, SdpI binding was found to be completely lost with both GST-GlyRβ78-PPAA and GST-
GlyRβ78-KKAA, with SdpI band intensities being reduced to 3.0 ± 1.5% and 6.3 ± 4.7% of control, 
respectively (n=3, p < 0.001). These values are similar to the SdpI band intensity value obtained 
upon incubation of SdpI with GST-GlyRβ49 (4.3 ± 3.8% of control)(Fig. 4.2.B and E). Notably, 
gephyrin co-precipitated with GST-GlyRβ49 and the GST-GlyRβ78 wild-type and mutant forms, but 
not with GST alone (Fig. 4.4.D).  
Together, these results show that the KxxPxxP motif is responsible for SdpI binding to the GlyRβ 
subunit, but not involved in gephyrin binding. Furthermore, these results agree with the peptide 
competition data and further support the hypothesis of an SH3 domain mediated interaction of 
SdpI with the GlyRβ subunit.   RESULTS 
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Fig. 4.4. Point mutations interfering with SdpI binding in GST pull-down experiments. A. Positions of point 
mutations. Proline-rich motifs are underlined in red. Arrows point to the proline and lysine residues within the large 
intracellular loop of GlyRβ that were mutated to alanines. B. GST fusion proteins of GlyRβ78 and GlyRβ49 as well as 
the mutated forms GlyRβ78-PPAA and GlyRβ78-KKAA were immobilized to a GSH-matrix and incubated with bacterial 
lysate containing His6-tagged SdpI. Anti-His6 western blot shows that the fusion protein GST-GlyRβ78 (lane1), but not 
GST-GlyRβ49 (lane 2) or the mutants GST-GlyRβ78-PPAA and GST-GlyRβ78-KKAA (lanes 3 and 4), co-precipitated with 
recombinant His6-syndapin I. Input: 50% of the His6-Sdp-I-containing lysate loaded per sample. C. Coomassie stained 
gel shows GST fusion proteins. D. Immundetection of His6-tagged E-domain binding to GST-GlyRβ78, GST-GlyRβ49, 
GST-GlyRβ78-PPAA and GST-GlyRβ78-KKAA, but not to GST. His-GE: His6-tagged E-domain of gephyrin. E. Quantification 
of relative SdpI-band intensities in the GST pull-down experiments shown in B. Values represent means ± SEM (n=3). 
Significant differences as compared to control (GST-GlyRβ78): ***, p < 0.001. 
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4.1.2  Interaction  between  Sdp  proteins  and  GlyRβ  in  a  mammalian  cell 
expression system 
The GST-pulldown experiments described under 4.1.1.1 demonstrated that two isoforms of Sdp, 
SdpI and SdpII, interact with GlyRβ78 in vitro. As new binding partners of GlyRβ, Sdp I and SdpII 
should form complexes with the GlyRβ subunit in vivo. Therefore, colocalization experiments 
were performed in a mammalian cell line transfected with cDNAs encoding both proteins. After 
fluorescent labelling with different Alexa dyes and digital recording, overlapping emission signals 
indicated close proximity of antigens within microscopically defined subcellular structures.  
4.1.2.1  Endoplasmic reticulum (ER) retention assay  
To clarify whether SdpI and the GlyRβ subunit interact in a mammalian cell expression context, 
colocalization  experiments  were  performed  in  COS-7  cells.  A  plasmid  encoding  the  GlyRβ 
subunit N-terminally tagged with monomeric red-fluorescent protein (mRFP) was transfected into 
COS-7 cells for 24 h. Red fluorescence then was found throughout the cytoplasm in speckled 
form. From previous studies it was already known that GlyRβ expressed in HEK 293 cells cannot 
exit  the  endoplasmic  reticulum  (ER)  in  the  absence  of  GlyRα  subunits  (Kirsch  et  al.  1995). 
Colocalization  experiments  with  an  anti-calnexin  antibody  (Fig.  4.5),  which  recognizes  an 
integral protein of the ER, confirmed that mRFP-GlyRβ expressed in COS-7 cells is retained in 
the ER. This demonstrates that retention of the singly expressed GlyRβ subunit in the ER is a 
general event. 
 
Fig. 4.5. Subcellular distribution of the GlyRβ subunit in COS-7 cells. COS-7 cells were transfected with mRFP-
GlyRβ.  24  h  after  transfection,  cells  were  stained  with  an  anti-calnexin  antibody  and  an  Alexa-488  anti-mouse 
antibody. Note the extensive colocalization as indicated in the overlay in yellow. Scale bar: 10 µm. 
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4.1.2.2  Gephyrin binding monitored by ER retention 
To establish the ER retention assay, mRFP-GlyRβ was co-transfected with N-terminally GFP-
tagged gephyrin (GFP-gephyrin), or GFP as control. After 24 hours, cells were fixed and the 
fluorescence  signals  of  the  mRFP  and  GFP  channels  were  detected  using  an  AxioImager 
equipped with an Apotome (Zeiss) and AxioVision software (Zeiss).  
As previously shown in many studies, there is high-affinity binding between gephyrin and the 
intracellular  loop  of  the  GlyRβ subunit  (Meyer  et  al.,  1995;  Sola  et al. 2004; Schrader et al. 
2004).  As  expected,  upon  co-expression  in  COS-7  cells,  GFP-gephyrin  colocalized  in  with 
mRFP-GlyRβ  in  the  ER  (Fig.  4.6.  overlay  in  middle  pannel).  Unexpectedly,  gephyrin  blob 
formation as seen in previous studies (Kirsch et al. 1995; Saiyed et al. 2007) upon recombinant 
expression of gephyrin, was absent when gephyrin was co-expressed with the GlyRβ subunit. 
Instead  of  recruiting  GlyRβ  into  gephyrin  blobs,  in  our  experiments  gephyrin-
immunofluorescence was restricted to the ER. In control experiments, little colocalization was 
seen  when  GFP  alone  or  a  gephyrin  mutant  harbouring  a  mutation  in  the  E-domain,  GFP-
gephyrinmut, and therefore being unable to bind to the GlyRβ loop (Sola et al., 2004), were co-
expressed with mRFP-GlyRβ (Fig. 4.6, overlays in top and bottom panels). 
 
Fig. 4.6. Colocalization of gephyrin 
with  the  GlyRβ  subunit  in  COS-7 
cells. COS-7 cells were co-transfected 
with  GFP,  GFP-gephyrin  or  GFP-
gephyrinmut (gephyrin mutant unable to 
bind  to  the  GlyR)  and  mRFP-GlyRβ 
and fixed 24h after transfection. Upon 
co-expression with mRFP-GlyRβ, GFP 
distributed mainly into the nucleus and 
little  colocalization  was  seen  near 
nucleus-ER  contacts  (overlay  in  top 
panel).  Note  extensive  colocalization 
of mRFP-GlyRβ with GFP-gephyrin in 
the ER as indicated in yellow (overlay 
in  middle),  but  lack  of  co-localization 
with  GFP-gephyrinmut  (overlay  in 
bottom panel). Scale bar: 10µm.  
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Thus,  the  gephyrin-GlyRβ  colocalization  experiments  in  COS-7  cells  show  that  retention  of 
gephyrin  on  the  ER  is  due  to  the  interaction  with  the  GlyRβ  subunit  and  exclude  that  ER 
retention-signals  in  gephyrin  or  other  secondary  events  could  be  responsible  for  this 
colocalization. Moreover, these results suggest that the ER retention assay can indeed be used 
to study interactions of putative binding proteins of the GlyRβ subunit. 
 
4.1.2.3  Binding of Sdps in the ER retention assay  
The colocalization experiments described above revealed that the ER retention assay can be 
used  to  study  interactions  with  GlyRβ  (see  4.1.2.2).  Therefore,  colocalization  assays  were 
performed in order to test whether SdpI binds to GlyRβ upon heterologous expression in COS-7 
cells. Additionally, the binding activity of the two splice variants of SdpII, SdpII-L and SdpII-S, 
was examined. 
4.1.2.3.1  Colocalization of SdpI with GlyRβ in COS-7 cells. 
Full-length mRFP-tagged GlyRβ was co-expressed with myc-tagged SdpI in COS-7 cells for 24 
h. As a control, a DsRed-tagged ER-marker was used to stain the ER, and myc-tagged dynein 
light chain 1 (myc-Dlc1) was used as a non-binding control protein. Myc-tagged proteins were 
stained with anti-myc and Alexa-488 anti-rabbit antibodies. The fluorescences of mRFP, DsRed 
and Alexa-488 were monitored as described under 4.1.2.2.  
Upon co-expression of myc-SdpI with DsRed-ER, anti-myc immunoreactivity was detected in the 
cytoplasm, and little colocalization was seen in the ER (see Fig. 4.7.A, top panel). However, 
when myc-SdpI was co-expressed with mRFP-GlyRβ, myc-SdpI anti-myc immunoreactivity was 
detected prominently in the ER and to a lesser extent in the cytoplasm (see Fig. 4.7.A, middle 
panel). In additional control experiments, myc-Dlc1 co-expression with mRFP-GlyRβ resulted in 
a cytoplasmic and nuclear localization of myc-Dlc1 and little co-localization of myc-Dlc1 with the 
mRFP-GlyRβ in the ER (see Fig. 4.7.A, lower panel). This indicates that recombinant GlyRβ 
changes the subcellular distribution of SdpI. Closer inspection of myc-SdpI and mRFP-GlyRβ 
colocalization  was  accomplished  using  the  ImageJ  software.  The  colocalization  rate  was 
quantified as percentage of ER area in the red channel that colocalized with the myc-tagged 
protein in the ER in the overlay image.  RESULTS 
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Fig. 4.7. Colocalization of SdpI with the GlyRβ subunit in COS-7 cells. A. Myc-tagged SdpI and Dlc1 were co-
transfected  with  mRFP-GlyRβ  and  DsRed-ER  control  marker  in  COS-7  cells.  After  24  h,  cells  were  fixed  and 
incubated with anti-myc antibody and Alexa-488 anti-rabbit. Note extensive co-localization of myc-SdpI in the ER of 
cells expressing mRFP-GlyRβ as indicated in yellow (middle panel), but only a background co-localization signal when 
expressed with the DsRed-ER control marker (top panel) or when myc-Dlc1 was co-expressed with mRFP-GlyRβ 
(bottom panel). Scale bar: 10 µm. B. The percentage of ER area colocalizing with myc-protein was quantified in the 
experiment shown in A. Values represent means ± SEM (n=3). Significant differences as compared to mRFP-GlyRβ 
and myc-SdpI co-expression: **, p < 0.01. 
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The colocalization rate in the ER was significantly higher upon myc-SdpI + mRFP-GlyRβ co-
expression  (32.3  ±  2.8  %)  than  upon  myc-SdpI  +  control  DsRed-ER-marker  (11.4  ±  1.7  %). 
Similarly, there was a background colocalization in the ER in cells co-expressing Dlc-1, a non-
related myc-tagged protein, and mRFP-GlyRβ, which was significantly reduced (9.5 ± 3.8%) as 
compared to myc-SdpI + mRFP-GlyRβ co-expression (Fig. 4.7.B). Thus, these results confirm 
that SdpI is a protein interacting with the GlyRβ subunit and demonstrate that both proteins can 
interact in a mammalian cell expression system.  
4.1.2.3.2  Colocalization of SdpII splice variants with GlyRβ in COS-7 cells 
From the SdpI isoform SdpII, two splice variants are generated in neuronal tissue: SdpII-S and 
SdpII-L (2.4.1.1). In order to clarify whether these splice variants also interact with the GlyRβ 
subunit in a cellular context, co-expression experiments in COS-7 cells were performed using 
myc-tagged forms of SdpII-S and -L following the protocol described above (4.1.2.3.1). 
When expressed alone in COS-7 cells, both myc-SdpII-S and myc-SdpII-L accumulated in the 
cytosol (data not shown). Upon co-expression with the DsRed-ER marker, myc-tagged SdpII 
splice variants displayed similar distributions, prominently in the cytosol and little at the plasma 
membrane. Overlays showed that both splice variants displayed background signals in the ER 
(Fig. 4.8). In contrast, when expressed with the mRFP-GlyRβ, both splice variants concentrated 
in the ER and were less intense in the cytosol (Fig. 4.8). Parallel co-expression of myc-Dlc1 with 
mRFP-GlyRβ  in  COS-7  cells  served  as  a control  for  unspecific  co-localization.  As  described 
above (4.1.2.3.1), myc-Dlc1 co-expressed with mRFP-GlyRβ displayed a cytosolic and nuclear 
distribution with background accumulation in the ER (data nor shown). These results indicate 
that,  similarly  to  what  is  seen  with  SdpI,  recombinant  GlyRβ  also  changes  the  subcellular 
distribution of myc-SdpII-S and myc-SdpII-L.  
A  more  accurate  analysis  of  ER  colocalization  was  performed  with  the  ImageJ  software  as 
described above (4.1.2.3.1). The area where proteins colocalized in the ER was significantly 
larger upon co-expression of myc-SdpII-L with mRFP-GlyRβ (33.5 ± 3.8 %) than with the DsRed-
ER marker (6.2 ± 2.9 %), or of myc-Dlc1 protein and mRFP-GlyRβ (8.1 ± 4.3 %) (Fig. 4.8). Co-
expression of myc-SdpII-S with mRFP-GlyRβ similarly resulted in 29.2 ± 2.9 % colocalization 
area. Again, this value was significantly higher than that obtained upon co-expression of myc-
SdpII-S and the DsRed-ER marker (6.0 ± 0.8 %), or with the myc-Dlc1 construct and  RESULTS 
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Fig. 4.8. Colocalization of SdpII-L and SdpII-S with GlyRβ in COS-7 cells. A and B. Myc-tagged SdpII-L (A) and 
SdpII-S (B) and Dlc1 (not shown) were co-transfected with mRFP-GlyRβ and DsRed-ER control marker in COS-7 
cells. After 24 h, cells were fixed and stained as in Fig. 4.7. Note the extensive co-localization of myc-SdpII-L and 
myc-SdpII-S in the ER of cells expressing mRFP-GlyRβ as indicated in yellow, but only background co-localization 
signal when expressed with the DsRed-ER control marker. Scale bar: 10 µm. C and D. Quantification of colocalization 
experiments as shown in A and B, respectively, was performed as in Fig. 4.7. Values represent means ± SEM (n=3). 
Significant differences as compared to GlyRβ-Sdp co-expression: *, p < 0.05; **, p < 0.01. RESULTS 
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mRFP-GlyRβ (3.7 ± 1.0 %) (Fig. 4.8.D). Together, these colocalization experiments demonstrate 
that the interaction with GlyRβ is not restricted to SdpI. Clearly, both splice variants of SdpII 
interact with GlyRβ in COS-7 cells. 
 
4.1.3  Interaction between Sdp proteins and gephyrin 
4.1.3.1  In vitro analysis 
Gephyrin  is  a  direct  binding  partner  of  the  GlyRβ  subunit  and,  presently,  the  only  protein 
reported to directly interact with the glycine receptor (Schmitt et al., 1987). Previous live imaging 
experiments have demonstrated that glycine receptors and gephyrin are co-transported as a 
complex along neurites (Maas et al., 2006). In order to test whether SdpI only binds the GlyRβ 
subunit or also gephyrin, GST pull-down experiments were performed using several GST fusion 
constructs  of  gephyrin  fragments  spanning  the  E,  E+linker  and  G  domains,  respectively. 
Preliminary data had already indicated weak binding of SdpI to the linker region but not the E-
domain (I. Paarmann, unpublished observation). 
4.1.3.2  SdpI-gephyrin interaction analysis in a mammalian cell expression system 
Upon  overexpression  in  heterologous  cells,  gephyrin  forms  intracellular  aggregates  usually 
named “blobs” (Kirsch and Betz, 1995; Meyer et al., 1995). These gephyrin aggregates recruit 
binding proteins, and hence subcellular colocalization as detected by fluorescence microscopy 
serves  as  a  well-established  assay  to  confirm  interactions  between  gephyrin  and  candidate 
binding  partners  (Fuhrmann  et  al.,  2002).  Here,  evidence  for  an  in  vivo  interaction  between 
gephyrin and SdpI as well as SdpII was obtained in a mammalian cell expression system by 
using  the  colocalization  assay.  To  this  end,  cDNAs  encoding  myc-tagged  SdpI,  SdpII-L  and 
SdpII-S were co-transfected with full-length mRFP-tagged gephyrin in COS-7 cells. As positive 
and negative controls for gephyrin binding, myc-tagged Dlc1 and GFP, respectively, were co-
transfected with mRFP-gephyrin. After 24 h, the cells were fixed and stained with anti-myc and 
Alexa-488  anti-rabbit  antibodies.  Subsequent  colocalization  analysis  revealed  that  myc-SdpI, 
myc-SdpII-L and myc-SdpII-S, like myc-Dlc1 (Furhmann et al., 2002), colocalized with mRFP-
gephyrin  upon  co-expression  in  COS-7  cells.  In  contrast,  upon  co-expression  of  GFP  with 
mRFP-gephyrin no colocalization was observed (Fig. 4.9).  RESULTS 
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Fig. 4.9. Gephyrin colocalization with SdpI and SdpII in COS-7 cells. cDNAs encoding GFP, myc-tagged SdpI, 
SdpII-L, SdpII-S and Dlc1, respectively, were co-transfected with mRFP-gephyrin in COS-7 cells. After 24 h, cells 
were fixed and sequentially incubated with anti-myc and Alexa-488 anti-rabbit antibodies. Myc-tagged SdpI, SdpII-L, 
SdpII-S and Dlc1 but not GFP colocalized with the cytoplasmic aggregates of gephyrin formed upon co-expression. 
Note that gephyrin cytoplasmic distribution varied upon co-expression with myc-SdpI, myc-SdpII-L or myc-SdpII-S. 
Arrows point to membrane associated of colocalization; arrowheads indicate colocalization in cytoplasmic gephyrin 
aggregates. Scale bar: 10 µm. 
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These results confirm that the above described in vitro interaction between SdpI and gephyrin 
(4.1.3.1) also occurs in mammalian cells.  They also show that both splice variants of SdpII also 
bind to gephyrin in COS-7 cells. In these colocalization experiments, the extent of overlap of 
myc-SdpI  with  mRFP-gephyrin  immunoreactivity  varied.  Specifically,  a  colocalization  of  both 
proteins  was  frequently  seen  in  the  plasma  membrane  and  less  frequently  in  cytoplasmic 
aggregates of reduced size (see Fig. 4.9). The number of cells showing cytoplasmic gephyrin 
aggregates was significantly reduced in cells co-expressing myc-SdpI and mRFP-gephyrin (15.6 
± 2.2 %) as compared to cells co-expressing myc-Dlc1, or GFP, and mRFP-gephyrin (35.6 ± 4.4 
% and 37.7 ± 3.3 % for myc-Dlc1 and GFP, respectively; 300 cells per sample, n=3, p < 0.05). 
These  results  indicate  that  SdpI  expression  redistributes  gephyrin  upon  co-expression  in  a 
heterologous system and suggest that SdpI is a binding protein which contributes to, or induces, 
gephyrin submembraneous clustering. 
 
Fig. 4.10. Effect of SdpI and SdpII co-expression in gephyrin blob formation in COS-7 cells. Quantification of 
cells showing cytoplasmic gephyrin aggregates in the experiment shown in Fig. 4.9. The number of COS-7 cells 
displaying gephyrin aggregates decreased when gephyrin was co-expressed with myc-SdpI, myc-SdpII-L and myc-
SdpII-S, but not myc-Dlc1 as compared to GFP co-expression. The number of cells displaying gephyrin aggregates 
was also reduced in myc-SdpI and myc-SdpII-S co-expressing cells as compared to myc-Dlc1 + mRFP-gephyrin co-
expressing cells. Values represent means ± SEM (n=3). Significant differences as compared to GFP and myc-Dlc1 
co-expression with mRFP-gephyrin: *, p < 0.05; **, p < 0.01. 
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4.1.4  SdpI competes with gephyrin for binding to GlyRβ78  
As shown above, the gephyrin and SH3 binding sites are both located in the large intracellular 
loop of the GlyRβ subunit. The gephyrin binding motif in the GlyRβ loop comprises amino acids 
394-411 (Meyer et al., 1995), whereas the SdpI binding site lies C-terminally of the gephyrin 
binding-motif,  i.e.  within  residues  427  to  448  (see  4.1.1.2).  Since  both  binding  sites  are 
separated by only 16 residues, we investigated whether the interaction of gephyrin with GlyRβ 
might influence the ability of SdpI to bind the receptor. To address this question, GST pull-down 
experiments  were  performed  as  mentioned  under  4.1.1,  but  increasing  amounts  of  lysates 
containing the His6-tagged gephyrin-E-domain (His-GE) were added to the His6-tagged SdpI-
containing lysates (His-SdpI). After Western blot detection with anti-His6 antibody, His-SdpI and 
His-gepyrin-E-domain were distinguished by their different molecular weights, 54 kDa and 47 
kDa,  respectively  (Fig.  4.11.A).  The  addition  of  0.1  µl  of  His-GE  lysate  already  reduced  the 
amount of SdpI protein bound, and increasing concentrations of His-GE proportionally inhibited 
the binding of His-SdpI to GST-GlyRβ78. SdpI band intensities were reduced to 61.3 ± 10.3 %, 
42.3 ± 14.2 %, 24.2 ± 6.6 % and 2.1 ± 1.3% of control in the presence of 0.1, 1, 10 and 100 µl of 
His-GE lysate, respectively (n=4). The addition of 100 µl of the His-GE lysate completely blocked 
SdpI-binding to GST-GlyRβ78 (Fig. 4.11.B). Since SdpI does not bind to the E-domain of gephyrin 
(see  4.1.3.1),  a  direct  inhibition  of  gephyrin  binding  by  the  SdpI-GlyRβ78  interaction  can  be 
excluded. Thus, binding of the E-domain of gephyrin appears to be sufficient to sterically impair 
the interaction of SdpI with the intracellular loop of GlyRβ. However, since the E-domains of 
gephyrin dimerize during postsynaptic scaffold formation (Sola et al., 2004), the biological role of 
E-domain interference with SdpI binding remains unclear.  RESULTS 
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Fig. 4.11. SdpI competes with gephyrin for binding to the GlyRβ subunit. A. Anti-His6 immune detection of SdpI 
and  GE  after  pull-down  with  GST  and  GST-GlyRβ78  fusion  proteins.  The  His-SdpI  lysate  was  incubated  with 
increasing concentrations of His-Gephyrin-E-domain (His-GE) prior to pull-down. The addition of His-GE inhibited His-
SdpI binding to GST-GlyRβ78 (top panel). No binding of His-GE or His-SdpI to GST was observed (bottom panel). B. 
Quantification of relative His-SdpI band intensities obtained in the GST-pull-down experiments shown in A. Addition of 
0.1 µl of His-GE lysate significantly reduced His-SdpI binding to GST-GlyRβ78. Subsequent addition of 1 and 10 µl of 
His-GE lysate increasingly reduced His-SdpI binding to GST-GlyRβ78. The addition of 100 µl of His-GE lysate blocked 
His-SdpI binding to GST-GlyRβ78 to a similar extent as seen with unspecific binding of His-SdpI to GST. Values 
represent means ± SEM (n=4). Significant differences as compared to control (GST-GlyRβ78 + His-SdpI) : **, p < 0.01; 
***, p < 0.001. 
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4.1.5  Localization of SdpI in spinal cord neurons 
SdpI is specifically expressed in neurons, and previous studies have reported its presynaptic 
localization by fluorescence microscopy, and its peri- and postsynaptic distribution at asymmetric 
synapses by electron microscopy (Qualmann et al., 1999;Pérez-Otaño et al., 2006). However, 
the  presence  of  SdpI  at  inhibitory  synapses  and  its  colocalization  with  inhibitory  synaptic 
markers  have  not  been  investigated.  Upon  subcellular  fractionation  of  rat  spinal  cord 
homogenate  and  Western  blotting,  SdpI  was  detected  in  the  fraction  containing  small 
membraneous organelles, suggesting an association of SdpI with intracellular membranes of 
spinal cord neurons (see Fig. 4.20).  
To gain further insight into the distribution of Sdp at different stages of neuronal differentiation, 
double immunostainings were performed with primary rat spinal cord neurons grown for 11-13 
and  20-22  DIV,  respectively.  Neurons  were  co-stained  with  the  anti-SdpI  antibody  kindly 
provided by Dr. B. Qualmann (Qualmann et al., 1999) and several markers of excitatory (PSD95) 
and  inhibitory  (VIAAT,  GAD67)  presynaptic  terminals  as  well  as  of  inhibitory  postsynapses 
(GlyR,  gephyrin).  After  incubation  with  anti-mouse  Alexa-488  and  anti-rabbit  Alexa-546 
secondary antibodies, fluorescence signal distributions along 50 µm of neuronal processes were 
analysed in an AxioImager microscope equipped with an Apotome grid projector (Zeiss). This 
revealed that SdpI staining was present in neuronal cell bodies and enriched along neuronal 
processes in intensely stained punctate structures (see Fig. 4.12.A, middle panel). Importantly, 
these  punctate  SdpI-positive  structures    colocalized  to  some  extent  with  the  immunoreactive 
spots of excitatory and inhibitory markers (see Fig. 4.12.A).  
Since the GlyRβ subunit is a key determinant of the synaptic clustering of GlyRs at inhibitory 
synapses,  a  prerequisite  for  a  functional  interaction  between  SdpI  and  the  GlyRβ  subunit  at 
synaptic  sites  is  their  in  situ  colocalization  at  inhibitory  postsynapses  in  vivo.  A  partial 
colocalization  was  found  along  neurites  double-stained  with  anti-SdpI  and  anti-GlyR,  anti-
gephyrin  as  well  as  anti-VIAAT  antibodies.  To  establish  the  presence  of  SdpI  at  inhibitory 
synapses, colocalization ratios with SdpI puncta were quantified. At 11-13 DIV, SdpI was often 
detected near GlyR puncta (27 ± 2 % colocalization rate Fig. 4.12.B). This value was significantly 
lower than the VIAAT colocalization rate (40 ± 3 %, p < 0.05) whereas gephyrin colocalization 
with SdpI (40 ± 9 %) was comparable to that seen for VIAAT.  RESULTS 
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Fig. 4.12. Localization of SdpI in processes of rat spinal cord neurons. A. Spinal cord neurons were fixed and 
double-stained  with  SdpI  antibody  and  antibodies  against  several  inhibitory  (gephyrin,  glyR,  VIAAT,  GAD67)  and 
excitatory (PSD95) synaptic markers. Note yellow signals indicating clear co-localization of SdpI-stained punctate 
structures with all synaptic markers used (overlays). Scale bar: 10 µm B. Quantification of the experiment shown in A. 
Percentages  of  immunoreactive  spots  of  each  synaptic  marker  colocalizing  with  SdpI  were  quantified.  Values 
represent means ± SEM (n=3). Significant differences as compared to VIAAT staining: *, p < 0.05. 
 
From  these  results  we  conclude  that  SdpI  is  present  at  inhibitory  synapses.  Due  to  the  low 
resolution that conventional fluorescence microscopy offers, pre- and postsynaptic localizations 
of  SdpI  at  inhibitory  synapses  cannot  be  distinguished.  Additionally,  the  difference  in  SdpI 
colocalization with GlyRβ and gephyrin suggests that, at this stage of differentiation, SdpI is 
present at both glycinergic and GABAergic synapses. 
To determine whether the SdpI puncta observed had a predominantly excitatory or inhibitory 
synaptic localization, colocalization rates were determined for different synaptic marker proteins RESULTS 
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as above but at a later stage of in vitro development (20-22 DIV, Fig. 4.12.A). Interestingly, 
similar  colocalization  values  were  found  for  excitatory  and  inhibitory  presynaptic  and 
postsynaptic markers (PSD95: 36 ± 3 %, VIAAT: 39 ± 4 %, gephyrin: 34 ± 2 %; n=3) in these 
experiments. This confirms that SdpI is present at excitatory as well as at inhibitory synapses 
(Fig. 4.12.B). Also, the percentages of SdpI puncta colocalizing with a presynaptic marker for 
GABAergic synapses and for GlyR revealed no major difference in relative colocalization rates 
(32 ± 5 % and 27.8 ± 2.7% for GAD67 and GlyR, respectively, n=3, p > 0.05). These results 
suggest that SdpI might be present at GABAergic, glycinergic and possibly also mixed GABA-
glycinergic synapses. 
4.1.6  Analysis of SdpI function at inhibitory synapses 
Sdps  are  proteins  involved  in  endocytosis  and  recycling  processes.  The  in  vitro  binding 
experiments presented above (see 4.1.1, 4.1.2 and 4.1.3) show that SdpI and SdpII bind to the 
GlyRβ loop and gephyrin. Based on these results, a possible role of SdpI as GlyR trafficking 
factor  was  examined.  First,  co-immunoprecipitation  studies  with  the  cytoplasmic  vesicle-rich 
fraction of rat spinal cord homogenates were performed. Subsequently, the localization of GlyRs 
in SdpI deficient mice and the effects of SdpI down-regulation in rat spinal cord neurons were 
analyzed. 
4.1.6.1  SdpI and the GlyR form complexes in vesicles 
The  immunocytochemical  experiments  described  above  show  that  SdpI  colocalizes  with 
punctate GlyR immunoreactivity, suggesting that SdpI and GlyR might form complexes in vivo 
(see 4.1.5). To investigate whether SdpI and the GlyR are associated endogenously in neurons, 
co-immunoprecipitation  experiments  were  performed  with  spinal  cord  homogenates.  After 
overnight  incubation  of  a  detergent  extract  prepared  from  the  cytoplasmic  vesicle-enriched 
fraction of a rat spinal cord homogenate with the SdpI antibody and subsequent incubation with 
protein  G  beads,  the  bound  protein  complexes  were  analysed  by  SDS-PAGE  and  Western 
blotting. Immunodetection with the mAb4 antibody, which recognizes GlyR subunits, revealed 
the presence of a band with a molecular weight of around 48 kDa corresponding to that of the α1 
subunit of the GlyR in the input, supernatant and the immunoprecipitate obtained with anti-SdpI, 
but not in the precipitate obtained with an unspecific IgG (Fig. 4.13). This result is consistent with 
SdpI and the GlyR being associated in intracellular vesicles of spinal cord neurons in vitro. RESULTS 
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Fig. 4.13. The GlyR co-immunoprecipitates with SdpI from detergent extracts of a vesicle-enriched fraction 
from spinal cord. Detergent extracts from spinal cord homogenates were pre-cleared with protein G-Sepharose and 
incubated overnight with the corresponding antibody. Antibody-protein complexes were precipitated by incubation with 
protein  G-Sepharose  beads.  After  repeated  washing,  bound  protein  complexes  were  eluted  from  the  beads  and 
analysed by SDS-PAGE followed by Western blot with anti-GlyR antibodies (mAb4). Note that GlyRα subunits (MW 
around 48 kDa) co-precipitated upon incubation with SdpI, but not unspecific IgG antibodies. Bands above 50 kDa in 
the immunopellet containing SdpI antibodies result from an unspecific reaction of the primary or secondary antibodies 
with the light chain of the SdpI antibody. 
 
4.1.6.2  Analysis of glycine receptor clustering in SdpI deficient neurons 
The data presented above suggested that the SdpI-GlyR interaction may take place in cytosolic 
vesicles,  and  hence  may  be  important  for  GlyR  trafficking.  To  investigate  whether  SdpI  is 
essential for GlyR transport, the synaptic localization of GlyRs was examined in neurons isolated 
from SdpI KO mice. Spinal cord neurons were prepared from SdpI -/- and wildtype mice and 
cultured in vitro using our standard protocol (see 3.5.5). At 20-22 DIV, the cultures were double-
stained with the mAb4 and VIAAT antibodies. Fluorescences were analyzed as described under 
3.5.11. The direct inspection of neuronal morphology and neurite formation did not reveal any 
obvious impairment in the neuronal development of SdpI -/- spinal cord neurons. GlyR clusters 
colocalized with VIAAT staining in both wildtype and SdpI -/- neurons (Fig. 4.14). To investigate 
the distribution of GlyR in more detail, the number and average size of GlyR immunoreactive 
clusters  along  50  µm  of  neuronal  processes  proximal  to  the  soma  were  analyzed  using  the 
ImageJ software. Automated image analysis revealed that the number of GlyR clusters per 50 
µm neurite did not differ between wildtype (41.7 ± 3.0 IR-spots) and SpdI -/- neurons (41.4 ± 5.3 
IR-spots;  10  neurons  each;  n=5;  p  >  0.05),  and  that  the  GlyR  mean  cluster  size  was  not 
significantly reduced upon SdpI -/- deficiency (76.4 ± 10.3 % of control; 10 neurons each; n=5; p 
> 0.05) (see Fig. 4.14.B). These results indicate that GlyR trafficking and synaptic clustering is 
not impaired in the absence of SdpI in 20-22DIV spinal cord neurons.  RESULTS 
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Fig.  4.14.  GlyR  clusters  in  cultured  +/+  and  SdpI-/-  spinal  cord  neurons.  A.  DIV20-22  spinal  cord  neurons 
cultured from +/+ or SdpI-/- mouse embryos were fixed and stained with primary mAb4 and VIAAT antibodies as well 
as the corresponding secondary antibodies, anti-mouse Alexa-488 and anti-rabbit Alexa 546. Note that regardless of 
genotype  GlyR  clusters  are  present  along  neurites  and  co-localize  with  VIAAT-enriched  puctate  structures  in  the 
overlay (left panel in yellow). Scale bar: 20 µm B. Quantification of the experiments shown in A. Number of GlyR 
puncta  per  50  µm  neurite  and  average  size  of  GlyR  clusters  were  quantified  with  the  ImageJ  software.  Values 
represent means ± SEM (n=5). No significant differences as compared to +/+: p > 0.05.  
 
Spinal  cord  neurons  can  be  maintained  in  culture  only  up  to  four  weeks.  To  investigate  a 
possible contribution of SdpI to GlyR trafficking mechanisms at later developmental stages, the 
distribution of synaptic GlyR clusters was also analysed in brainstem sections prepared from 
adult wildtype and SdpI -/- mice. Specifically, cryostat sections from brainstems of wildtype and RESULTS 
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littermate  SdpI  -/-  mice  were  fixed  and  double-stained  (3.5.10.2)  with  VIAAT  and  mAb4,  or 
mAb7, antibodies to reveal presynapses as well as GlyR and gephyrin clusters, respectively. 
Both the GlyR and gephyrin puncta colocalized with VIAAT in wildtype and SdpI -/- mice (data 
not shown). Also, GlyR cluster numbers per 30 µm
2 field were similar for wildtype (16.7 ± 2.7 IR-
spots) and SdpI -/- mice (16.7 ± 1.6 IR-spots). Additionally, quantification of the GlyR mean 
cluster size showed no significant change in SdpI -/- (98.2 ± 24.3 % of control, n=3, p > 0.05) as 
compared to wildtype mice (see Fig. 4.15.A and B). Similarly, the analysis of gephyrin clusters 
did not disclose any significant change in cluster density/ 30 µm
2 and mean cluster size in SdpI -
/- (92.8 ± 6.5 % and 95.5 ± 8.5 % of control, respectively) as compared to littermate wildtype 
mice (see Fig. 4.15.A and B). Based on these results we conclude that SdpI is not a limiting 
factor for GlyR and gephyrin trafficking to inhibitory synaptic sites in both developing and adult 
SdpI -/- neurons.  
 
Fig. 4.15. GlyR distribution analysis in brainstem of +/+ and SdpI-/- mice. A. Brain stem-sections of adult +/+ and 
SdpI-/- mice were stained with the mAb4 and mAb7 antibodies to detect GlyR and gephyrin clusters, respectively. 
Scale bar: 20 µm. B. Quantification of the experiments shown in A. Number of GlyR and gephyrin puncta per optical 
field and average size of GlyR as well as gephyrin clusters were quantified with the ImageJ software. Shown are 
mean values ± SEM (n=5). No significant differences as compared to +/+ : p-value > 0.05.  RESULTS 
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4.1.6.3  GlyR distribution in rat spinal cord neurons after acute SdpI down-regulation 
The results presented above indicate that SdpI and both splice variants of SdpII interact directly 
with  the  GlyRβ  subunit ( see  4.1.1.1).  However,  SdpI-/-  neurons  and  mice  did  not  show  any 
changes in GlyR and gephyrin cluster densities and sizes. Alternative transport mechanisms or a 
redundant function of Sdps in GlyR trafficking might explain our negative results. Here, acute 
SdpI knock-down experiments were performed to investigate whether the function of SdpI might 
be compensated. To down-regulate SdpI in neurons, a sequence for the knock-down of SdpI by 
RNA interference, kindly provided by Dr. Britta Qualmann, was cloned into a second generation 
small-hairpin interference RNA vector (miR). Since standard lipid-mediated transfection methods 
function unefficiently in spinal cord neurons, a recombinant adeno-associated viral system was 
employed t o  reach  a  high  infection  rate.  The  SdpI-miR  sequence  was  then  cloned  into  a 
recombinant  adeno-associated  viral  vector  (rAAV).  Additionally,  myc-tagged  SdpI  resistant  to 
SdpI-miR was also cloned into a rAAV vector in order to rescue SdpI expression (SdpI-siR). 
Then 6-7 DIV spinal cord neurons were infected with equivalent infectious units (i.u.) of rAAV 
viruses containing the SdpI-miR sequence (SdpI-miR-rAAV) or a control miR vector (cont-miR-
rAAV). For the rescue experiment, the neurons were co-infected with two rAAV viruses encoding 
SdpI-miR-rAAV  and  SdpI-siR-rAAV,  respectively.  In  our  cultures,  rAAV  viruses  showed  an 
infection  efficiency  of  ~50%.  Cont-miR-rAAV  and  SdpI-miR-rAAV  infected  neurons  were 
identified  by  direct  observation  due  to  GFP  reporter  gene  expression  encoded  in  the  rAAV 
vector. SdpI-siR-rAAV infection was detected by myc staining.  
In initial control experiments, neurons were harvested at 20-21 DIV, and their protein contents 
were  analysed  by  Western  blot.  β3-Tubulin,  analyzed  to  check  for  cell  viability,  showed  a 
significant reduction upon SdpI-miR-rAAV infection as compared to cont-miR-rAAV infection (see 
Fig. 4.16.A). This reduction in β3-tubulin content was strictly increased upon co-infection of the 
SdpI-miR and SdpI-siR viruses, indicating that viral infection reduced the survival of neural or 
glial cells. We then determined SdpI protein concentrations as normalized to the β3-tubulin band 
to monitor SdpI downregulation. Western blotting with an anti-SdpI antibody revealed a ~60% 
reduction in SdpI protein content upon infection with the SdpI-miR-rAAV virus (39.0 ± 15.8 % of 
control)  as  compared  to  control-miR  virus ( Fig.  4.16.B).  This  indicates  that  the  SdpI-miR 
sequence effectively down-regulates the expression of the SdpI protein. Additionally, when SdpI-
siR  was  incubated  in  the  presence  of  SdpI-mIR,  Western  blot  analysis  showed  about  8-fold 
increase in SdpI expression (Fig. 4.16.A, right lane), indicating that SdpI-siR-rAAV induced the RESULTS 
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overexpression  of  SdpI  in  spinal  cord  neurons  in  the  presence  of  SdpI-miR-rAAV  and  thus 
allowed rescue of SdpI expression.  
 
 
Fig. 4.16. Knock-down of SdpI in spinal cord neuron cultures. A. Spinal cord neurons were infected at DIV7 with 
control-miR,  SdpI-miR,  and  SdpI-siR  virus.  DIV20  spinal  cord  neurons  were  harvested  and  homogenates  were 
analyzed by Western blotting with anti-SdpI and anti-β3 tubulin antibodies. B. Quantification of band intensity of SdpI 
normalized to β3-tubulin expression in western blots of three independent experiments. SdpI band expression was 
significantly decreased in neurons infected with the SdpI-miR virus when compared to neurons infected with a control-
miR virus (p< 0.05).  
 
In order to investigate the effects of SdpI down-regulation on GlyR cluster distribution, spinal 
cord neurons were infected from DIV7 to DIV20 with cont-miR-rAAV, SdpI-miR-rAAV and SdpI-
miR-rAAV  +  SdpI-siR-rAAV.  Cont-miR-rAAV  and  SdpI-miR-rAAV  infection  was  monitored  by 
endogenous GFP expression. GlyR and SdpI-siR expression was detected with mAb4 and myc 
antibodies, which stained GlyR and myc-tagged SdpI-siR proteins respectively. Staining with the 
corresponding secondary antibodies Alexa-635-anti-mouse and Alexa-546-anti-rabbit allowed to 
monitor the expression of the three proteins. Fluorescences from the GFP, myc-546 and GlyR-
635 channels were analysed as described in 4.1.6.2. Subsequently, GlyR cluster numbers and 
average sizes in cont-miR and SdpI-miR infected neurons were determined along 50 µm neurite 
(n=10) in the proximity of the soma of GFP-positive neurons. These analyses showed that upon 
SdpI down-regulation GlyR cluster numbers/50 µm were reduced from 35.9 ± 6.1 in control-miR RESULTS 
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infected neurons to 16.9 ± 3 in SdpI-miR infected neurons (~50 % reduction, n=3, p < 0.01)(see 
Fig. 4.17). In the same neurons, GlyR mean cluster size dropped from 2.3 ± 0.1 µm
2  in cont-miR 
infected to 1.6 ± 0.3 µm
2 in SdpI-miR infected neurons (~30% reduction, n=3, p < 0.05)(see Fig. 
4.17).  In  rescue  experiments  with  doubly  SdpI-miR-rAAV  +  SdpI-siR-rAAV  infected  neuronal 
cultures, GlyR clusters were examined in cells double-positive for GFP and myc expression. In 
these cells, GlyR cluster density rose from 48.0 ± 6.7% upon SdpI knock-down to 111.8 ± 23.6 
% of control upon SdpI-siR co-expression (16.9 ± 3 immunoreactive puncta/50 µm in SdpI-miR 
vs. 37.2 ± 2.4 puncta in doubly SdpI-miR + SdpI-siR infected neurons; n=3, p < 0.05). Similarly, 
the reduction of GlyR mean cluster size to 69.5 ± 9.4 % of control observed upon SdpI down-
regulation was fully rescued upon SdpI-siR overexpression to 125.9 ± 4.3 % of control (1.6 ± 0.3 
µm
2 in SdpI-miR vs. 2.9 ± 0.1 µm
2  in double-infected neurons, respectively; n=3, p < 0.05).  
Together these results indicate that the acute downregulation of SdpI impairs GlyR clustering at 
inhibitory  synaptic  sites.  Furthermore,  they  also  suggest  that  Sdps  are  implicated  in  a  GlyR 
transport mechanism, which is not strictly SdpI-dependent, but may also use other Sdp isoforms 
or other trafficking proteins. Finally, our rescue experiments confirm that the reductions in GlyR 
number  and  mean  cluster  size  observed  upon  SdpI  down-regulation  are  indeed  specific,  i.e. 
SdpI-dependent.  RESULTS 
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Fig. 4.17. SdpI knock-down reduces GlyR cluster and size. A. Rat spinal cord neurons were infected at DIV7 with 
cont-miR-rAAV, SdpI-miR-rAAV and double-infected with SdpI-miR-rAAV + SdpI-siR-rAAV. DIV20 neurons were fixed 
and stained with mAb4 and myc antibodies as well as the corresponding secondary antibodies, Alexa-635-anti-mouse 
and  Alexa-546-anti-rabbit,  to  detect  GlyR  and  SdpI-siR  proteins.  miR-rAAV  infection  induced  GFP  reporter  gene 
expression. Scale bar: 5 µm. B. Quantification of the experiments shown in A. Number and average size of GlyR 
clusters per 50 µm neurite were determined. Values represent means ± SEM nomalized to control-miR-rAAV infection 
(n=3). Significant differences compared to control-miR-rAAV infected neurons: *, p < 0.05; **, p < 0.01 RESULTS 
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4.1.6.4  Effect of SdpI down-regulation on the synaptic localization of different inhibitory 
pre- and postsynaptic proteins 
Our  gephyrin/Sdp  colocalization  data  had  suggested  that  Sdps  may  contribute  to  gephyrinʼs 
association with the plasma membrane (see 4.1.3.2). To find out whether SdpI may contribute to 
gephyrin  trafficking,  both g ephyrin  and  GlyR  clusters  were  analyzed  under  the  same  SdpI-
knockdown conditions as used above (see 4.1.6.3). To this end, spinal cord neurons infected at 
DIV7 with cont-miR or SdpI-miR were fixed at DIV20-21 and stained with mAb7 or mAb4a and 
the  corresponding  secondary  Alexa-546-anti-mouse  antibodies ( Fig.  4.18.A).  Images  of  the 
gephyrin and GlyR clusters in proximal neurites of GFP expressing neurons were collected and 
analyzed  as  detailed  under  4.1.6.3.  This  disclosed  a  slight  but  not  significant  reduction  in 
gephyrin cluster density of ~10% (89.5 ± 18.5 % of control) in neurons with SdpI down-regulation 
as compared to control neurons (n=3, each; p > 0.05). In contrast, GlyR cluster densities were 
again reduced by ~30% in the down-regulated neurons (67.8 ± 11.6 % of control; n=3, p < 0.05). 
The analysis of gephyrin cluster size showed a reduction to 72.8 ± 21.3 % of control in neurons 
with SdpI down (n=3, p > 0.05) (see Fig. 4.18.B). However, when mean GlyR cluster sizes were 
analyzed in cont-miR and SdpI-miR infected neurons, a highly significant reduction was found 
(55.7 ± 7.9 % of control; n=3, p < 0.01). In summary, SdpI knock-down induces highly significant 
changes in mean GlyR cluster numbers and sizes whereas mean gephyrin cluster numbers and 
sizes are only slightly but not significantly reduced. Thus, SdpI appears to be important for GlyR 
but not gephyrin synaptic distribution.  
To  investigate  whereas  changes  in  GlyR  cluster  number  and  size  affect  presynaptic 
differentiation,  VIAAT  staining  was  analyzed  under  SdpI  knock-down  conditions.  Images  of 
VIAAT  fluorescence  in  proximal  neurites  from  GFP  expressing  neurons  were  collected  and 
analyzed  as  described  above.  This  revealed  no  significant  difference  in  densities  of  VIAAT 
immunoreactive terminals between SdpI-miR (96.8 ± 13.9 % of control; n=3, p > 0.05) and cont-
miR infected neurons. In contrast, the mean size of VIAAT puncta was reduced to 73.8 ± 13 % of 
control upon SdpI down-regulation (Fig. 4.18.B). However this reduction was not significant (n=3; 
p > 0.05), indicating that SdpI depletion does not primarily disrupt inhibitory presynaptic function.  
Previous  studies  have  demonstrated  that  SdpI  localizes  near  GAD67  in  spinal  cord  neurons 
(4.1.5). In order to investigate whether SpdI function is restricted to GlyR clustering, GABAAR 
clusters were also examined under SdpI knock-down conditions. For the staining of GABAARs, RESULTS 
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antibodies against the GABAARγ2 subunit were employed, and synaptic images were collected 
and  evaluated  as  mentioned  under  4.1.6.3.  SdpI-miR  infected  neurons  exhibited  23.0  ±  7.6 
immunoreactive puncta per 50 µm
 neurite, and cont-miR infected neurons 35.5 ± 7.2 per 50 µm 
neurite (reduction to 62.8 ± 9.9 % of control; n=3, p < 0.05). GABAARγ2 clusters exhibited an 
average size of 2.6 ± 0.6 µm
2 in cont-miR and of 1.4 ± 0.2 µm
2 in SdpI-miR infected neurons 
(reduction to 56.6 ± 5.2 % of control; n=3, p < 0.01) (see Fig. 4.18.B). In conclusion, about 40% 
and ~45% reductions in GABAARγ2 mean cluster number and size were observed in neurons 
upon  SdpI  down-regulation.  Thus,  the  loss  of  SdpI  affects  both  GlyR  and  GABAAR  synaptic 
localization.  
 RESULTS 
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Fig. 4.18. SdpI knockdown affects inhibitory postsynaptic receptor clustering. A. Rat spinal cord neurons were 
infected  at  DIV7  with  cont-miR-rAAV  and  SdpI-miR-rAAV.  DIV20-21  neurons  were  fixed  and  stained  with  mAb4, 
mAb7, γ2 and VIAAT antibodies as well as the corresponding secondary antibodies, Alexa-546-anti-mouse or anti-
rabbit, to detect GlyR, gephyrin, GABAARγ2, and the vesicular inhibitory aa tranporter. miR-rAAV infection induced 
GFP reporter gene expression. Scale bar: 5 µm. B. Quantification of the experiments shown in A. Numbers and 
average sizes of puncta per 50 µm neurite were determined with the ImageJ software. Values represent means ± 
SEM nomalized to control-miR-rAAV infection (n=3). Significant differences as compared to control-miR-rAAV infected 
neurons: *, p < 0.05; **, p < 0.01 RESULTS 
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4.2  Analysis of the interaction between vacuolar protein sorting 35 
(Vps35) and the GlyRβ subunit  
In  addition  to  the  proteomic  screen  in  which  SdpI  was  isolated  (4.1),  another  screen  was 
performed in an attempt to find other new binding partners for GlyRβ. In this screen, a GST 
fusion  protein  encompassing  49  amino  acids  (positions  378  to  426)  of  the  intracellular  loop 
between transmembrane domains 3 and 4 of the GlyRβ subunit (GlyRβ49) was utilized as bait for 
the isolation of binding proteins from a rat brain detergent extract. One of the protein bands 
found exhibited an apparent molecular weight of about 90 kDa and was identified by matrix-
assisted  laser  desorption/ionisation-time  of  flight  mass  spectrometry  (Maldi-ToF)  analysis  as 
Vps35 (I. Paarmann et al., unpublished data).  
4.2.1  In vitro analysis of the interaction between Vps35, the GlyRβ subunit and 
gephyrin 
As  for  SdpI  (4.1.1),  a  GST  pull-down  assay  was  employed  here  in  order  to  investigate  the 
interactions between Vps35 and other putative binding proteins. Vps35 is part of the retromer 
complex and interacts with Vps29 (see introduction 2.4.2.1). Therefore a GST-tagged Vps29 
construct was used as positive control for Vps35 binding in GST pull-down experiments. GST 
fusions  of  GlyRβ49,  gephyrin,  Vps29  and  GST  alone  were  incubated  with  a  bacterial  lysate 
containing  the  recombinant  His6-tagged  Vps35  (His-Vps35).  A  His6-tagged  fragment  of 
collybistin  II  (first  240  aa)  served  as  a  positive  control  for  gephyrin  binding ( I.Paarmann, 
unpublished). Anti-His6 Western blot analysis revealed a band of about 94 kDa, corresponding to 
the expected molecular weight of His-Vps35 that was found with the GST-fusion of Vps29 and 
the GST fusions of GlyRβ49 and gephyrin but was absent in the GST eluate (see Fig. 4.19). This 
result indicates that Vps35 interacts in vitro with the intracellular loop of the GlyRβ subunit and 
gephyrin.  RESULTS 
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Fig. 4.19. Vps35 interacts with the GlyRβ loop and gephyrin in vitro. GST fusion proteins of GlyRβ49, gephyrin, 
Vps29 and GST were incubated with bacterial lysate containing the recombinant His6-tagged-Vps35. A corresponding 
bacterial  lysate  containing a   His6-tagged  fragment  of  collybistin-II  (His-CbII)  was  incubated  with  GST-gephyrin  to 
confirm that the recombinant gephyrin protein was “active”. Western blot and anti-His6 immunodetection revealed a 
~94 kDa protein band, corresponding to the molecular weight of His-Vps35, in the eluates from GlyRβ49, gephyrin, 
Vps29 but not GST. A protein band of ~30 kDa, corresponding to the 240 aa fragment of collybistin-II, also bound to 
GST-gephyrin. Bands below 36 kDa in the GST-Vps29 and His-Vps35 Input lanes represent degradation products of 
Vps35 or unspecifically bound proteins. 
 
4.2.2  Localization of Vps35 in the central nervous system 
If the interaction between Vps35 and the GlyRβ subunit would occur in neurons, both proteins 
should  show  overlapping  subcellular  localizations. Here,  the  subcellular  distribution  of  Vps35 
was  investigated  by  immunocytochemistry.  Commercially  available  antibodies  against  Vps35 
only worked in Western blot analysis, but failed to detect the native Vps35 protein in situ (data 
not  shown).  Therefore,  an  antibody  suitable  for  the  immunocytochemical  and 
immunohistochemical  detection  of  Vps35  was  needed.  Hence,  polyclonal  antibodies  against 
Vps35 were generated in collaboration with the group of Dr. Jaroslav Blahos at the Academy of 
Sciences of the Czech Republic (Czech Republic). 
4.2.2.1  Generation of polyclonal antibodies against Vps35 
Full-length Vps35 was expressed as a His6 fusion protein in E.coli BL21, purified on a Ni-NTA 
matrix  under  stringent  conditions  and  dialysed  as  previously  described  under  3.3.7.2.  The 
purified recombinant protein was employed as antigen for the immunization of four guinea pigs 
and two rabbits. After the third immunization, (see 3.3.10 for immunization protocol), antibody 
immunoreactivity was examined by Western blotting and immunocytochemistry. RESULTS 
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4.2.2.2  Characterization of anti-Vps35 antibodies 
4.2.2.2.1  Western blot analysis 
First,  the  Vps35  antisera  were  tested  for  their  specificity  using W estern  blot  analyses.  This 
revealed that the antisera were able to recognize the recombinant Vps35 protein expressed in 
bacteria  as  well  as  the  protein  endogenously  expressed  in  spinal  cord  neurons  Moreover, 
putative  cross-reactions  of  the  antisera  with  another  GST-tagged  protein  of  the  retromer 
complex,  GST-Vps29,  were  investigated.  Bacterial  lysates  containing  GST  fusion  proteins  of 
Vps35  and  Vps29  and  the  original  antigen  (His6-Vps35)  were  separated  by  SDS-PAGE  and 
probed for antibody binding by Western blotting. From the six different sera examined, the rabbit 
anti-Vps35  antibodies  in  serum  08  (Vps35-Rb08)  detected  a  band  of  about  118  kDa 
corresponding to the molecular weight of GST-Vps35 and a band of ~ 94 kDa corresponding to 
the apparent molecular weight of His6-Vps35 (Fig. 4.20.A). No band was detected in the GST-
Vps29  sample,  indicating  that  the  Vps35-Rb08  antibodies  recognized  the  antigen  used  for 
immunization and also the bacterially expressed GST-Vps35 protein but did not cross-react with 
GST-Vps29 protein. The antibodies also bound to a protein of approximately 90 kDa in the spinal 
cord  homogenate, which  is  consistent  with  the  molecular  weight  of  endogenous  Vps35  (Fig. 
4.20.B). Together, these results indicate that the Vps35-Rb08 antiserum specifically recognized 
the denatured Vps35 protein. 
Fig. 4.20. Specificity test of a rabbit polyclonal Vps35 antiserum revealed by Western blot analysis. A. The 
following samples were separated by SDS-PAGE and tested for anti-Vps35 reactivity using the Vps35-Rb08 serum: 
GST-Vps35,  GST-Vps29  and  antigen  (His-Vps35).  B.  Additionally,  spinal  cord  homogenate  was  analysed  as 
described  in  A.  Western  blots  show  that  the  antiserum  recognized  the  antigen,  GST-Vps35,  but  no  GST-Vps29. 
Moreover, the Vps35 antiserum specifically recognized the endogenous Vps35 in spinal cord homogenate. Protein 
bands below 90 kDa correspond to weak unspecific reactivity of the Vps35-Rb08 antibodies.  
 RESULTS 
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4.2.2.2.2  Immunocytochemistry 
After having demonstrated reactivity against denatured Vps35 protein by Western blot analysis, 
the  ability  of  the  Vps35  antisera  to  recognize  the  native  protein  in  mammalian  cells  was 
examined.  For  this  purpose,  Vps35  antiserum-specificity  was  analyzed  by  means  of 
immunocytochemical  experiments.  COS-7  cells  were  transfected  with  cDNAs  encoding  GFP-
tagged Vps35 and GFP alone and fixed 24 h later. Cells were subsequently incubated with the 
Vps35  antisera  and  stained  with  Alexa-546  conjugated  anti-rabbit  antibodies  following  the 
standard protocol used for immunocytochemical staining (see 3.5.9). From the two rabbit sera 
tested, only the Vps35-Rb08 serum stained cells expressing GFP-tagged Vps35 (Fig. 4.21.A) 
but  not  cells  expressing  GFP  alone ( Fig.  4.21.B),  indicating  that  the  Vps35-Rb08  serum 
specifically  recognizes  Vps35  and  does  not  cross-react  with  unspecific  proteins  in  a  native 
environment. 
 
 
Fig. 4.21. Specificity of the Vps35 Rb-08 antiserum demonstrated by immunostaining of transfected COS-7 
cells. COS-7 cells transfected with cDNAs encoding GFP (A) or GFP-tagged Vps35 (B) were stained with the Vps35-
Rb08 antiserum and secondary Alexa-546-conjugated anti-rabbit antibodies. Cell nuclei were stained with DAPI. Note 
that  the  Vps35-Rb08  antiserum  stained  cells  expressing  GFP-Vps35 ( overlay  of  the  bottom  panel),  but  not  cells 
expressing GFP (no yellow signal in the overlay of the top panel). Scale bar: 10 µm. 
 RESULTS 
  90 
4.2.2.3  Immunocytochemical  analysis  of  the  localization  of  Vps35  in  spinal  cord 
neuronal cultures 
After  the  last  immunization  (see  3.3.10  for  immunization  protocol),  specific  antibodies  were 
purified from the Vps35-Rb08 sera by means of antigen-affinity-chromatography as described 
under 3.3.11.  
In order to test whether the purified Vps35 antibody recognizes specifically the native protein in 
neuronal cells, DIV20 spinal cord neuron cultures were fixed and stained with the anti-Vps35 
antibody as primary and Alexa-546-anti-rabbit as secondary antibodies. Since there is no Vps35 
-/- mouse available, as a negative control the antibody was pre-incubated in the presence of an 
excess  of  the  GST-tagged  Vps35  protein  immobilized  on  a  GSH  matrix.  This  should  cause 
specific antibody depletion and, hence reduce immunostaining. As a positive control, the same 
procedure was performed by pre-incubating the antibody solution in the presence of an excess 
of immobilized GST. 
These  experiments  showed  that  the  purified  Vps35  antibody  stained  cultured  spinal  cord 
neurons in the presence of GST (see Fig. 4.22.B), whereas in the presence of GST-Vps35 the 
staining of neurons was prevented (see Fig. 4.22.A). Closer inspection of the staining pattern 
revealed  that  Vps35 i mmunoreactivity  in  cultured  spinal  cord  neurons  was  enriched 
perisomatically  and  along  neurites  often  in  punctate  structures  (see  Fig.  4.22.D);  again,  this 
staining was absent upon incubation with GST-Vps35 (see Fig. 4.22.C).  
These  results  are  consistent  with  the  antisera  results  and  show  that  the  purified  antibody 
specifically recognizes Vps35. Together, they provide strong evidence for Vps35 expression in 
spinal  cord  neurons,  where  Vps35  seems  to  be  present  both  at  somatic  locations  and  in 
neuronal processes. Additionally, the punctate staining pattern is consistent with an association 
of Vps35 with transport vesicles. Double-stainings using anti-Vps35 and anti-GlyR antibodies 
could  not  be  performed  during  the  time  available  but  may  help  to  identify  the  subcellular 
structures, in which GlyRs and Vps35 are associated in spinal cord neurons.  RESULTS 
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Fig. 4.22. Immunocytochemical analysis of Vps35 localization in rat spinal cord neurons. DIV20 rat spinal cord 
neuron cultures were fixed and stained with purified Vps35 antibody that had been pre-incubated with GST-Vps35 (A 
and C) or GST (B and D) protein immobilized on a GSH matrix. Bound antibody was visualized with Alexa-546 anti-
rabbit secondary antibodies. Note that Vps35 antibody pre-incubated with GST, but not with GST-Vps35, stained 
neuronal cell bodies (arrowheads). Magnification shows the staining pattern of Vps35 in punctate structures in soma 
and along neurites (arrows) of neurons stained with Vps35 antibody pre-incubated with GST (D), but not with GST-
Vps35 (C). Maximal projections were taken at 40X (A and B, scale bar: 50 µm) and 63X magnification (C and D, scale 
bar: 20 µm).  RESULTS 
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4.3  Analysis of the interaction between Neurobeachin and the GlyRβ 
subunit  
In the proteomic screen used for the isolation of Vps35 from brain lysate (see 4.2), an additional 
protein  band  with  a  molecular  weight  of  approx.  350  kDa  had  been  identified  by  Maldi-ToF 
analysis as Neurobeachin (Nbea) (Paarmann, unpublished observation). Here, the significance 
of this proteomic result was examined by pull-down experiments and immunocytochemistry.  
4.3.1  In vitro binding of Nbea to the GlyRβ subunit 
As  for  SdpI  (4.1.1)  and  Vps35  (4.2.1),  a  GST  pull-down  assay  was  employed  in  order  to 
investigate the interactions between Nbea and the GlyRβ subunit. Since there was no construct 
available that encompassed the huge full-length Nbea coding sequence (> 8.8 kb; see Wang et 
al., 2000), three GFP-tagged fragments of the Nbea cDNA provided by the Kilimann group were 
employed ( Fig.  4.23.A,  see  3.1.13).  These  constructs,  which  together  cover  the  entire  Nbea 
open reading frame (Fig. 4.23.A), were transfected into HEK 293T cells, and protein expression 
was allowed for 24 h. The GFP-tagged Nbea-fragments were normally expressed and localized 
to the cytosol of HEK 293T cells (Fig. 4.23.B). Anti-GFP Western blot analysis of HEK 293T cell 
homogenates  confirmed  that  the  recombinant  NbeaBCD  protein  matched  the  expected 
molecular  weights  of  131  kDa,  indicating  a  proper  expression  of  this  fragment.  In  contrast, 
recombinantly expressed NbeaA and NbeaEFG proteins were detected at molecular weights of 
~ 110 kDa and ~ 131 kDa, e.g. below the expected sizes of 130 kDa and 154 kDa, respectively, 
suggesting partial cleavage of the polypeptides (see Fig. 4.23.C). Additionally, the band intensity 
of the NbeaEFG fragment was reduced as compared to the band intensities of the NbeaA and 
NbeaBCD fragments, indicating that the GFP-NbeaEFG protein is less efficiently expressed in 
HEK 293T cells than NbeaA-GFP and GFP-NbeaBCD (see Fig. 4.23.C).  
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Fig.  4.23.  Expression  of  three  Nbea  fragments.  A.  Schematic  representation  of  GFP-tagged  Nbea  fragments. 
Numbers indicate the amino acid positions at the N- and C-termini of the respective Nbea fragments. B. Transfected 
HEK 293T cells express the different GFP-tagged Nbea fragments. Note the cytosolic distribution of all GFP-tagged 
proteins. Scale bar: 10 µm. C. Anti-GFP Western blot analysis of transfected HEK 293T detergent extracts shows the 
band sizes of the recombinant GFP-Nbea proteins and a reduced expression of GFP-NbeaEFG as compared to GFP-
NbeaBCD or NbeaA-GFP. 
 
 
In pull-down experiments, detergent extracts of HEK 293T cells expressing the three different 
Nbea  fragments  were  incubated  with  either  the  GST-tagged  GlyRβ49  loop  construct  (GST-
GlyRβ49) or GST as a negative control. As a positive control for GlyRβ49 binding, GFP-gephyrin 
was also expressed in HEK 293T cells. Following SDS-PAGE, anti-GFP Western blot analysis 
revealed that prominent bands corresponding to the molecular weight of GFP-gephyrin, GFP-
NbeaBCD and GFP-NbeaEFG were present in the GST-GlyRβ49 pull-downs, but absent or only 
weakly seen in the GST control lanes. These results suggest that, similar to gephyrin, Nbea 
interacts with GlyRβ49 in vitro through its BCD and EFG domains, whereas the A domain of Nbea 
is not required for this interaction (Fig. 4.24). RESULTS 
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Fig. 4.24 In vitro interaction between Nbea fragments and the GlyRβ loop. GST fusion proteins of GlyRβ49 and 
GST were incubated with HEK 293T detergent extracts containing GFP-tagged Nbea fragments. GFP-gephyrin was 
used as a positive control for GlyRβ49-binding. The top panel shows the anti-GFP Western blot analysis, in which 
GFP-Nbea BCD, GFP-NbeaEFG and GFP-gephyrin bands co-precipitated with GST-GlyRβ49 but not or only little with 
GST. GST-protein loads are shown in the Coomassie stained gel below. Double bands for GST-GlyRβ49 result from 
partial cleavage between GST and the fused GlyRβ49 sequence.  
 
4.3.2  Subcellular localization of Nbea in neurons. 
An in vivo interaction of Nbea with the GlyR requires that both proteins are present in the same 
neuronal compartments. In order to investigate Nbea distribution and localization at excitatory 
and  inhibitory  synapses,  double  immunolabeling  experiments  were  performed  with  cultured 
hippocampal  and  spinal  cord  neurons.  As  a  first  approach t o  investigate  Nbea  distribution, 
DIV14 hippocampal neurons were stained with a Nbea antibody provided by Dr. M. W. Kilimann 
(Wang et al., 2000). Nbea immunoreactivity was predominant in the soma and sparse along the 
neuronal  processes.  The  presence  of  Nbea  near  trans-Golgi  membranes  was  confirmed  by 
double immunofluorescence, in which hippocampal neurons where co-stained with Nbea and a 
trans-Golgi network marker (TGN38). Fluorescence analysis revealed a clear colocalization of 
Nbea with the TGN38 in the cell bodies and along neurites (Fig. 4.25), indicating that Nbea is 
located near the trans-Golgi network in the soma and along neuronal processes.  RESULTS 
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Fig.  4.25.  Neurobeachin  is  found  at  the  trans-Golgi  network  in  primary  hippocampal  neurons.  DIV14 
hippocampal  neurons  were  fixed  and  stained  with  the  Nbea  antibody  and  for  the  TGN38  marker.  Nbea 
immunoreactivity  largely  colocalized  with  the  TGN-marker  as  indicated  in  the  overlay  in  yellow  (right  panel). 
Magnification  shows  the  colocalization  of  Nbea  and  TGN38  along  a  neurite.  The  arrowhead  points  to  a  signal 
overlapping in the neuronal cell bodies, and arrows in the magnification point to signals overlapping along neuronal 
processes. Scale bar: 10 µm.  
 
Subsequently, in order to examine Nbea localization at synapses, double immunostainings were 
performed  in  DIV20-22  spinal  cord  cultures  with  the  Nbea  antibody  and  antibodies  against 
several  inhibitory  presynaptic  (VIAAT,  GAD67)  and  postsynaptic  (gephyrin,  GlyR),  marker 
proteins as well as an excitatory postsynaptic (PSD95) marker (Fig. 4.26.A). As observed in 
hippocampal  neurons,  Nbea  staining  was  present  predominantly  in  neuronal  cell  bodies  and 
along neuronal processes forming intensely stained punctate structures. These enrichments in 
Nbea immunoreactivity partially colocalized with the different synaptic marker proteins stained 
along neurites of spinal cord neurons. 
The quantification of colocalizing puncta was performed as previously described under 4.1.5. 
Fluorescence  analysis  revealed  no  significant  difference  between  the  colocalization  of 
presynaptic and postsynaptic as well between excitatory and inhibitory presynaptic markers with 
Nbea immunoreactive puncta. The percentage of puncta of each synaptic marker co-localizing 
with or being apposed to Nbea puncta was 17.8 ± 3.9% for PSD95, 22.4 ± 8.5% for VIAAT, 16.5 
± 6.5% for GAD67, 18.6 ± 3.5 for GlyR and 16.4 ± 3.5% for gephyrin (n=3, p > 0.05). These 
results  agree  with  a  previous  report  showing  a  localization  of  Nbea  near  postsynaptic 
membranes  (Wang  et  al.,  2000).  They  also  indicate  that  Nbea  is  located  synaptically  and 
additionally  suggest  that  Nbea  is  not  preferentially  found  at  specific  synapses  but  is  equally 
present at excitatory and inhibitory synapses (Fig. 4.26.B, p > 0.05). RESULTS 
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Fig. 4.26. Localization of Nbea in processes of spinal cord neurons. A. Spinal cord neurons were fixed and co-
stained with Nbea antibody and several inhibitory (gephyrin, glyR, VIAAT, GAD67) and excitatory (PSD95) synaptic 
markers  at  DIV20-22.  Note  the  yellow  signal  indicating  clear  co-localization  of  Nbea  immunoreactive    punctate 
structures with all the synaptic markers used (overlays). Scale bar, 10 µm B. Quantification of the experiment shown 
in A. Percentage of puncta of each synaptic marker colocalizing with Nbea. Values represent means ± SEM (n=3). No 
significant differences as compared to Nbea colocalization with VIAAT was found for all markers examined: p > 0.05.  
 DISCUSSION 
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5  DISCUSSION 
 
The GlyR mediates inhibitory neurotransmission in spinal cord and brain stem. Fast and efficient 
inhibitory  neurotransmission  takes  place  due  to  GlyR  and  GABAAR  clustering  at  inhibitory 
postsynaptic specializations. GlyRs localize to synaptic sites by virtue of their interaction with 
gephyrin  mediated  by  the  GlyRβ  subunit.  So  far  gephyrin  was  the  only  protein  identified  as 
binding partner of GlyRβ. Other proteins that may play a role in the synaptic localization and 
function of GlyRs had not been discovered. In this thesis, the interactions of three proteins found 
to  bind  the  GlyRβ  subunit  were  investigated.  These  proteins  had  been  identified  by  affinity 
purification  and  subsequent  MALDI-TOF  analysis  as  SdpI,  Vps35  and  Nbea  (I.  Paarmann, 
unpublished data).  
Sdp proteins contain F-BAR and SH3 domains, which are involved in membrane tubulation and 
protein-protein  interactions,  respectively.  Sdps  were  proposed  to  interconnect  actin 
polymerization and membrane remodelling. Vps35 is a component of the retromer complex that 
is involved in the retrieval of receptors from endosomes to the TGN and in receptor recycling to 
the plasma membrane. Nbea is a A-kinase anchoring protein known to be localized at the TGN 
and to be involved in the trafficking of synaptic membrane proteins. In this thesis, I investigated 
the interaction between these proteins and the GlyRβ subunit as well as their function in GlyR 
localization  at  synaptic  sites.  The  in  vitro  results  presented  here  demonstrate  that  SdpI  and 
SdpII, Vps35 and Nbea bind directly to the GlyRβ intracellular loop, and that SdpI and Vps35 
also interact with the GlyR scaffolding protein gephyrin. Deletion mapping, peptide competition 
and point mutation analysis indicate that the interaction of SdpI with the GlyRβ loop is SH3-
domain dependent. Immunocytochemical analyses show that the SdpI and Nbea proteins are 
localized  at  inhibitory  synapses  whereas  Vps35  distributes  along  the  neurites  of  spinal  cord 
neurons.  SdpI d own-regulation  studies  suggest  that  SdpI  is  involved  in  proper  clustering  of 
GlyRs at synaptic sites.  
 
 DISCUSSION 
  98 
5.1  Sdp proteins 
5.1.1  The SH3 domain of SdpI is required for interaction with GlyRβ  
In  co-immunoprecipitation  experiments  using  the  fraction  of  a  spinal  cord  homogenate 
containing small membrane organelles, we obtained evidence for an association of SdpI with 
GlyR-containing cytoplasmic vesicles. Co-expression experiments in COS-7 cells revealed that 
the GlyRβ subunit interacts with SdpI as well as both isoforms of SdpII in mammalian cells; this 
confirms  that  the  GlyRβ  subunit  is  responsible  for  Sdp  binding  to  the  GlyR.  GST-pulldown 
experiments confirmed that the interaction of SdpI and SdpII with the GlyRβ loop is a direct one. 
The further delineation of the Sdp binding site through deletion, peptide competition and point 
mutation approaches presented here indicates that the Sdp-GlyRβ loop interaction is specific 
and SH3 domain-ligand dependent (see 4.1). SH3 domains are highly conserved among all Sdp 
isoforms (Moddregger et al., 2000). This explains why both SdpI and SdpII bind to GlyRβ and 
also suggests a possible interaction between SdpIII and this GlyR subunit.  
The Sdp binding region in the GlyRβ loop contains a class I R/KxxPxxP proline-rich motif i.e. one 
of the classical SH3 domain recognition sequences (Li, 2005). The KKxxPxxP motif is highly 
conserved in the GlyRβ subunits of rat, human, chick and zebrafish, suggesting that SH3 domain 
dependent interactions of Sdps with GlyRβ might occur in all vertebrates. Proline-rich motifs are 
widely  distributed  in  the  proteomes  of  prokaryotes  and  eukaryotes,  and  hundreds  of  SH3 
domain-containing proteins can be found in the human proteome (Rubin et al., 2000). However, 
some SH3 domains display specificity for selected proline-rich motifs. This specificity relies on 
basic  residues  such  as  arginine  and  lysine,  which  provide  extra  binding  energy  through 
electrostatic interactions and additionally orient the ligand within the binding groove of the SH3 
domain (Li, 2005). The results presented here demonstrate the importance of proline and lysine 
residues in the KKxxPxxP motif for SdpI-GlyRβ binding (see 4.1.1). A similar motif has been 
already shown to underlie SdpI-dynamin binding (Angonno et al., 2007). In the proline-rich motif 
of dynamin, arginine residues instead of lysine residues provide the positive charges required for 
binding  to  the  SH3  domain  of  Sdp,  and  the  ligand  motif  is  unusually  extended.  The 
dephosphorylation of serine residues within the proline-rich motif has been found to constitute a 
key regulatory element in the phosphorylation-dependent interaction between SdpI and dynaminI 
(Angonno et al., 2007). Since the proline-rich motif in the GlyRβ loop does not contain serine 
residues, binding of SdpI to GlyR should not be phosphorylation-dependent.  DISCUSSION 
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SH3 ligands such as proline-rich motifs have been identified in both the α and β subunits of the 
GlyR (Lynch et al., 2004). Notably, GlyRα and β subunits contain different classes of proline-rich 
motifs in their intracellular loops. Class-III proline-rich motifs, with the standard sequence RxxK, 
are present at different positions in GlyRα and β subunits near the N-terminus of the TMD3-4 
loop. The TMD3-4 loops harbour in the GlyRβ α1 and α2 subunits additional proline-rich motifs 
near their C-termini; however, these correspond to class-II proline-rich motifs (PxxPx[K/R])(Fig. 
5.1).  Moreover,  the  GlyRβ  subunit  contains  a  class-I  proline-rich  consensus  sequence 
([R/K]xxPxxP)  close  to  the  N-terminal  loop  sequence ( Fig.  5.1).  These  different  classes  of 
proline-rich motifs might be important in determining the specific interactions of different GlyR 
subunits with SH3 domain-containing proteins like SdpI.  
 
 
Fig. 5.1. Proline-rich motifs in the intracellular loops of several GlyR subunits. Proline-rich sequences in the 
intracellular loops of several GlyRα- and β-subunits are highlighted. Shown are the last 40 aa of each intracellular loop 
preceding TMD4. Aa numbering starts at the signal peptide of every GlyR subunit (Uniprot database). GlyRα- and β-
subunits contain proline-rich sequences of different classes. Underlined are proline-rich sequences of class I (red), 
and class II (blue) as well as undefined (black) proline-rich motifs.  
 
SH3 recognition domains have been postulated to serve as interaction sites involved in GlyR 
trafficking or cytoskeletal attachment (Lynch et al., 2004). The results presented in this thesis 
provide the first evidence for a function of the GlyRβ-SH3 binding motif (SBM) in Sdp-mediated 
GlyR  trafficking.  Since  the  TMD3-TMD4  intracellular  loops  of  several  GlyRα-subunits  also 
comprise SBMs, GlyRα subunits may mediate other trafficking events through SH3 interactions. 
5.1.2  SdpI is a gephyrin binding protein 
Several  cytoskeletal  and  cytosolic  proteins  such  as  tubulin,  collybistin,  mena/vasodilator-
stimulated phosphoprotein (VASP) and profilin have been found to interact with gephyrin (Kirsch 
et al., 1991; Kins et al., 2000; Giesemann et al., 2003). Here, apart from binding to the GlyRβ 
subunit, SdpI is shown to also bind gephyrin (see 4.1.3). Upon heterologous co-expression in a 
mammalian cell line, SdpI colocalized with the aggregates formed by full-length gephyrin. In vitro DISCUSSION 
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pull-down experiments provided evidence for SdpI binding at the linker region of gephyrin. In 
agreement with this result, gephyrin sequence analysis revealed the presence of proline-rich 
motifs in the linker region of gephyrin (see Table 4). However, further deletion and point mutation 
experiments are required to confirm that the interaction of SdpI with gephyrin is mediated by the 
recognition of these proline-rich motifs by the SdpI-SH3 domain.  
Co-expression of collybistin II with gephyrin in a heterologous expression system leads to the 
redistribution of gephyrin into submembraneous microclusters that colocalize with collybistin II 
(Kins  et  al.,  2000;  Harvey  et  al.,  2004).  Interestingly,  Sdp  co-expression  similarly  induced  a 
plasma membrane association of gephyrin in COS-7 cells (see Fig. 4.9). This redistribution of 
gephyrin resembles that observed in mammalian cells upon co-expression of collybistin II. SdpI 
and collybistin II activate N-WASP directly or through Cdc42 activation, respectively (Reid et al., 
1999; Dharmalingam et al., 2007). However, a recent study has excluded a role of Cdc42 in 
collybistin-induced gephyrin microcluster formation (Reddy-Alla et al., 2010). By analogy, the 
activation of N-WASP and the actin polymerization induced by SdpI might be dispensable for 
gephyrin  redistribution  in  COS-7  cells.  Notably,  the  redistribution  pattern  of  gephyrin  to  the 
plasma  membrane  induced  by  Sdp  is  different  from  that  of  gephyrin  microcluster  formation 
induced by collybistin II. This could be due to differences in the membrane binding activities of 
Sdp and collybistin II. Domain deletion and point mutation studies with colllybistin II indicate that 
PH domain binding to phosphatidylinositol 3-phosphate (PI3P) is required for the targeting of 
gephyrin into membrane-associated microclusters (Harvey et al., 2004; Kalscheuer et al., 2009; 
Reddy-Alla et al., 2010). In the case of SdpI, its F-BAR domain is responsible for the recruitment 
of  SdpI  to  the  plasma  membrane,  due  to  its  ability  to  bind  phosphatidylserine-containing 
membranes  (Dharmalingam  et  al.,  2007).  Therefore,  differences  in  lipid  binding  between 
collybistin II and SdpI may underlie the different gephyrin redistribution patterns observed upon 
co-expression  of  these  proteins.  Further  deletion  and  point  mutation  studies  should  clarify 
whether  membrane  binding  of  Sdps  through  the  F-BAR  domain  is  required  for  gephyrin 
redistribution in mammalian cells.  
5.1.3  The GlyR, gephyrin and SdpI: Mutually exclusive gephyrin/SdpI binding to 
the GlyR or a ternary complex? 
Gephyrin  binds  to  the  GlyRβ  loop  through  an  18  aa  long  hydrophobic  motif  called  gephyrin 
binding motif (GBM) (Meyer et al., 1995). Our mapping and point mutation analyses of the SdpI 
binding region in the GlyRβ subunit indicate that SdpI binds to a  proline-rich motif, which is DISCUSSION 
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located 16 aa away from the GBM (Fig. 4.2 and Fig. 4.3). Therefore, simultaneous binding of 
gephyrin and SdpI to the GlyRβ loop could be possible. However, our protein competition assays 
showed that gephyrinʼs E-domain interferes with SdpI binding to the GlyRβ loop (see Fig. 4.11). 
This could be due to steric hindrance caused by the higher affinity of gephyrin binding to the 
GlyRβ  subunit.  Our  results  suggest  that  gephyrin  and  SdpI  are  mutually  exclusive  binding 
partners of the GlyRβ subunit.  
Hetero-pentameric  GlyRs c ontain  three  GlyRβ  subunits  (Grundzinska  et  al.,  2005).  Gephyrin 
interacts with GlyRβ at postsynaptic inhibitory synapses and intracellularly during motor protein 
driven transport (Maas et al., 2006 and 2009). At synaptic sites, gephyrin forms a hexagonal 
lattice through dimerization of the E-domain and trimerization of the G-domain (Sola et al., 2001 
and 2004). A structural model for the binding of GlyRs to gephyrin trimers has suggested that 
the three GlyRβ subunits of a single receptor might bind the three E-domains of a gephyrin 
trimer  in  the  submembraneous  scaffold  (Sola  et  al.,  2004).  However,  the  number  of  GlyRβ 
subunits occupied by gephyrin during intracelllular transport or lateral diffusion of the receptor in 
the  plasma  membrane  is  still  unclear.  Furthermore,  gephyrin-free  trafficking  and  diffusion  of 
GlyRs  occurs  in  gephyrin-deficient  (Feng  et  al.,  1998)  and  probably  also  wildtype  mice.  An 
analysis of the diffusion properties of a GlyRα1 chimera containing the gephyrin binding site of 
the  GlyRβ  subunit  in  the  presence  of  gephyrin  variants  able  and  unable  to  trimerize  has 
suggested that the amount of gephyrin bound to the GlyR is small (Ehrensperger et al., 2007). 
Additionally, this study reported multiple association states between GlyRs and gephyrin and 
also estimated that about 40% of the extrasynaptic GlyR chimeras are associated with gephyrin. 
Taking  into  account  previous  studies  and  the  in  vitro  results  of  our  protein  competition 
experiments (see 4.1.4) which show that, in the presence of gephyrinʼs E-domain, SdpI is not 
able to bind the GlyRβ loop, we propose a model for GlyR/gephyrin/SdpI binding during synaptic 
and extrasynaptic transport. At synaptic sites, GlyRs are localized postsynaptically and do not 
bind SdpI due to high-affinity binding of gephyrin, which occupies all three subunits. SdpI might 
accumulate adjacent to postsynaptic scaffolds due to low-affinity binding to gephyrin or might be 
located extrasynaptically due to interactions with other proteins of the endocytotic and recycling 
pathway.  When  heteropentameric  GlyRs  have  to  be  transported,  two  models  of 
GlyR/gephyrin/SdpI complex formation might be considered. According to the first model, GlyRs 
might be transported as ternary complexes which bind simultaneously gephyrin trimers and SdpI 
through their interactions with different GlyRβ subunits (Fig. 5.2.a). The second model proposes 
that GlyRs are transported either as gephyrin-bound complexes or as gephyrin-free complexes. DISCUSSION 
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Gephyrin-bound  GlyRs  might  have  all  three  β  subunits  interacting  with  a  gephyrin  trimer, 
whereas gephyrin-free GlyRs might have all three β subunits complexed to SdpI (see Fig. 5.2.b). 
Thus sorting to different transport pathways may be accomplished through mutually exclusive 
binding to either gephyrin or SdpI. Since gephyrin was present in the protein samples of our first 
pull-down  experiments  employed  to  isolate  SdpI  from  brain  lysate  (I.  Paarmann,  data  not 
shown), it seems rather plausible that GlyRs, gephyrin and SdpI may be associated in a ternary 
complex. In the work presented here, immunoprecipitation of GlyR subunits from a rat spinal 
cord  homogenate  could  be  achieved  using  specific  SdpI  antibodies  (see  4.1.6.1).  Further 
analysis  of  gephyrin  co-immunoprecipitation  employing  SdpI  antibodies  or  SdpI  co-
immunoprecipitation with gephyrin or GlyR antibodies from tissue extracts might help to disclose 
whether a ternary complex composed of gephyrin-Sdp-GlyR proteins may be formed in vivo. 
Fig. 5.2. Proposed models for the interaction of GlyRs with gephyrin and SdpI at synaptic and extrasynaptic 
sites.  Heteropentameric  GlyRs  at  synaptic  sites  bind  gephyrin´s  E-domains  of  the  submembraneous  hexagonal 
scaffold. High-affinity binding of gephyrin to GlyRβ subunits inhibits SdpI binding to the GlyR at synaptic sites. Thus, 
SdpI might localize perisynaptically or might distribute at the periphery of inhibitory postsynaptic scaffolds through its 
binding to gephyrin. GlyRs at extrasynaptic sites might recruit SdpI. In a first model (a), gephyrin binds as trimer to 
one  or  two  GlyRβ  subunits,  allowing  additional  unoccupied  GlyRβ  subunits  to  bind  SdpI.  Thus,  GlyR  binds 
simultaneously gephyrin and SdpI and each β subunit interacts either with gephyrin or with SdpI. In a second model 
(b), GlyRs to be transported can be classified into two pools: gephyrin-bound or gephyrin-free GlyRs. In the gephyrin-
bound GlyR pool, the three GlyRβ subunits of the pentameric receptor bind the three E-domains of a gephyrin trimer. 
In the gephyrin-free GlyR pool, all three GlyRβ subunits bind SdpI. Thus, binding to either gephyrin or SdpI might 
determine the pathway into which GlyRs are sorted.  
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5.1.4  Localization of Sdp protein family members at inhibitory synapses 
In  the  central  nervous  system,  SdpI  has  been  found  at  excitatory  pre-  and  postsynaptic 
structures  in  the  rat  hippocampus  and  presynaptically  at  reticulospinal  synapses  in  lamprey 
(Qualmann  et  al.,  2009;  Perez-Otaño  et  al.,  2006;  Andersson  et  al.,  2008).  However,  the 
ocurrence of SdpI at inhibitory synapses had not been reported. In agreement with SdpI mRNA 
detection in mouse spinal cord (Allen spinal cord atlas http://mousespinal.brain-map.org/), here 
the presence of Sdp protein in cultured rat spinal cord neurons could be demonstrated (see 
4.1.5). SdpI immunoreactivity in cultured spinal cord neurons was found at the periphery of cell 
bodies and as intense punctate staining along neurites. This staining pattern of SdpI in spinal 
cord neurons resembled the distribution of SdpI-immunoreactivity in cultured cortical neurons 
(Qualmann  et  al.,  1999),  suggesting  that  SdpI  distribution  might  be  similar  in  neurons  from 
different areas of the CNS. Quantification of the GlyR, gephyrin and VIAAT immunoreactive-
spots  colocalizing  with  SdpI  at  early  stages  (DIV11-13)  showed  that  SdpI colocalized  with  a 
small fraction of the GlyR clusters, but more prominently with VIAAT and gephyrin puncta. This 
suggests  two  distribution  patterns  of  SdpI  at  inhibitory  synapses:  a  GlyR-independent  SdpI 
distribution at synaptic sites and a GlyR-dependent SdpI distribution (see Fig. 4.12). Spinal cord 
neurons of later stages (DIV20-22) present a higher density of GlyR clusters as compared to 
young neurons, consistent with the developmental maturation of glycinergic synapses. However, 
the  number  of  SdpI-immunoreactive  puncta  colocalizing  with  GlyR-immunoreactive  spots  at 
DIV20-22 was only slightly higher that at DIV11-13, indicating that SdpI association with synaptic 
and  non-synaptic  GlyR  does  not  change  significantly  during  development.  Additionally,  in 
agreement with a continuous localization of SdpI at synaptic sites, the colocalization rates of 
SdpI with VIAAT and gephyrin did not change or decreased only slightly during development 
(see 4.1.5).  
Gephyrin clusters can be GABAergic, glycinergic or mixed GABA-glycinergic (Colin et al., 1998). 
The results obtained here on the colocalization of SdpI-immunoreactivity with GlyR clusters and 
GAD67-terminals  suggest  that  SdpI  is  concentrated  at  both g lycinergic  and  GABAergic 
synapses  (see  4.1.5).  Additionally,  our  colocalization  analysis  revealed  similar  extents  of 
apposition between SdpI and PSD95 as well as gephyrin immunoreactive sites, suggesting an 
accumulation of SdpI at both excitatory and inhibitory synapses in mature spinal cord neurons. 
Our results are in agreement with previous studies demonstrating that SdpI is localized at the DISCUSSION 
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postsynaptic density (PSD) and at perisynaptic sites of glutamatergic synapses (Perez-Otaño et 
al,  2006).  On  the  same  line,  quantification  of  SdpI  colocalization  with  inhibitory  pre-  and 
postsynaptic  markers  did  not  reveal  a  preferential  enrichment  of  SdpI  at  specific  synaptic 
structures. Presently, robust data that confirm the pre- and/or postsynaptic distribution of SdpI at 
GABAergic and glycinergic synapses are lacking. Therefore, high-resolution imaging techniques, 
like STED microscopy and immunogold electron microscopy, should be used to provide further 
insight into the role of SdpI at inhibitory synapses. 
5.1.5  Sdp is involved in GlyR and GABAAR clustering 
The broad expression pattern of SdpI in the central nervous system, its localization at inhibitory 
and excitatory synapses as well as its ability to interact with many different proteins involved in 
endocytosis, recycling, neurotansmitter responses and actin polymerization indicate that SdpI is 
a multifunctional player in the central nervous system. At lamprey reticulospinal synapses, SdpI 
has been implicated in vesicle formation following intense stimulation of presynaptic terminals 
(Andersson et al., 2008). Studies at the neuromuscular junctions of D. melanogaster indicate 
that  Sdps  act  postsynaptically  in  the  formation  of  the  subsynaptic  reticulum  and  exclude  a 
function in vesicle endocytosis at the presynapse (Kumar et al., 2008 and 2009). Together these 
data  suggest  a  broad  spectrum  of  functions  for  Sdps,  which  is  different  depending  on  the 
synaptic system that is analyzed. In hippocampal neurons, SdpI has been found to mediate the 
endocytosis-dependent removal of NR3 containing NMDA receptors (NMDARs) from excitatory 
synapses. Interference with SdpI-NR3 interactions led to an increase in the cluster size of NR3 
containing NMDARs (Perez-Otaño et al., 2006). The reduction in GlyR cluster size and number 
observed here in SdpI knock-down experiments argue against a similar function of SdpI in GlyR 
trafficking (see 4.1.6.3). SdpI binds to NR3 containing NMDARs through their NPF repeats and 
has been proposed to serve as linker between NMDARs and the endocytic machinery (Perez-
Otaño et al., 2006). The results presented here demonstrate that the GlyRβ-Sdp interaction is 
SH3 domain-dependent. The difference in the SdpI mediated interactions with these receptors 
correlates with the different functions of SdpI at NMDARs and GlyRs. In agreement with this, the 
binding of NR3 and GlyRβ subunits to Sdps differs in that NR3 binding is restricted to SdpI and 
GlyRβ interacts with both SdpI and SdpII. This suggests a Sdp-mediated trafficking process of 
higher complexity for the GlyR.  
Disruption of SdpI function by antibody microinjection leads to an impairment in synaptic vesicle 
recycling under intense stimulation (Andersson et al., 2008). Notably, the clustering of GlyRs is DISCUSSION 
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activity-dependent (Kirsch and Betz, 1998; Maas et al., 2009), and a loss of synaptic vesicle 
recycling implies a subsequent disruption of neurotransmitter release. The depletion experiments 
performed here show that the number of VIAAT clusters is not significantly affected by SdpI 
down-regulation (Fig. 4.18). This result is in agreement with previous publications showing that 
SdpI inactivation induces a reduction in vesicle number at presynaptic sites, but no change in 
presynapse  morphology  (Andersson  et  al.,  2008).  Furthermore,  the  slight  but  insignificant 
change  in  VIAAT  distribution  found  upon  SdpI  down-regulation  suggests  that  SdpI  is  not 
implicated in inhibitory presynaptic maturation. Therefore, changes in GlyR cluster distribution 
induced by SdpI knock-down may not be attributed to presynaptic dysfunction. 
In spinal cord neurons, GlyRs cluster at glycinergic synapses, but about 30% of the GlyRs share 
postsynaptic localizations with GABAARs at mixed glycinergic/GABAergic synapses (Dumoulin et 
al.,  2000).  Additionally,  SH3  ligand  binding  sites  at  inhibitory  postsynaptic  proteins  are  not 
restricted to GlyRβ but also present on GlyRα subunits, gephyrin, neuroligin-2 and GABAA but 
not  GABAC  receptor  proteins  (see  Table  4).  The  SdpI  depletion  results  presented  here  (see 
4.1.6) revealed similar reductions in cluster number and size for heteropentameric GlyRs and γ2-
subunit containing GABAARs, suggesting that SdpI participates in a trafficking process shared by 
both types of inhibitory postsynaptic receptors. This is consistent with different GABAAR subunits 
containing different types of SH3 ligand binding motifs in their TMD3-4 intracellular loops (see 
Table 4). Future studies will show whether GABAAR subunits bind Sdp directly through SH3-
proline-rich motifs mediated interactions.  
The SdpI depletion results presented in this thesis showed a reduction of ca. 40% in cluster 
number, and of about 45% in cluster size for both GlyRs and GABAARs. The remaining 60% and 
55% of synaptic GlyR and γ2 containing GABAAR clusters might reflect residual SdpI expression 
due to incomplete knock-down but also could be due to redundant functions of SdpII and SdpIII 
or even compensation by Sdp-independent protein transportation pathways. On the same line, 
our analysis of GlyR and gephyrin distribution in the brain stem of SdpI -/- mice demonstrates 
that  SdpI-deficiency  does  not  affect  GlyR  and  gephyrin  clustering  at  inhibitory  synapses,  in 
agreement  with  the  results  obtained  on  spinal  cord  cultures  of  SdpI  -/-  mice  (see  4.1.6.2). 
Moreover, the absence of a GlyR cluster phenotype in SdpI -/- mice correlates with the lack of 
neuromotor symptoms in these mice (Koch et al., submitted). However, in our SdpI depletion 
experiments we saw a decrease in the densities of γ2 subunit containing GABAAR clusters in 
spinal  cord  neurons.  Assuming  that  SdpI  would  similarly  contribute  to  inhibitory  receptor 
trafficking  in  forebrain  regions,  the  epileptic  seizures  that  SdpI  -/-  mice  present  under  stress DISCUSSION 
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conditions (Koch et al., submitted) might be explained. As discussed above, the absence of a 
clear effect on GlyR distribution might be due to compensatory effects of SdpII and SdpIII in 
brainstem and spinal cord. The generation of constitutive and conditional triple SdpI/SdpII/SdpIII 
-/- mice and the specific knockdown of all Sdps in neurons should allow to clarify the roles of 
these proteins in neurotransmitter receptor trafficking.  
 
Protein  Species  Motif 1  Motif 2  Motif 3  Motif 4 
GABAAα1  Rat  -  1*+ 1*  1*+ 2*  1* 
GABAAα2  Rat  -  -  -  1 
GABAAα3  Rat  1*  1*  1*  0 
GABAAα4  Rat  1*  -  2*+ 3*  - 
GABAAα5  Rat  -  -  1  - 
GABAAα6  Rat  -  -  1 + 4*  - 
GABAAβ1  Rat  -  -  3  - 
GABAAβ2  Rat  -  -  1  - 
GABAAβ3  Rat  -  -  1  - 
GABAAγ1  Rat  -  -  -  - 
GABAAγ2  Rat  -  1* + 1*  2* + 1*  1* 
GABAAγ3  Rat  -  -  2  - 
GABAAδ  Rat  -  -  2  - 
GABAAε  Rat  -  -  -  - 
GABAAπ  Rat  -  -  -  - 
GABAAΘ  Rat  -  -  1  - 
Gephyrin  Rat  -  -  3* + 1  - 
Neuroligin-2  Rat  -  -  1 + 1 + 9*  - 
Table 4. Putative SH3 ligand binding motifs in inhibitory postsynaptic proteins. Predictions by the eukaryotic 
linear motifs (ELM) program. Standard sequences for SH3 ligand binding motifs are: 1- [RKY]xxPxxP, 2- PxxPx[KR], 
3- xxx[PV]xxP, 4- KPxx[QK]xxxx. *: Overlapping. Sequences analyzed are: the large intracellular loop of GABAAR 
subunits, linker regions of gephyrin and the C-terminal region of Neuroligin 2. No putative intracellular SH3 ligand 
binding motifs were found in GABACR subunits (from del Pino et al., in preparation).  DISCUSSION 
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5.1.6  A role of SdpI in gephyrin clustering? 
A  co-transport  of  GlyRs  and  gephyrin  to  and  from  synaptic  sites  is  thought  mediated  by 
microtubule-associated  motor  proteins,  namely  kinesin  and  dynein  in  the  anterograde  and 
retrograde  directions,  respectively  (Maas  et  al.,  2006  and  2009).  Here,  the  SdpI  depletion 
experiments resulted in a reduction of about 45% of the synaptic GlyRs but only about 30% of 
the  gephyrin  cluster  size  as  well  as  a  reduction  of  ~30%  in  synaptic  GlyR  cluster  density, 
whereas the density of gephyrin clusters was only marginally reduced (10%) (see 4.1.6.3). Due 
to the modest effect of SdpI depletion on gephyrin cluster distribution, it remains unclear whether 
SdpI participates actively in any gephyrin transport mechanism or is just a secondary effect of 
the loss of synaptic GlyRs and GABAARs.  
Studies  on  conditionally  and  constitutively  collybistin-deficient  mice  found  a  loss  in  synaptic 
gephyrin and GABAAR cluster densities in particular regions of the CNS, e.g. in the stratum 
radiatum and stratum oriens of the hippocampus, the cerebellum, the amygdala, etc; however, 
no effect on glycinergic synapses was observed (Papadopoulos et al., 2007 and 2008). Here, 
brain  stem  sections  from  +/+  and  SdpI-/-  (Koch  et  al.,  submitted)  mice  did  not  show  any 
significant difference in gephyrin cluster distribution (see 4.1.6.2). These results do not support a 
role of SdpI in gephyrin oligomerization and clustering at glycinergic and GABAergic synapses in 
brain stem and spinal cord.  However, similarly to  what was observed by Papadopoulos and 
colleagues, a detailed analysis of gephyrin distribution in several regions of the SdpI-/- brain 
might  clarify  whether  SdpI  is  required  for  gephyrin  clustering  at  a  subset  of  GABAergic  or 
glycinergic synapses in specific regions of the CNS.  DISCUSSION 
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5.1.7  Possible roles of SdpI in GlyR trafficking: potential sites of action 
The results presented in this thesis show that SdpI depletion leads to a reduction in the cluster 
size and number of inhibitory postsynaptic receptors but has no significant effect on gephyrin 
cluster  distribution.  As  possible  mechanistic  explanations  of  how  SdpI  may  function  in  GlyR 
trafficking, three different models may be considered:  
Model 1: SdpI mediates gephyrin-independent ER/TGN exit of αβ heteropentameric GlyRs  
A prerequisite for GlyR exit from the ER is the assembly of GlyRα and GlyRβ subunits into 
pentameric receptors (Griffon et al., 1999). Similarly, GABAAR subunits need to assemble at 
proper stoichiometries to allow ER exit. Previous studies have identified two cytosolic proteins, 
PIC1 and BIG1, which bind GABAAR subunits and promote the translocation of fully assembled 
receptors from the ER and TGN to the plasma membrane (Charych et al., 2004; Saliba et al., 
2008). Additionally, complex formation of SdpII with dynamin II has been demonstrated to be 
important  for  transport  vesicle  formation  from  the  TGN  in  heterologous  expression  systems 
(Kessels et al., 2006). For synaptic receptor clustering, the insertion of receptors into the plama 
membrane and thus their availability for recruitment to postsynaptic scaffolds is a prerequisite of 
synapse formation. However it is still unclear whether newly synthesized GlyRs are recruited 
after directional insertion near postsynaptic sites in addition to being captured by lateral diffusion 
from extrasynaptic insertion sites. It has been reported that the GlyR α1 subunit, which forms 
heteropentameric receptors with the GlyRβ subunit, is extrasynaptically inserted at the cell soma 
and in the proximal regions of dendrites (Rosenberg et al., 2001). Also, exocytosis of GABAARs 
has been shown to occur exclusively at extrasynaptic sites (Thomas et al., 2005; Bogdanov et 
al., 2006). GlyRs are thought to be co-transported with gephyrin (Mass et al., 2006 and 2009), 
but  GlyR  and  GABAAR  surface  expression  proceeds  in  gephyrin-deficient  mice  (Feng  et  al., 
1998; Kneussel et al., 1999). Therefore, for insertion into the plasma membrane GlyRs can use 
gephyrin-independent  trafficking  mechanisms.  We  hence  propose  in  a  first  model  that  Sdp-
dynamin complex formation is required for transport vesicle formation in the TGN of neurons, 
and that GlyRs and GABAARs are inserted at extrasynaptic sites followed by lateral diffusion to 
synaptic  sites. Accordingly,  the  partial  loss  of  inhibitory  postsynaptic  receptors  from  synaptic 
sites seen upon SdpI depletion may be induced by an impairment of GlyR and GABAAR exit 
from the TGN to the plasma membrane. In this model, SdpI would act in a gephyrin-independent 
manner as regulator of assembled GlyR trafficking. SdpI would allow properly assembled GlyRs DISCUSSION 
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to enter budding vesicles formed at the TGN for delivery to the plasma membrane and facilitate 
vesicle formation through binding to dynamin. Vesicles generated form the TGN would fuse at 
extrasynaptic sites with the plasma membrane, and the inserted GlyRs would diffuse laterally 
until gephyrin scaffolds trap them. In the absence of SdpI, extrasynaptic insertion of GlyR into 
the plasma membrane would be impaired, and consequently the number of GlyRs available for 
trapping at synaptic sites would be reduced (Fig. 5.3).  
Model 2. SdpI mediates anterograde trafficking of αβ heteropentameric GlyRs  
Time-lapse imaging has revealed a somatodendritic anterograde co-transport of gephyrin and 
GlyR along microtubules in hippocampal neurons, which requires the interaction of gephyrin with 
kinesin (Maas et al., 2009). Here, an interaction of SdpI with the GlyRβ subunit but also with 
gephyrin was demonstrated. Maas et al. (2006) have shown that GlyR and gephyrin interact in 
the  neuronal  membrane  fraction  containing  cytosolic  vesicles.  Using  the  same  membrane 
fraction from spinal cord tissue, an interaction of SdpI with GlyR was found here (see 4.1.6.1). 
Moreover, our in vitro results suggest that binding of the gephyrin E-domain to the GlyRβ loop 
impairs  the  interaction  with  SdpI.  Therefore,  assuming  that  SdpI  and  gephyrin  can  bind 
simultaneously the GlyR through interactions with different GlyRβ subunits, a role of SdpI in the 
anterograde  transport  of  GlyR  containing  vesicles  appears  feasible.  The  loss  of  inhibitory 
postsynaptic  receptors  at  synaptic  sites  found  upon  SdpI  depletion  may  then  be  due  to  an 
impairment of GlyR anterograde transport along microtubules. According to this second model, 
SdpI  would  act  as  an  adaptor  protein  that  binds  both  gephyrin  and  the  β  subunit  of 
heteropentameric GlyRs at transport steps preceding gephyrin oligomerization at postsynaptic 
sites. Hence, SdpI would be required for ternary complex formation and facilitate the binding of 
gephyrin  to  GlyRs  during  somatodendritic  anterograde,  but  not  retrograde,  transport.  Down-
regulation of SdpI would reduce GlyR-gephyrin complex formation in cytoplasmic vesicles and 
thereby decrease the amount of surface GlyR available for postsynaptic clustering. Additionally, 
a loss of SdpI might lead to misrouting of GlyRs to other trafficking pathways (see Fig. 5.3). 
 
Model 3: SdpI is involved in synaptic GlyR recycling 
At glutamatergic synapses, endocytic zones have been identified at stable positions adjacent to 
the postsynaptic densities (PSDs) (Blanpied et al., 2002; Racz et al., 2004). Follow-up studies 
revealed that these endocytic zones are essential for the recycling of alpha-amino-3-hydroxy-5-DISCUSSION 
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methyl-4-isoxazolepropionic  acid  (AMPA)  receptors  during  basal  transmission  and  synaptic 
potentiation  (Petrini  et  al.,  2009).  The  PSD-adjacent  positioning  of  endocytic  zones  is  very 
important and depends on a direct interaction between the large GTPase dynamin III and the 
postsynaptic  scaffold  complex  containing  the  Homer  and  Shank  proteins  (Lu  et  al.,  2004). 
Presently,  there  is  no  evidence  supporting  the  existence  of  endocytic  zones  at  inhibitory 
synapses. However, recycling of GABAARs from internal pools has been reported to occur in 
heterologous expression systems and also in neurons (Kittler et al., 2000; van Rinjnsoever et al., 
2005).  Furthermore,  the  recycling  of  GABAARs  in  neurons  is  regulated  through  interactions 
between GABAARβ subunits and the Huntingtin-associated protein 1 (HAP1) and between the 
GABAARγ2 subunits and the calcium-modulating cycophilin ligand (CAML) (Kittler et al., 2004; 
Yuan et al., 2008). The huntingtin protein itself has been suggested to be an integral component 
of the HAP1-KIF5 complex and to be involved in the trafficking of GABAAR containing vesicles, 
since  a  mutant  huntingtin,  polyQ-huntingtin,  disrupts  GABAAR  surface  accumulation 
(Twelvetrees et al., 2010). On the other hand, different lines of evidence support a participation 
of SdpI in the endocytosis and recycling of membrane proteins. SdpI is required for presynaptic 
activity-dependent  vesicle  recycling,  which  depends  on  SdpI-dynamin-N-WASP  complex-
formation (Andersson et al., 2005), and for transferrin receptor recycling, which is SdpI-EHD 
complex-dependent (Braun et al., 2005). Additionally, SdpI binds through its SH3 domain to the 
huntingtin protein (Modregger et al., 2002). Therefore, assuming that GlyRs undergo the same 
recycling processes like GABAARs, the reduced GlyR clustering seen upon SdpI down-regulation 
can be explained by disruption of GlyR recycling. Accordingly, SdpI would be implicated in the 
recruitment of αβ GlyRs to the endocytic zones and thus facilitate delivery of the receptor to a 
recycling pool. SdpI depletion would imply that GlyRs are not recruited to endocytic zones. As a 
result,  GlyRs  would  further  diffuse  from  synaptic  to  extrasynaptic  sites  where  they  are  not 
efficiently  recycled,  and  hence  the n umber  of  perisynaptic  GlyRs  available  for  trapping  at 
synaptic gephyrin scaffolds would be reduced, resulting in a decrease of synaptic GlyR cluster 
size. Alternatively, SdpI might target endocytosed GlyRs to the recycling pool. This could prevent 
GlyR degradation and facilitate receptor recycling to the plasma surface. In this scheme, down-
regulation of SdpI would result in the lack of a signal supporting GlyR sorting during the recycling 
process and allow for misssorting of GlyRs to other trafficking pathways (see Fig. 5.3). As a 
consequence, again the number of surface GlyRs would decrease, and GlyR cluster size would 
be reduced.  DISCUSSION 
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It  remains  unclear  in  which  of  these  presumptive  mechanisms  SdpI  is  actually  participating. 
Biotinylation experiments would be required to clarify whether the number of GlyRs at the cell 
surface is reduced in the absence of SdpI. In addition, high-resolution imaging techniques should 
shed light on the SdpI-dependent trafficking mechanism that controls the intracellular pools and 
plasma membrane concentrations of αβ GlyRs, such us live-cell single particle tracking with the 
quantum dot method as well as metabolic labelling based on fluorescently-tagged amino acid 
incorporation into proteins. These methods should be useful for identifying the specific trafficking 
mechanisms, in which Sdps are involved. 
 
 
 
Fig. 5.3. Possible sites of SdpI function in GlyR trafficking. Model 1: ER/TGN exit of heteropentameric GlyRs. 
After synthesis and assembly in the ER, GlyRs undergo post-translational modifications at the Golgi apparatus. SdpI 
might recruit heteropentameric GlyRs to budding vesicles in the TGN, thus regulating their sorting to somatodendritic 
extrasynaptic sites in the plasma membrane. From these extrasynaptic sites, GlyRs diffuse laterally in the plasma 
membrane and get trapped at gephyrin scaffolds formed at synaptic sites. Model 2: Anterograde trafficking of 
GlyR-gephyrin  complexes.  GlyRs  are  co-transported  with  gephyrin  along  microtubules  through  the  binding  of 
gephyrin to kinesin 5 (Maas et al., 2009). SdpI might be required in this process for the sorting of GlyRs to the 
anterograde trafficking pathway by binding simultaneously heteropentameric GlyRs and gephyrin. Model 3: Synaptic 
recycling of heteropentameric GlyRs. Similarly as for the recycling of synaptic GABAARs, GlyRs might undergo a 
recycling process, which involves their endocytosis to a subsynaptic intracellular pool and reinsertion into the plasma 
membrane. SdpI might be implicated in this recycling process, either by recruiting GlyRs diffusing out of synaptic sites 
to endocytic zones or by stabilizing the endocytosed GlyRs in the subsynaptic pool by inhibiting their degradation and 
inducing their sorting to the plasma membrane. In models 2 and 3, gephyrin is depicted as monomer at some stages. 
This has only been done to make the models as simple as possible. Presumably, intracellular gephyrin is trimeric.  DISCUSSION 
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5.2  Vps35 
5.2.1  Vps35 interacts with the GlyRβ subunit and gephyrin 
The retromer complex drives the retrieval of receptors in yeast, plants and mammals (Seaman et 
al., 1998; Bonifacino and Hurley, 2008). A broad spectrum of receptor types is sorted by the 
retromer complex for internalization or recycling, e.g. wingless, the ion transporter DMT1, the 
cation-independent mannose-6-phosphate receptor, the polymeric immunoglobulin receptor, etc. 
(Vergés et al., 2004; Arighi et al., 2004; Belenkaya et al., 2008; Tabuchi et al., 2010). Vps35 
plays a central role in the receptor retrieving function of the retromer, because it is the subunit 
responsible for the interaction with the cytoplasmic tails of the receptors (Nothwehr et al., 2000). 
Here, the GlyRβ subunit was shown to bind Vps35. In vitro studies demonstrated that Vps35 
interacts  directly  with  49  aa  of  the  GlyRβ-intracellular  loop ( see  4.2.1).  Furthermore,  these 
studies also revealed that gephyrin binds directly to Vps35 in vitro (see 4.2.1). However, the 
domains and binding motifs driving the Vps35-GlyRβ and Vps35-gephyrin interactions remain to 
be elucidated.  
Previous studies have shown that different Vps35 mutant alleles exhibit cargo-specific defects in 
membrane protein retrieval, demonstrating that distinct motifs in the sequence of yeast Vps35 
govern binding to cytosolic domains of different cargo proteins (Nothwehr et al., 1999). Thus, it 
appears conceivable that different binding motifs of Vps35 bind independently to the GlyR and 
gephyrin. In vitro competition assays using an immoilized GST-Vps35 construct and the GlyRβ 
loop and gephyrin as binding proteins might help to clarify this question. It should however, be 
noted that consensus sequences for the general retrieval of receptors by the retromer complex 
have not been identified. Short hydrophobic sequence motifs, such as WLM and FLV, in the 
cytosolic  tails  of  the  cation-independent  mannose-6-phosphate  receptor  and  sortilin, 
respectively, have been found to serve as crucial binding sites for cargo recognition (Seaman 
2007). Similarly, in the cytosolic tail of dipeptidyl aminopeptidase A the sequence FxFxD was 
found to be required for its interaction with Vps35 (Nothwehr et al., 2000). Common features of 
the  yeast  and  mammalian  binding  motifs  are  hydrophobicity  and  the  presence  of  aromatic 
residues (Bonifacino and Hurley, 2008). Inspection of the GlyRβ loop and gephyrin sequences 
confirmed that none of the Vps35 recognition motifs identified so far is present in these proteins. 
Notably, the 49 aa of the GlyRβ loop displaying Vps35 binding comprise one aromatic residue 
F400, which is highly conserved in mouse, rat, human and zebrafish (see Fig. 5.4.A). Thus, this DISCUSSION 
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residue might form part of the Vps35 recognition motif. Additionally, the F400 residue is known 
to be involved in gephyrin binding (Meyer et al., 1995). Assuming that Vps35 interacts with the 
F400 residue, this would imply an overlap of the Vps35 and gephyrin binding sequences, and 
hence mutually exclusive binding of these proteins to the GlyRβ subunit.  
In gephyrin, a phenylalanine repeat sequence FQFIL resembling the FxFxD motif in dipeptidyl 
aminopeptidase A and a short sequence motif FPV reminiscent of the FLV recognition motif of 
sortilin  are  highly  conserved  in  the  gephyrin−E-  and  G-domains,  respectively,  of  mammals, 
chicken and gephyrin isoform 1 from zebrafish (see Fig. 5.4.B). An additional short sequence 
motif  FVV  in  the  G-domain  is  conserved  in  mammals  and  chicken  (see  Fig.  5.4.B).  These 
sequences contain hydrophobic residues such as phenylalanines that might be hidden in the 
domains and not accessible from the surface. However, the gephyrin crystal structure shows 
that  the  phenylalanine  repeat  in  the  E-domain  and  the  FPV  sequence,  but  not  the  FVV 
sequence, of the G-domain are exposed in the folded protein even after E-domain dimerization 
and G-domain trimerization. The substitution of the phenylalanine residues in these motifs of 
both gephyrin and the GlyRβ loop might disclose a putative consensus motif important for Vps35 
recognition,  such  as  the  phenylalanine  repeats  FxF  or  the  highly  hydrophobic  motifs  FφV  (φ 
stands for an hydrophobic residue). Clearly, further studies are required to uncover the binding 
motifs for retromer-specific retrieval of synaptic receptors. 
 
Fig. 5.4. Putative Vps35 binding sites in the GlyRβ loop and gephyrin. A. Multiple alignments of the protein 
sequences from aa 418 to 422 of the GlyRβ intracellular loops from different species. The phenylalanine residue in the 
49 aa construct used for the pull-down of Vps35 by the GlyRβ loop is boxed in red. This residue is proposed to be 
required  for  Vps35  binding.  B.  Multiple  alignments  of  gephyrin  fragments  from  different  species.  The  fragments 
depicted  correspond  to  the  aa  sequences:  155  to  162,  596  to  600  and  736  to  743. P henylalanine-containing 
sequences, thought to constitute putative binding sequences for Vps35 are boxed in red. Asterisks indicate conserved 
aa in all species. Dots indicate aa conserved in mammals and chicken.  
 DISCUSSION 
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5.2.2  Role of Vps35 in GlyR trafficking? 
The  retromer  was  first  described  in  yeast  as  a  complex  mediating  retrieval  of  Vps10p,  the 
carboxypeptidase  Y  vacuolar  protein  receptor  (Seaman  et  al.,  1998). T wo  members  of  the 
Vps10 family of receptors, SorLA and sortilin, have been identified as interacting partners of the 
retromer complex in the mammalian CNS (Small et al., 2005, Rogaeva et al., 2007). Here, the 
GlyRβ subunit was found to be a new binding partner of Vps35 (see 4.2) suggesting that the 
GlyR is the third receptor known to associate with the retromer complex in neurons. Since Vps35 
binds directly not only to the GlyRβ loop but also to gephyrin (see 4.2.1), the possible existence 
of ternary Vps35/GlyR/gephyrin complexes will have to be examined in neurons.  
Several  studies  have  demonstrated  that  the  retromer  complex  is  required  for  the  sorting  of 
membrane  receptors  for  acid  hydrolases  to  lysosomes,  transcytosis  of  the  polymeric 
immunoglobulin receptor 8, Wnt gradient formation, recycling of the iron transporter DMT1 and 
processing of the amyloid precursor protein in neuronal and non-neuronal cells (Arighi et al., 
2004;  Vergés  et  al.,  2004;  Coudreuse  et  al.,  2006;  Muhammad  et  al.,  2008;  Tabuchi  et  al., 
2010). This is consistent with the retromer complex functioning in a general transport pathway 
that is essential for the retrieval or recycling of transmembrane proteins. Our demonstration that 
the GlyRβ subunit binds directly to Vps35 provides the first evidence for a role of the retromer 
complex in  the retrieval or recycling of synaptic receptors. We also found by using Western 
blotting that Vps35 is expressed in spinal cord tissue, and by immunocytochemistry that Vps35 
is present in the soma and along processes of cultured spinal cord neurons. These findings 
support  the  concept  of  retromer-mediated  transport  of  GlyRs  in  the  spinal  cord.  Future 
experiments should show whether Vps35 binding is restricted to GlyRs or also occurs with other 
inhibitory receptors, such as GABAARs or the excitatory NMDARs and AMPARs.  
The generation of Vps26 -/- mice has shown that mice homozygous for the inactive Vps26 allele 
present  gross  developmental  abnormalities  and  are  not  viable  (Lee  et  al.,  1992).  Moreover, 
analysis of the heterozygous animals has revealed that reduced protein levels of Vps26 cause a 
secondary reduction of Vps35, leading to retromer deficiency. Behavioural studies performed in 
the  heterozygous  Vps26  -/-  mice  indicate  that  retromer-deficient  animals  have  a  defect  in 
hippocampus-dependent memory formation but no motor, sensory or motivational deficits. The 
investigation of inhibitory receptor distribution in these retromer-deficient mice should help to DISCUSSION 
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disclose a putative role of the retromer in synaptic receptor trafficking and elucidate the roles of 
the retromer complex in synaptic receptor clustering and neurotransmission.  
Expression of the Vps35 gene in the grey matter of mouse spinal cord is documented by in situ 
hybridization  data  in  the  Allen  Brain  Atlas  (http://mousespinal.brain-
map.org/gene/detail/Vps35.html).  The  immunocytochemical  work  performed  here  proves  the 
presence of Vps35 protein in neuritic processes of spinal cord neurons. Future analyses of the 
subcellular  localization  of  Vps35  by  electron  microscopy  might  clarify  whether  the  retromer 
complex  is  synaptic  or  perisynaptically  localized,  next  to  postsynaptic  structures  or  in 
subsynaptic vesicles. Similarly, histological studies might establish the expression pattern of this 
protein in the CNS and resolve whether the involvement of the retromer complex in synaptic 
receptor trafficking is brain region-dependent.  DISCUSSION 
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5.3  Nbea 
5.3.1  Nbea interacts with the GlyRβ subunit 
Nbea was initially identified as a neuron specific A-kinase anchoring protein (AKAP) (Wang et 
al., 2000). Nbea interacts with the type II regulatory subunit of protein kinase A (PKA), which has 
been the unique interaction partner known so far. In this thesis, the GlyRβ subunit was identified 
as a binding partner of Nbea, which binds to 49 aa, from position 378 to 426, of the GlyRβ 
intracellular loop. However, the Nbea domain responsible for the binding to the GlyRβ subunit 
could not be mapped during the time available. The in vitro results presented here show that 
both  the  NbeaBCD  and  NbeaEFG  fragments  interact  with  the  GlyRβloop.  This  suggests  the 
presence  of  multiple  binding  sites  for  GlyRβ  binding  in  Nbea.  Future  mapping  experiments 
should reveal whether the interaction of Nbea with the GlyR depends on single domain-ligand 
recognition or involves the interaction of multiple domains of Nbea with the GlyRβloop.  
Investigation of the interaction of Nbea with PKA has revealed that a short sequence of 19 aa in 
the NbeaB domain is responsible for binding to the type II regulatory subunit of PKA (Wang et 
al., 2000). NbeaB as well as NbeaD domains share low similarity with the Nbea isoform BGL 
which  might  explain  the  specific  Nbea-PKA  interaction  in  neurons.  Similarly,  the  NbeaB  and 
NbeaD domains might be the regions implicated in specific Nbea-GlyRβ loop interaction. Further 
analysis  of  a  putative  interaction  between  BGL  and  the  GlyRβ  loop  should  help  to  disclose 
whether the GlyRβ interaction with BEACH domain-containing proteins is restricted to Nbea. 
5.3.2  Synaptic localization of Nbea  
The distribution of Nbea in the CNS had been investigated previously by immunocytochemistry 
both at the light and electron microscopic level in forebrain regions such as the hippocampus 
(Wang et al, 2000). Additionally, the expression of the Nbea gene has been analyzed in the 
mouse brain by in situ hybridization (http://mouse.brain-map.org/brain/Nbeal2.html?ispopup=1). 
However, the presence of Nbea protein in spinal cord had not been studied. Here, the antibody 
employed in immunocytochemical studies by Wang et al. was used to investigate the localization 
of Nbea in spinal cord neurons. Nbea expression was demonstrated by Western blotting (data 
not  shown)  and  immunocytochemistry ( see  4.3.2)  in  spinal  cord  neurons.  Additionally, DISCUSSION 
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examination of the staining pattern revealed that Nbea is found in the neuronal somata and 
along neurites in hippocampal as well as spinal cord neurons (see 4.3.2).  
The immuno-electron microscopic analysis performed by Wang et al. (2000) has revealed Nbea 
near the TGN in rat cerebellar neurons. In agreement with this, colocalization experiments using 
antibodies specific for Nbea and the TGN-marker TGN38 showed that Nbea displays a near 
TGN localization in the soma and along neuronal processes of hippocampal neurons (see 4.3.2). 
In  addition  to  being  present  near  the  TGN,  Nbea  immunoreactivity  has  been  also  reported 
previously at subpopulations of synapses near postsynaptic plasma membranes (Wang et al., 
2000). However, a preferential association of Nbea with excitatory or inhibitory synapses had not 
been  examined.  This  work  shows  for  the  first  time  that  Nbea  staining  is  apposed  to  both 
excitatory and inhibitory synaptic markers (see 4.3.2), indicating that Nbea does not display a 
preferential  localization  at  distinct  synapses.  Consistent  with  this  result,  recent 
electrophysiological studies performed in the Nbea -/- mice have shown that excitatory as well 
as inhibitory postsynaptic currents are impaired (Medrinah et al., 2009), suggesting a role of 
Nbea at both types of synapses.  
5.3.3  A role of Nbea in GlyR trafficking? 
Nbea is a member of the BEACH domain family of proteins. Homologs of this family such as the 
lysosomal trafficking regulator (LYST) have been proposed to mediate the subcellular targeting 
of membrane proteins (Nagle et al., 1996; Faigle et al 1998). Nbea -/- mice show reduced levels 
of a subset of synaptic proteins and reduced numbers of synaptic contacts (Medrinah et al., 
2009). This suggests a general role of Nbea in synapse formation and function. The results 
presented here revealed a direct interaction of Nbea with the GlyRβ subunit, and colocalization 
immunocytochemistry  supports a n  accumulation  of  Nbea  at  inhibitory  synapses  (see  4.3). 
Together these results are in agreement with a synaptic function of Nbea, which involves direct 
interactions  with  membrane  receptors.  However,  the  analysis  of  GlyR  contents  by  Western 
blotting  showed  that  receptor  levels  are  not  affected  upon  Nbea  knockout  (Medrinah  et  al., 
2009). This indicates that Nbea is not involved in GlyR degradation pathways. Whether Nbea is 
indeed involved in GlyR trafficking pathways needs further investigation, in particular a careful 
analysis of receptor surface expression. So far, functions of Nbea in the trafficking of different 
types of inhibitory and excitatory receptors remain speculative.  BIBLIOGRAPHY 
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Zusammenfassung 
 
An  chemischen  Synapsen  findet  die  Reizweiterleitung  durch  präsynaptische 
Neurotransmitterausschüttung  in  den  synaptischen  Spalt  statt,  wo  durch  Rezeptoren  in  der 
postsynaptischen  Plasmamembran  aktiviert  werden.  Glyzin  und  γ-Aminobuttersäure  (GABA) 
sind  die  häufigsten  inhibitorischen  Neurotransmitter  im  Zentralnervensystem  der  Säuger.  Sie 
aktivieren Glyzinrezeptoren (GlyR) und Typ A GABA-Rezeptoren (GABAAR), ligandengesteuerte 
Chloridkanäle,  an  inhibitorischen  Synapsen.  Eine  schnelle  synaptische  Reizweiterleitung 
erfordert, dass diese Rezeptoren an der Postsynapse in räumlich präzise angeordneten Clustern 
gegenüber der präsynaptischen Endigung organisiert sind. An inhibitorischen Synapsen werden 
diese  Cluster  von  Glyzin-  und  GABAA-Rezeptoren  in  der  postsynaptischen  Plasmamembran 
durch das Gerüstprotein Gephyrin verankert. 
GlyR  bestehen  aus  α-  und  β-Untereinheiten,  die  entweder  α-Homopentamere  oder  α2β3-
Heteropentamere  bilden.  Gephyrin  verankert  heteropentamere  GlyR  an  postsynaptischen 
Endigungen durch die direkte Bindung an die große intrazelluläre Schleife (Loop) zwischen den 
Transmembrandomänen 3 und 4 der GlyRβ-Untereinheit (GlyRβ-Loop). GlyR können zusammen 
mit Gephyrin auch extrasynaptisch gefunden werden. Diese GlyR-Gephyrin-Komplexe werden 
sowohl  in  anterograder  als  auch  in  retrograder  Richtung  entlang  von  Mikrotubuli  durch  die 
Interaktion  von  Gephyrin  mit  den  Transportproteinen  Kinesin-5  beziehungsweise  Dynein 
transportiert.  Zusätzlich  können  GlyR  lateral  in  der  Plasmamembran  diffundieren.  Diese 
Diffusionsdynamik  kann  durch  synaptisches  oder  extrasynaptisches  Gephyrin  beeinflusst 
werden,  was  die  Bildung  von  GlyR-Gephyrin-Komplexen  durch  laterale  Diffusion  in  der 
Plasmamembran nahelegt.  
Gephyrin  ist  bislang  der  einzige  beschriebene  Bindungspartner  der  GlyRβ-Untereinheit.  Um 
tiefere  Einblicke  in  die  molekulare  Organisation  inhibitorischer  glyzinerger  Postsynapsen  zu 
bekommen, wurden affinitätschromatographisch aus Rattenhirn drei weitere Bindungspartner für 
den  GlyRβ-Loop  isoliert  und  über  Massenspektrometrie  identifiziert:  synaptisches  Dynamin-
bindendes Protein (Sdp) I, vakuoläres Sortierungsprotein 35 (Vps35) und Neurobeachin (Nbea). 
In  dieser  Arbeit  wurden  die  Interaktionen  dieser  Proteine  mit  GlyRβ  genauer  analysiert  und 
charakterisiert.  ZUSAMMENFASSUNG 
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Die Sdp-Proteinfamilie besteht aus drei Isoformen (Sdp I, II, III) und zwei Spleißvarianten 
von SdpII (SdpII-S und –L). Das Sdp-Protein besitzt eine F-BAR- und eine SH3-Domäne und ist 
in die Endozytose und das Recycling von Vesikeln involviert. Die F-BAR-Domäne ist an der 
Induktion und Stabilisierung von Membranwölbungen beteiligt, wohingegen die SH3-Domäne mit 
Prolin-reichen Domänen (PRD) verschiedener zytosolischer Proteine wie z.B. Dynamin und dem 
neuronalen  Wiskott-Aldrich  Syndrom-Protein  interagiert.  In  Hippocampusneuronen  spielt  SdpI 
außerdem  eine  Rolle  in  der  Endozytose  und  beim  Entfernen  von  NR3A-Untereinheiten-
enthaltenden N-Methyl-D-aspartat-Rezeptoren von der Synapse. 
In  immunzytochemischen  Experimente  wurde  beobachtet,  dass  sowohl  SdpI  als  auch  beide 
SdpII-Spleißvarianten  mit  der  GlyRβ-Untereinheit  in  COS7-Zellen  kolokalisieren. 
Bindungsexperimente  mit  bakteriell  exprimierten  Glutathion-S-Transferase  (GST)-
Fusionsproteinen  und  His6-markierten  Proteinen  bestätigten,  dass  SdpI  und  beide 
Spleißvarianten von SdpII mit dem GlyRβ-Loop in vitro interagieren. Über die Generierung von 
verschiedenen  Deletionskonstrukten  konnte  die  SdpI-Bindungsstelle  auf  22  Aminosäuren 
eingeengt  werden.  Peptid-Kompetitionsexperimente  bestätigten  die  Spezifität  der  Interaktion 
zwischen SdpI und dem GlyRβ-Loop.  
Durch  die  Analyse  von  Punktmutationen  konnte  eine  Prolin-reiche  Sequenz  als  SdpI-
Bindungsstelle der GlyRβ-Untereinheit identifiziert werden. Da die Bindungsstellen für Gephyrin 
und SdpI sehr dicht beieinander im GlyRβ-Loop liegen, wurde der Einfluss der Gephyrin- auf die 
SdpI-Bindung an den GlyRβ-Loop untersucht. In Protein-Kompetitionsstudien wurde bestätigt, 
dass  die  E-Domäne  von  Gephyrin  mit  dem  GlyRβ-Loop  um  die  SdpI-Bindung  konkurriert. 
Darüber  hinaus  wurde  eine  mögliche  Interaktion  zwischen  SdpI  und  Gephyrin  untersucht. 
Bindungsexperimente in Säugerzellen zeigten, dass SdpI und beide SdpII-Spleißvarianten mit 
Gephyrin interagieren. 
Außerdem wurde eine mögliche Funktion von SdpI in der Regulation der Verteilung synaptischer 
GlyR  untersucht.  Dabei  wurde  eine  partielle  Kolokalisation  von  SdpI  mit  verschiedenen 
inhibitorischen und exzitatorischen synaptischen Markern in kultivierten Rückenmarksneuronen 
detektiert.  Die  Anzahl  der  SdpI-immunreaktiven  Puncta,  die  mit  inhibitorischen  und 
exzitatorischen synaptischen Markern kolokalisierte, war ähnlich groß, was demonstriert, dass 
SdpI an beiden Synapsentypen vorhanden ist. 
Bei  Ko-Immunpräzipitationsexperimenten  mit  SdpI-spezifischen  Antikörpern  wurde  eine 
endogene  SdpI-GlyR  Assoziation  in  der  vesikulär-angereicherten  Fraktion  aus ZUSAMMENFASSUNG 
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Rückenmarksgewebe der Ratte beobachtet. Dennoch zeigten Studien SdpI-defizienter Mäuse, 
dass die GlyR-Verteilung sowohl in kultivierten Rückenmarksneuronen als auch im Hirnstamm 
beim  Fehlen  von  SdpI  nicht  signifikant  verändert  ist.  Wegen  möglicher  kompensatorischer 
Effekte durch die beiden weiteren Sdp-Isoformen und andere Proteintransportwege in diesen 
Experimenten wurden zusätzlich SdpI-Knockdown Experimente durchgeführt. In der Tat führte 
der  rAAV-Virus-vermittelte  Knockdown  von  SdpI  mit  SdpI-spezifischer  shRNA  in  kultivierten 
Rückenmarksneuronen von Ratten zu einer klaren Reduktion der Dichte und Größe von GlyR-
Clustern. Durch die Überexpression shRNA-resistenter SdpI-Proteine konnte die ursprüngliche 
Anzahl  und  Größe  der  GlyR-Cluster  wiederhergestellt  werden.  Weitere  immunzytochemische 
Analysen  zur  Verteilung  von  Gephyrin,  der  GABAARγ2-Untereinheit  und  des  vesikulären 
inhibitorischen Aminosäuretransporters unter SdpI-Knockdown Bedingungen zeigten zusätzlich, 
dass die Anzahl und die Größe von GABAARγ2-Untereinheiten-beinhaltenden GABAAR Clustern 
signifikant  reduziert  war.  Diese  Ergebnisse  weisen  auf  eine  mögliche  Rolle  von  SdpI  im 
intrazellulären Transport inhibitorischer Neurotransmitterrezeptoren hin. Weiterhin könnte SdpI 
notwendig  für  die  synaptische  Clusterbildung  von  GABAARγ2-Untereinheiten-beinhaltenden 
GABAAR in Rückenmarks- und Hirnstammneuronen sein.  
 
Die Übermittlung von verschiedenen Rezeptortypen vom Endosom zum Golgi-Apparat 
wird  in  allen  eukaryontischen  Zellen  von  Hefe  bis  zu  den  Säugern  vom  sogenannten 
Retromerkomplex vermittelt. Dieser Retromerkomplex besteht aus zwei Unterkomplexen, dem 
die Fracht erkennenden Unterkomplex aus Vps35, Vps29 und Vps26, und dem Sortin-Nexin-
Komplex,  der  in  Hefe  aus  Vps5p  und  Vps17p  aufgebaut  ist.  Vps35  ist  innerhalb  des 
Retromerkomplexes  für  die  Erkennung  der  zytoplasmatischen  Aminosäuresequenzen  der  zu 
transportierenden  Rezeptoren  zuständig.  In  dieser  Arbeit  wurde  über  GST-Pulldowns 
nachgewiesen,  dass  Vps35  in  vitro  mit  dem  GlyRβ-Loop  und  Gephyrin  interagiert.  Um  die 
Verteilung  von  Vps35  im  ZNS  untersuchen  zu  können,  wurden  spezifische  polyklonale 
Antikörper gegen Vps35 hergestellt und charakterisiert. Mit diesen Antikörpern konnte Vps35 im 
Soma  und  entlang  der  Neuriten  von  Rückenmarksneuronen  detektiert  werden,  was  auf  eine 
mögliche Interaktion zwischen Vps35 und GlyR unter physiologischen Bedingungen hindeutet.  
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Nbea ist ein Proteinkinase A-bindendes neuronales Protein mit einer BEACH-(Beige and 
Chediak Higashi Syndrome) Domäne, das in den neuronalen Membrantransport impliziert ist. 
Interaktionsstudien mit GST-Pulldowns zeigten, dass zwei Fragmente von Nbea an den GlyRβ-
Loop  binden.  Immunzytochemische  Experimente  bestätigten  die  somatische  und  synaptische 
Lokalisation  von  Nbea  in  Primärkulturen  von  Rückenmarksneuronen.  Außerdem  wurde  eine 
teilweise Kolokalisation von Nbea mit inhibitorischen synaptischen Markern gefunden, was ein 
Indiz für eine mögliche Interaktion zwischen Nbea und dem GlyR an inhibitorischen Synapsen in 
Rückenmark und Hirnstamm ist.  
Zusammenfassend kann gesagt werden, dass SdpI, SdpII, Vps35 und Nbea als neue 
Bindungspartner der GlyRβ-Untereinheit identifiziert und näher charakterisiert werden konnten. 
Zusätzlich konnte gezeigt werden, dass SdpI, SdpII und Vps35 ebenfalls mit dem Gerüstprotein 
Gephyrin  interagieren.  Immunzytochemische  Experimente  weisen  darauf  hin,  dass  SdpI  und 
Nbea  an  inhibitorischen  und  exzitatorischen  Synapsen  lokalisiert  sind.  Über  die  Etablierung 
eines Antikörpers gegen Vps35 konnte dessen Lokalisation im Soma und entlang der Neuriten 
von  Rückenmarksneuronen  demonstriert  werden.  Die  Charakterisierung  der  Interaktion 
zwischen SdpI und der GlyRβ-Untereinheit ergab, dass die SH3-Domäne von SdpI mit einer 
Prolin-reichen  Sequenz  der  GlyRβ−Untereinheit  interagiert.  Die  SdpI-Knockdown  Ergebnisse 
sind ein starker Hinweis auf eine Rolle von SdpI in der Clusterbildung von GlyR- und GABAARγ2-
Untereinheiten beinhaltenden GABAAR-Komplexen an inhibitorischen Synapsen. Die Ergebnisse 
dieser Arbeit liefern erste Hinweise auf die Funktion und Regulation des GlyR an inhibitorischen 
Synapsen  durch  diese  neu  identifizierten  Interaktionspartner.  Spätere  Analysen  könnten  die 
exakte  Funktion  dieser  Proteine  sowohl  im  intrazellulären  Transport  als  auch  in  der  GlyR-
Clusterbildung aufdecken.  
 ACKNOWLEDGMENTS 
  134 CURRICULUM VITAE 
  135 
 ERKLÄRUNG 
  136 
 
Erklärung 
 
Die anfänglichen Mapping und GST-Pulldown Experimente von SdpI wurden von Dr. I. 
Paarmann  in  der  Abteilung  Neurochemie  des  Max-Planck-Instituts  für  Hirnforschung 
durchgeführt (siehe Seiten 58 und 59). 
 
 
 
 
 
 
 
 
 
Ich erkläre hiermit, dass ich diese Doktorarbeit selbständig verfasst und keine anderen als 
die angegebenen Quellen und Hilfsmittel verwendet habe. 
 
 
Frankfurt am Main, den………………….       _______________________ 
                               Isabel del Pino Pariente 